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Major histocompatibility complex (MHC) class II associated invariant chain is a chaperone of the 
mammalian MHC class II antigen presentation pathway.  It is responsible for targeting the MHC class 
II dimer to the endocytic pathway, which allows for the loading of exogenous antigens onto the MHC 
class II receptor.  Two genes showing significant sequence similarity to the mammalian invariant 
chain gene have been identified in rainbow trout.  S25-7 and INVX are thought to play a role within 
the teleost MH class II antigen presentation pathway similar to that performed by the mammalian 
invariant chain.  In vivo and in vitro methods have been used to investigate the regulation of these 
genes upon immune system activation.  To induce an immune response both rainbow trout and the 
macrophage-like cell line RTS-11 were treated with phorbol myristate acetate (PMA).  PMA is a 
stimulator of protein kinase C, which is involved in the activation of both B and T cells.  After PMA 
treatment, individuals were sacrificed at several time points and tissues were collected for analysis.  
Up-regulation of IL-1β transcript, as detected by RT-PCR analysis, demonstrated the successful 
induction of an immune response in vivo.  S25-7 transcript levels remained unchanged in gill, spleen, 
peripheral blood leukocytes and liver.  However, the transcript was found to be significantly 
decreased in head kidney beginning 24 hours post-stimulation.  INVX transcript levels remained 
unchanged in all tissues analyzed.  In addition, the level of S25-7 transcript is higher in all tissues 
than INVX transcript.    
Western blot analysis detected both S25-7 and INVX proteins within gill and spleen, indicating the 
presence of cell populations capable of presenting extracellular antigen within the MH class II dimer.  
Similar to transcript analysis, the level of invariant chain in these tissues remained unchanged during 
immune system activation.  Neither INVX nor S25-7 was detected in head kidney, indicating this 
tissue may not function as a secondary immune tissue, as previously thought.  Finally, western blot 
analysis failed to detect either INVX or S25-7 protein within liver, as expected in a non-immune 
tissue.   
RTS11 analysis demonstrated a similar pattern of invariant chain expression in vitro.  S25-7 
transcript levels remained stable throughout the PMA stimulation time course, while INVX transcript 
was down-regulated at 48 and 96 hours post-stimulation, with a subsequent increase at 168 hours.  
However, both S25-7 and INVX protein levels remained unchanged during immune stimulation. 
These results demonstrate a pattern of invariant chain tissue expression, providing information 
about the type of immune functions carried out at these sites.  In addition, the results indicate that 
 
 iv 
neither INVX nor S25-7 is up-regulated, at either the transcript or protein level upon immune system 
activation.  This is in contrast to the mammalian invariant chain, which is up-regulated at both the 
transcript and protein level during an immune response, indicating that teleosts have evolved a unique 
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1.1 General Overview of the Vertebrate Immune System 
Leukocytes are the effector cells of the immune system and are responsible for the elimination of 
foreign pathogens.  In mammals these cells are produced within bone marrow from a multipotent 
stem cell precursor (Kaushansky, 2006).  These stem cells undergo a number of differentiation 
processes to give rise to a variety of cell populations, including monocytes, neutrophils, eosinophils, 
basophils, T cells, B cells and natural killer (NK) cells, which are all involved in the immune 
response.  The bone marrow is known as a primary immune organ because immune cells mature 
within this tissue.  In teleosts, the head kidney functions as a primary immune organ as it is the site of 
hematopoiesis (Fange, 1986).  In addition, the thymus also serves as a primary immune organ in both 
mammals and teleosts as the site of T cell maturation (Janeway et al, 2001, Press and Hansen, 1999). 
Mature immune cells exit the primary immune organs and enter circulation.  These cells migrate 
throughout the body to provide constant surveillance for potential pathogens.  Upon infection, the 
circulating B and T cells must be activated to respond to the pathogen.  In mammals, this activation 
occurs within the lymph nodes and the spleen, which are known as secondary immune organs.  
Within teleosts, the spleen and head kidney are thought to function as secondary immune organs 
(Press and Evensen, 1999, Kaattari and Irwin, 1985)   
Upon exposure to a pathogen, the first line of defense is the effector cells of the innate immune 
system.  A number of these cells are phagocytic and capable of ingesting and degrading pathogens.  
In addition, many innate effectors cells express Toll-like receptors (TLR) that recognize conserved 
structures on pathogen surfaces (Tosi, 2005).  When a TLR binds to a pathogen, a signaling cascade 
pathway is initiated, resulting in the expression of a number of genes involved in the immune 
response.  Many activated cells express cytokines and chemokines, small secreted proteins, which can 
recruit and activate other immune cells (Janeway et al, 2001). 
In cases where the innate immune system is unable to eliminate a pathogen, the adaptive immune 
system is recruited and activated.  The effector cells of the adaptive immune system are the B 
lymphocytes and T lymphocytes.  These cells express surface receptors which bind to foreign protein 
fragments.  During cellular maturation, genes encoding the B cell and T cell receptors undergo a 
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series of recombination events, which leads to the generation of a large number of cells capable of 
recognizing very diverse ligands (Janeway et al¸2001).  Thus, these cells are able to bind and activate 
a response against a very large number of foreign peptides.  The B lymphocytes are responsible for 
humoral immunity.  These cells synthesize and secrete antibodies upon stimulation by a specific 
pathogen.  The secreted antibodies coat pathogen surfaces to inhibit entry into a target cell and also 
facilitate phagocytosis and destruction of pathogen by macrophage, a type of innate effector cell. 
Once a pathogen has entered a cell, antibodies are no longer able to control the infection.  In this 
case, T lymphocytes, the effectors of cellular immunity, are required.  These cells are able to mediate 
the specific killing of infected cells, to prevent the proliferation and spread of the pathogen.  There are 
two types of T cells, identified as CD4+ or CD8+, depending on which of these cell surface molecules 
are expressed.  The CD8+ T cells are cytolytic cells and are responsible for the killing of infected 
cells, while the CD4+ T cells are helper cells which synthesize and secrete a number of factors that 
maintain an immune response.   
T lymphocytes express surface receptors, the T cell receptors, which are activated upon the 
specific binding of a small foreign peptide fragment present on the surface of target cells.  These 
peptides are presented by the MHC proteins, which are surface-bound heterodimers that interact with 
both the T cell receptor and the co-receptor molecules CD4 and CD8.  The interaction of CD4 and 
CD8 with the MHC proteins differentiates between the target cells recognized by each T cell subtype.  
The CD8+ T cells bind to MHC class I proteins, which are present on all nucleated cells, allowing any 
cell with the potential for a pathogen infection to activate a cytolytic response.  On the other hand, the 
CD4+ T cells are helper cells and are activated by a small population of cells known as antigen 
presenting cells (APCs), which express MHC class II.  These cells are able to endocytose pathogens, 
cleave pathogenic proteins into small peptides and present these peptides to activate CD4+ T cells.  
Macrophage, dendritic cells and B cells are the major antigen presenting cells (Janeway et al, 2001). 
The CD4+ T cells are further divided into the TH1 and TH2 subpopulations, which are defined by 
the repertoire of cytokines produced.  TH1 cells produce IL-2 and IFNγ, which are required for the 
proliferation of CD8+ T cells as well as for the activation of macrophage (Wang, 2001; Pardoll and 
Topalian, 1998).  TH2 cells express IL-4, IL-5 and IL-10, which are involved in the activation of B 
cells (Janeway et al, 2001).  In addition, the cytokines produced by TH1 cells inhibit TH2 cell 
responses and vise versa.  Once a specific response is induced, the activated TH cells stimulate this 
response while simultaneously suppressing the other response.  
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1.2 The Major Histocompatibility Complex 
The MHC, or major histocompatibility complex, is a region of DNA which encodes a number of 
genes involved in the presentation of foreign peptides to T lymphocytes (Williams, 2001).  In 
humans, the MHC is located on chromosome 6 and in mice it is located on chromosome 17 (Janeway 
et al, 2001).  This region encodes the MHC class I and MHC class II genes, along with various 
accessory molecules for these antigen presentation pathways as well as a number of non-related genes 
(Williams, 2001).  Since these genes are located together on the same chromosome, they are linked 
and will be inherited as a set by offspring.    
The MHC class I and MHC class II genes are highly polymorphic, with the majority of the 
polymorphism occurring within sequences encoding the peptide binding groove (Williams, 2001).  
Both MHC receptors are heterodimers, with MHC class I being composed of an α-chain bound to β2-
microglobulin while the MHC class II is composed an α-chain and β-chain.  The peptide binding 
groove is formed by the α1 and α2 domains in MHC class I and the α1 and β1 domains in MHC class 
II, thus the majority of the polymorphism is found within these regions (Williams, 2001).  This 
peptide binding groove polymorphism allows binding of a wide variety of peptides by MHC alleles.  
In humans, the inheritance of three MHC class I heavy chain genes and three MHC class II loci from 
each parent results in a total of 6 alleles for each MHC class, and the gene polymorphism increases 
the chance that each allele will bind a different peptide repertoire.  Thus, the MHC is capable of 
presenting a diverse selection of peptides to T lymphocytes. 
The segregation of the MHC class I and MHC class II antigen presentation pathways results in a 
distinct set of peptides presented for CD8+ and CD4+ T cells activation, as shown in figure 1.1.  MHC 
class I presents a variety of intracellular peptides, which allows CD8+ T cells to detect infected cells 
(Janeway et al, 2001).  In contrast, MHC class II presents extracellular peptides, as antigen presenting 
cells endocytose and process extracellular pathogens to activate a CD4+ T cell response without being 
directly infected by the pathogen.  The distinction between class I and class II is essential for the 
activation of the proper effector function. 
1.2.1 MHC Class I Antigen Presentation Pathway 
As stated above, MHC class I is present on the surface of all nucleated cells and is responsible for the 
presentation of intracellular peptides.  Peptide loading of MHC class I occurs within the endoplasmic 
reticulum, as shown in figure 1.1.  The newly synthesized MHC class I heavy chain and β2- 
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Figure 1.1:  Schematic representation of MHC antigen presentation pathways.  (A) An overview 
of the MHC class II pathway is shown on the left side of this figure (Li et al, 2005).  After associating 
with the invariant chain in the ER, the MHC class II complex travels through the Golgi apparatus and 
enters the endosomal pathway. The class II dimer traffics through multiples intracellular pathways to 
maximize the variety of antigens loaded into the peptide binding groove.  Pathway 1 represents the 
direct transport from the Golgi apparatus into lysosomal compartments, while pathway 2 represents 
the transport of the complex to the cell surface, followed by endocytosis of this complex into early 
endosomal compartments.  Pathway 3 represents the transport of the complex from the Golgi 
apparatus through the early endosomes.  Finally, pathway 4 represents the endocytosis of mature 
loaded MHC class II dimers from the cell surface for reloading with new antigen.  Upon exposure to 
antigens, the CLIP peptide is exchanged for antigenic peptide by the chaperone DM.  The loaded 
class II complex then travels to the cell surface to activate CD4+ T cells.  (B) The MHC class I 
antigen presentation pathway is summarized on the right side of this diagram.  Proteins present in the 
cytoplasm are degraded by the proteasome and transported into the ER by the transporter associated 
with antigen presentation (TAP).  The peptide antigens are then loaded into the peptide binding 


















microglobulin initially interact with the ER chaperone calnexin, which facilitates the assembly of the 
class I complex (Ahluwalia et al, 1992).  Once this complex has formed, calnexin dissociates and is 
replaced by the ER chaperones calreticulin and Erp57, as well as the protein tapasin (Pamer and 
Cresswell, 1998).  Tapasin is responsible for the association of the empty MHC class I complex with 
the TAP transporter, which transports short peptides from the cytosol into the ER.  These peptides are 
produced by proteasome-mediated degradation of cytosolic proteins (Pamer and Cresswell, 1998).  
Once an empty class I dimer has bound an antigenic peptide, the loaded complex dissociates from the 
ER chaperones and travels through the Golgi apparatus to the cell surface.  Expression of MHC class 
I genes, as well as TAP and some proteasome subunits are upregulated by IFNγ, which is expressed 
by virally infected cells (Janeway et al, 2001).  Thus, the cellular response to viral infection is the 
induction of the MHC class I antigen presentation pathway, leading to an increased expression of 
foreign peptide at the cell surface to activate cytolytic CD8+ T cells. 
1.2.2 MHC Class II Antigen Presentation Pathway 
The MHC class II is present on the surface of antigen presenting cells and is responsible for the 
presentation of extracellular peptides.  The loading of these peptides occurs within endosomal 
vesicles.  To begin, the α- and β- chains are translated and transported into the endoplasmic reticulum, 
where they rapidly associate with the ER chaperone calnexin (Anderson and Cresswell, 1994).  The 
MHC class II dimer then binds to another chaperone, the MHC class II associated invariant chain 
(Anderson and Miller, 1992).  Calnexin remains associated with both the MHC class II dimer and the 
invariant chain until a nonomeric complex is formed consisting of an invariant chain trimer bound to 
three class II dimers (Anderson and Cresswell, 1994).  Once the nonamer has formed, calnexin 
dissociates and the complex traffics out of the endoplasmic reticulum, through the Golgi apparatus 
and enters the endocytic pathway, where antigen loading can occur.     
There are four possible pathways for the intracellular transport, which are shown in figure 1.1.  
Cellular fractionation experiments of B lymphoblasts show that MHC class II is located within the 
early and late endosomes as well as lysosomes, indicating that MHC class II traffics through the 
endosomal pathway (Castellino and Germain, 1995).  The complex may travel from the Golgi 
apparatus to the cell surface, where it is rapidly endocytosed, or it may travel directly to the 
endosomal pathway, entering either an early endosome or a lysosomal compartment (Roche et al, 
1993; Brachet et al, 1999; Pond and Watts, 1999; Peters et al, 1991).  The major pathway for MHC 
class II trafficking likely involves direct entry into the endosomal pathway, while a minor pathway 
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consists of uptake from the cell surface or direct entry into a lysosomal compartment, since the 
removal of early endosomes greatly decreases the production of stable class II dimers (Brachet et 
al,1999).  Finally, another minor trafficking pathway involves the recycling of mature MHC class II 
dimers from the cell surface.  Evidence for this minor pathway is demonstrated in studies of truncated 
MHC class II dimers lacking the internalization signals in the cytoplasmic domain (Pinet et al, 1995).  
Some antigenic peptides are not presented by the truncated dimer but are presented by the full length 
dimer.  These results indicate that some mature MHC class II complexes may be internalized from the 
cell surface independent of invariant chain and loaded with new peptides.  This ability to enter several 
endosomal and lyosomal compartments likely increases the variety of antigens presented by the MHC 
class II dimer. 
As the MHC class II - invariant chain complex travels through the endosomal pathway, the 
invariant chain is degraded in a stepwise manor by a number of proteases found within various 
endosomal compartments (Villadangoes et al, 1999).  The initial cleavage removes the trimerization 
domain, resulting in the Iip22 peptide (Villadangoes et al, 1999).  Next, another large portion of the 
extracellular domain is cleaved off, giving the Iip10 peptide, which consists of only the CLIP domain 
and the N-terminal region.  The final cleavage leaves only the CLIP associated with the MHC class II 
peptide binding groove.  This stepwise degradation is essential for the removal of invariant chain 
from the class II dimer and the subsequent loading of antigen into the peptide binding groove. 
The cleavage of invariant chain is carried out by a variety of cellular proteases, including the 
asparagine-specific endopeptidase (AEP) as well as a number of cysteine proteases, specifically 
cathepsin S and cathepsin L (Lautwein et al, 2004; Villadangoes et al, 1999).  While the proteases 
involved in the initial steps of invariant chain degradation have not yet been identified, knockout 
studies have illustrated the essential roles played by cathepsin L (Cat L) and Cat S in the cleavage of 
Iip10 to CLIP.  These two proteases are differentially expressed, with Cat S being expressed in B 
cells, dendritic cells and macrophages while Cat L is expressed by macrophage and cortical thymic 
epithelial cells (cTECs) (Lennon-Dumenil et al, 2002).  MHC class II dimers remain bound to Iip10 
in cTECs of Cat L deficient mice resulting in an impaired in CD4+ T cell selection, while the MHC 
class II – Iip10 complex is found in dendritic cells and B cells in Cat S deficient mice (Nakagawa et 
al, 1999).  Studies have shown that active AEP, Cat S and Cat L are all located in late endosomal 
structures, which matches well with results showing that the invariant chain is mostly intact in within 
the early endosomal compartments, while it is present at a much lower level in late endosomal 
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structures (Romagnoli et al, 1993; Lautwein et al, 2004).  Thus, as the invariant travels into the late 
endosomal structures, it undergoes proteolytic cleavage until only the CLIP domain remains bound 
the MHC class II dimer.   
In addition to the processing of the invariant chain, antigenic proteins from the extracellular space 
must also be degraded into short peptide of approximately 13-17 amino acids for loading into the 
peptide binding groove of the MHC class II dimer (Janeway et al, 2001).  Antigen presenting cells 
can take up antigen by nonspecific endocytosis or by receptor mediated endocytosis (Wolf Bryant et 
al, 2002).  The antigens enter the endocytic pathway where they encounter the same variety of 
proteases that are responsible for invariant chain degradation (Lennon-Dumenil et al, 2002).  The 
reductase GILT (γ-IFN induced lysosomal thiol reductase) is thought to be involved in the initial 
steps of disulfide bond reduction to unfold proteins (Hsing and Rudensky, 2005).  The subsequent 
steps involve both endopeptidases, which release internal epitopes, as well as exopeptidases, which 
trim the ends of the peptides (Lennon-Dumenil, 2002).  The degradation of proteins into antigenic 
peptides is carried out by a number of proteases, as evidenced by the variety of terminal residues 
found in class II bound peptides (Wolf-Bryant et al, 2002).    Studies have shown that AEP, as well as 
Cat B and Cat S are the basic requirements for complete antigen processing (Wolf-Bryant et al, 
2002).  Since invariant chain and antigenic proteins are degraded by the same types of proteases, this 
indicates that antigens are targeted to the same intracellular compartments as the MHC class II 
dimers. 
The final step in the MHC class II antigen loading pathway involves the removal of the CLIP 
peptide, which occurs within the MHC class II compartment (MIIC) (Sanderson et al, 1994).  There 
has been some debate as to the identity of the MIIC, as some believe it is a unique late endosomal-
like compartment that is not part of the endosomal pathway (Peters et al, 1991), while others argue 
that it is a classical late endosomal compartment (Castellino and Germain, 1995).   Subsequently, 
there have been some guidelines put forth to define the identity if the MIIC.  A MIIC is an acidic 
intracellular structure containing the chaperone DM and MHC class II which is accessible by bulk 
phase endocytosed or receptor mediated antigen uptake.  This compartment must have both unloaded 
and loaded MHC class II, and it must have the ability to transport MHC class II molecules to the cell 
surface (Neefjes, 1999).  It is likely that there is not one single MIIC that can be defined for all cell 
types, and both late endosomal and early lysosomal structures can be thought of as the MIIC.  Once 
the MHC class II reaches the MIIC, the CLIP must be removed from the peptide binding groove to 
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allow for the binding of an antigenic peptide.  The release of CLIP is mediated by the chaperone DM 
(Denzin and Cresswell, 1995).  This molecule is a dimer of α- chain and β- chain proteins which form 
a complex very similar in structure to MHC class II, but lacking the peptide binding groove (Mosyak 
et al, 1998).  In the absence of DM, the majority of MHC class II dimers remain associated with the 
CLIP (Denzin and Cresswell, 1995).  It is thought that DM binds to an unstable MHC class II dimer 
and stabilizes an open conformation of the peptide binding groove, facilitating the release of unstably 
bound peptides (Busch et al, 2000).  The empty MHC class II can either bind antigenic peptide or 
may aggregate with other empty class II molecules and be degraded.  In addition to the removal of 
CLIP, DM can also facilitate the removal of other peptides (Sloan et al, 1995).  In this way DM acts 
to edit the peptides presented by MHC class II to ensure the most stable binding, resulting in MHC 
class II antigen complexes with a longer half life at the cell surface.  However, there are some alleles 
of MHC class II that have a very low affinity for CLIP, and the CLIP peptide can dissociate naturally 
in the absence of HLA-DM (Busch et al, 2005).  This allows DM independent antigen loading to 
occur in endosomal structures other than the MIIC, which leads to the presentation of antigenic 
peptides that may be degraded in more acidic compartments.  Thus, it is likely that the picture of 
MHC class II intracellular transport and antigen loading is very complicated in which some DM 
independent loading can occur for certain MHC class II alleles within the early endosomal 
compartments while the majority of antigen loading occurs by a DM dependent mechanism within the 
MIIC.  After peptide loading, a vesicular intermediate forms from the MIIC and fuses with the cell 
membrane to carry the antigen loaded MHC class II complex to the cell surface (Pond et al, 1997). 
1.3 Functions of Invariant Chain 
The invariant chain is a type II transmembrane protein originally identified by co-precipitation with 
MHC class II dimers (Jones et al, 1978).  The human invariant chain is encoded by a gene located on 
chromosome 5, which is not linked to the MHC region (Claesson-Welsh et al, 1984).  The single 
invariant chain gene undergoes alternative splicing and alternative translational initiation to produce 
four different protein isoforms (Strubin et al, 1986).  As shown in figure 1.2, p35 and p43 have an 
additional 16 amino acid N-terminal sequence while p41 and p43 have an additional domain within 
the C-terminal extracellular region.  The following sections will describe the function of invariant 




Figure 1.2: Schematic representation of the various isoforms of invariant chain.   Mammalian 
invariant chain isoforms p35/33 and p43/41 are shown at the top of this figure.  In addition, the three 
invariant chain proteins from rainbow trout, INVX, S25-7 and 14-1 are also shown, along with the 
zebrafish invariant chain-like proteins, Iclp-1 and Iclp-2.  Abbreviations: TMD – transmembrane 
domain, CLIP – class II associated invariant chain peptide, TD – trimerization domain, tTD – 
truncated trimerization domain, Tg – thyroglobulin domain, RR – ER retention signal, ML, LL and IL 
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1.3.1 Chaperone that Differentiates MHC Class II from MHC Class I 
The invariant chain plays an essential role in the MHC class II antigen presentation pathway, which is 
required not only for the activation of CD4+ T cells, but also for the development of these cells 
(Janeway et al, 2001).  Mice lacking the invariant chain gene have only 30% of the normal CD4+ T 
cell population (Viville et al, 1993).  Although the animals from this study remained healthy, this is 
because they were raised in a pathogen free environment.  The greatly decreased CD4+ T cell 
population would interfere with the ability of these animals to maintain a CD8+ T cell response as 
there would be a deficient level of IL-2 production, which is needed for T cell survival.   
The major role of all isoforms of invariant chain is to act as a chaperone for the MHC class II 
dimer (Anderson and Miller, 1991).  When αβ dimers are expressed in cells in the absence of 
invariant chain, there is very slow transport of the dimers to the Golgi apparatus as the majority of 
dimers are retained in the ER.  In addition, those dimers that are eventually transported to the cell 
surface have an altered conformation compared to dimers from invariant chain expressing cells.  
Furthermore, in invariant chain knockout mice, MHC class II also has an altered conformation and 
the majority of the MHC class II is retained in the ER (Viville et al, 1993).  Thus, invariant chain is 
required for the proper folding of the MHC class II dimers and the subsequent delivery of these 
dimers out of the ER. 
It has been shown that invariant chain binds directly to the peptide binding groove and this 
interaction is required for proper folding of the dimer (Ghosh et al, 1995).  In addition to chaperone 
function, the blocking of the peptide binding groove also plays an essential role in the functional 
separation of MHC class II from MHC class I.  As described above, MHC class I is loaded with 
intracellular antigens within the ER (Pamer and Cresswell, 1998).  If the peptide binding groove of 
MHC class II remained unoccupied in the ER, it could also bind to intracellular antigens, resulting in 
an overlap in the peptide repertoire of MHC class I and MHC class II.  However, invariant chain is 
able to block the binding of peptide to MHC class II in the ER.  When empty MHC class II dimers are 
exposed to an antigen, 94% of the dimers are able to bind the peptide, however, in the presence of 
invariant chain less than 0.3% of the dimers bind to the peptide (Roche and Cresswell, 1990).  
Treatment of the MHC class II- invariant chain complex with SDS increases the ability of the dimer 
to bind to antigenic peptide and indicates that the invariant chain must be removed for the loading of 
the peptide binding groove.  Thus, binding of invariant chain to the MHC class II dimer within the ER 
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is able to block the binding of any intracellular peptides to maintain the segregation of antigens 
presented by MHC class I and MHC class II. 
1.3.2 MHC Class II Intracellular Trafficking 
Once the MHC class II dimer has bound to the invariant chain, it leaves the ER and enters the 
endosomal pathway.  The intracellular transport of MHC class II is controlled by the invariant chain 
(Lotteau et al, 1990).  When MHC class II dimers are expressed in the absence of invariant chain, the 
dimers are only found in the ER, the Golgi apparatus and at the cell surface (Lotteau et al, 1990).  
However, when the invariant chain is co-expressed, the dimer is localized to endosomal 
compartments.  In order for proper intracellular targeting, proteins must contain the proper sorting 
signal, in the absence of a sorting signal the protein will remain in the cytosol (Alberts et al, 2002).  
To identify the sorting signal in invariant chain responsible for endosomal targeting, a series of 
invariant chain proteins containing deletions of the cytoplasmic domain were constructed and 
intracellular localization was examined (Pieters et al, 1993).  The invariant chain was found to have 
two localization signals, as the deletion of residues 1-20 eliminated any endosomal localization while 
deletion of residues 1-11 or 12-20 retained endosomal localization.  To identify the specific residues 
involved in the intracellular sorting, researchers looked for similarities to other known sorting signals.  
A tyrosine based sorting signal has been identified for a number of endosomal and lysosomal resident 
proteins (Peters et al, 1990; Williams and Fukuda, 1990).  In addition, a di-leucine targeting signal 
has also been identified in studies of the T cell receptor components CD3-γ and CD3-δ (Letourneur 
and Klausner, 1992).  While there is no tyrosine based sorting signal present in the first 20 residues of 
the invariant chain, there does appear to be two leucine based signals, L7I8 and M16L17 (Bremnes et al, 
1994).  Point mutation of any of one of these residues decreased, but did not eliminate, the endosomal 
targeting of a chimeric protein (Odorizzi et al, 1994). This indicates that L7I8 and M16L17 are 
responsible for the targeting of invariant chain and the MHC class II dimer to the endosomal pathway.  
All four isoforms of invariant chain contain these residues and are able to mediate the trafficking of 
MHC class II. 
The intracellular targeting of the MHC class II invariant chain complex is dependent on the 
multimerization of the invariant chain.  After synthesis of the invariant chain, it forms a homotrimer, 
which subsequently binds three MHC class II dimers to give a nonomeric complex (Lamb et al, 1992; 
Roche et al, 1991).  Studies of invariant chain targeting show that the invariant chain must be present 
at least as a dimer for proper intracellular transport (Arneson and Miller, 1995).  This study used a 
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non-immune cell line expressing MHC class II, along with either wild type invariant chain or an 
invariant chain lacking residues 2-17.  The results show that a complex containing a single wild type 
invariant chain, and thus only one targeting sequence, targets the complex to the cell surface.  
Complexes containing more than one wild type invariant chain traffic to the endosomal pathway.  
This demonstrates that the formation of the invariant chain trimer is essential for proper intracellular 
trafficking.  
In addition to the endosomal targeting signals, the alternatively spliced p35 and p43 also have an 
ER retention sequence (Schutze et al, 1994).  When p35 is expressed alone in the absence of MHC 
class II dimers it remains in the ER, while p33 travels to the endosomal pathway (Lotteau et al, 1990). 
To identify the exact residues within the amino-terminal extension required for this retention, a series 
of deletion constructs were tested for intracellular location (Schutze et al, 1994).  Deletion of the first 
four residues eliminated the ER retention and point mutation analysis indicated that any two of the 
three arginine residues R3R4R5 are involved in retention as mutation of any one but not two of these 
residues retain ER localization.  In addition, the expression of p35 together with p33 also results in 
retention within the ER (Arunachalam et al, 1994).  Thus, as long as a single ER retention signal is 
present within an invariant chain trimer, the entire complex will remain in the ER.  This is essential to 
the role of invariant chain as a chaperone, as this ensures a pool of invariant chain will always be 
available in the ER to associate with new class II dimers.  Since p43 has the same amino-terminal 
extension, it will also mediate the ER retention of unbound invariant chain trimers. 
Once the MHC class II has been bound, the complex must overcome this ER retention signal for 
entry into the endosomal pathway.  This appears to be reliant on both the phosporylation of the 
invariant chain and also the association with MHC class II dimers.  Analysis shows that the p35 
invariant chain is phosporylated at both S6 and S8, which are not present in p33 (Anderson and Roche, 
1998).  Inhibition of phosphorylation decreases the trafficking rate of MHC class II complexes out of 
the ER.  The trafficking was not entirely blocked because p33 is also expressed and any complexes 
containing trimers of p33 are able to enter the endosomal pathway due to the absence of the ER 
retention signal.  In addition to phosphorylation, the association with the MHC class II is also 
required for the exit of the p35 invariant chain from the ER (Khalil et al, 2003).  When a truncated 
class II β chain, lacking the cytoplasmic domain is expressed along with p35, the complex is retained 
in the ER.  However, a complex of p35 with full length MHC class II proteins can exit the ER.  Thus, 
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the phosphorylation of p35 as well as the association with MHC class II dimers is required for 
transport out of the ER.   
It has been shown that phosphorylated p35 can also associate with the protein 14-3-3, which is 
known to bind to phosphoserine motifs (Kuwana et al, 1998; Aitken, 1996).  This interaction may 
influence the intracellular transport of the MHC class II complex as 14-3-3 has been shown to rescue 
a clathrin mutation in S. cerevisiae (Gelperin et al, 1995).  Since p33 and p41 do not have this S6S8 
motif, p35 and p43 may be able to interact with different cellular components to alter the path the 
MHC class II complex travels through the endosomal pathway.  This may be beneficial to increase 
the variety of antigens the complex is exposed to, thus increasing the peptide repertoire expressed on 
the cell surface. 
1.3.3 Mediator of Self Release 
As stated above, in studies of cells lacking DM, the vast majority of MHC class II dimers remain 
bound to CLIP, indicating the importance of DM in the loading of peptides (Busch et al, 2005).  
However, a small number of dimers are bound to antigenic peptide, indicating that MHC class II has 
the ability to release CLIP without DM, albeit at a greatly reduced rate.  The release of CLIP has been 
shown to be mediated by the invariant chain, by a sequence located within the CLIP region (Vogt et 
al, 1995).  The CLIP peptide is composed of 81-104 in human p33 and 81-109 in mouse p31 
(Bijlmakers et al, 1994; Freisewinkel et al, 1993).  Subsequent analysis has indicated that this region 
can be thought to contain three separate regions, the N-terminal CLIP region, the CLIP and the C-
terminal CLIP region (Kropshofer et al, 1995; Ghosh et al, 1995).  The CLIP region is composed of 
residues 91 to 99 and this segment lies within the peptide binding groove to directly inhibit the 
binding of endogenous peptides (Ghosh et al, 1995).  The N-terminal and C-terminal regions also 
interact with the MHC class II dimer, but they do so at a separate site, located outside of the peptide 
binding groove (Vogt et al, 1995; Siebenkotten et al, 1998).  The separate site of interaction indicates 
that these regions are not directly involved in blocking antigen binding; however, the additional 
interaction with the MHC class II dimer likely has a function.   
The N-terminal region, consisting of residues 77-92, appears to play a role in peptide loading of 
the class II dimers through the interaction with an allosteric binding site on the MHC class II dimers 
(Adams and Humphreys, 1995; Vogt et al, 1995).  The MHC class II dimer exists in two different 
conformations, an immature conformation with a rapid on/off rate for peptide binding, and a mature 
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conformation with a slow on/off rate (Sadegh-Nasseri et al, 1994).  The loading of antigens within the 
endosomal pathway benefits from a rapid on/off rate, as this allows for the release of peptides that do 
not bind strongly to the peptide binding groove.  However, once a high affinity antigen has been 
bound, a slow on/off rate increases the half life of the surface antigen- class II complex, allowing 
more time for T cell activation.  It appears that the N-terminal region may increase the amount of time 
the MHC class II dimer spends in the immature rapid on/off conformation.  When Ii(71-88) was 
incubated with empty MHC class II dimers and an antigenic epitope, initially there was an inhibition 
of antigenic peptide binding, although the antigenic peptide eventually bound and resulted in the 
inhibition of Ii(71-88) binding (Vogt et al, 1995).  This is not due to direct binding of Ii(71-88) to the 
peptide binding groove as the CLIP region is not included in this peptide.  These results indicate that 
MHC class II exists in two different conformational states, one which is capable of binding Ii(71-88) 
and one which is not.  The ability of invariant chain to increase the half life of the rapid on/off MHC 
class II conformation may allow for easier release of invariant chain from the peptide binding groove, 
as well as increase the time for peptide exchange within the endosomal pathway, which will lead to 
formation of more stable antigen- class II complexes.  This mechanism likely interacts with the DM-
mediated peptide release to increase the repertoire of peptides presented by MHC class II at the cell 
surface. 
1.3.4 Protease Inhibition Activity 
The alternative splicing of the invariant chain gene leads to the inclusion of a 65 residue domain with 
sequence similarity to the thyroglobulin type 1 domain in both p41 and p43 isoforms (O’Sullivan et 
al, 1987).  This domain is found in a variety of proteins with multiple functions (Turk et al, 1999).  
To determine the function of the thyroglobulin domain in the invariant chain, in vitro studies were 
performed in which either p41 or p33 were expressed along with the MHC class II genes (Fineschi et 
al, 1995).  The cells expressing p41 have a longer invariant chain half life compared to the p33 
expressing cells, indicating a difference in protease degradation.  Furthermore, when p41 and p33 
were expressed together, it was shown that p41 also increases the half life of p33.  Thus, the 
thyroglobulin domain appears to play a role in modulating the proteases involved in the invariant 
chain degradation. 
The thyroglobulin domain of p41/p43 has been found to associate with cathepsin L in vivo 
(Ogrinc et al, 1993).  Subsequent studies have shown that the p41/p43 thyroglobulin domain inhibits 
Cat L as the incubation of free Cat L with this fragment leads to the rapid inhibition of enzyme 
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activity (Bevec et al, 1996).  This p41/p43 thyroglobulin domain represents a new class of protease 
inhibitor, as it does not show sequence similarity to any other cysteine protease inhibitors (Guncar et 
al, 1999).  The inhibition mediated by the p41/p43 thyroglobulin domain is also very specific, as it 
does not inhibit Cat B, Cat C or Cat S, in contrast to many cysteine protease inhibitors which have a 
broad specificity (Bevec et al, 1996; Guncar et al, 1999).  In addition to invariant chain, other 
proteins containing the thyroglobulin domain have also been shown to modulate proteolytic activity 
(Lenarcic and Bevec, 1998).  It appears that the conserved thyroglobulin type I domain may be able to 
interact with a variety of proteases, and it is the individual variations of this conserved domain that 
give protease specificity to each protein (Turk et al, 1999). Structural comparisons of the interaction 
between Cat L and either p41/43 thyroglobulin domain or stefin B, a broad specificity inhibitor, 
demonstrates the specificity of p41/p43 (Guncar et al, 1999).  While both p41/43 and stefin B bind to 
the bottom of the Cat L active site, the p41/43 thyroglobulin domain also binds to two regions higher 
up in the active site.  It is these interactions that give specificity to p41, as these interactions with Cat 
S are unfavorable due to steric hindrance as well as electrostatic clashes between Cat L and p41 
residues (Turk et al, 1999).  Thus, multiple contact points with the cathepsin L active site results in 
the specific inhibition of Cat L. 
In addition to a role in modulating the degradation of invariant chain, the binding of p41 to Cat L 
also appears to be required for the maturation of Cat L (Lennon-Dumenil et al, 2001).  In a study of 
transgenic mice expressing no invariant chain or either p41 or p33 alone, it was found that there was a 
decrease in mature Cat L in both Ii-/- mice as well as p31 expressing mice, while the p41 expressing 
mice had normal levels of mature Cat L.  It appears that p41 protects Cat L from degradation, in the 
absence of p41, pro-cathepsin L is processed to the active form, but it is then further degraded, either 
by other cysteine proteases or by active Cat L proteins.   
Finally, Cathepsin L may play a role in the degradation of the extracellular matrix during an 
immune response (Fiebiger et al, 2002).  In cells expressing only p41 or wild type cells, Cat L is 
found to be secreted from the cell.  The Cat L-p41 complex is stable at neutral pH, the Cat L is active 
and has been shown to degrade an elastin substrate.  Furthermore, there is an increase in Cat L–p41 
complexes when cells are treated with IFNγ.  Thus, immune system activation has the effect of 
increasing the secretion of active Cat L from any antigen presenting cells at the site of infection, 




1.3.5 Cell Surface Expression of Invariant Chain 
The invariant chain also carries out a number of functions in antigen presenting cells independent of 
MHC class II chaperone function.  The invariant chain has been shown to be expressed at the cell 
surface in the absence of MHC class II (Henne et al, 1995).  The surface expressed invariant chain 
appears to be the cellular receptor for the macrophage inhibitory factor (MIF), a cytokine responsible 
for macrophage activation (Leng et al, 2003).  Macrophage that do not express invariant chain are 
unable to respond to MIF.  Although the invariant chain is likely involved in the cell signaling 
cascade initiated by MIF binding, the cytoplasmic domain of the invariant chain is very short and 
unlikely to initiate the signal cascade on its own.  To identify a co-receptor, groups used the results 
from previous studies demonstrating an interaction between invariant chain and CD44, an adhesion 
molecule present on the surface of all leukocytes (Naujokas et al, 1993; Ponta et al, 2003).  
Subsequent studies have shown that the activation of macrophage by MIF requires both invariant 
chain and CD44 (Shi et al, 2006).  CD44 acts as a co-receptor for the MIF-invariant chain signal 
cascade by interacting with the tyrosine kinase family Src (Bourguignon et al, 2001).  In addition, the 
invariant chain is phosphorylated by protein kinase A (PKA) at residues S6 and S8 in response to MIF 
binding (Shi et al, 2006).  Thus, the binding of MIF to the invariant chain results in the activation of 
the intracellular protein kinases PKA and the Src family, which in turn phosphorylate the cytoplasmic 
domains of both invariant chain as well as CD44.  This leads to the recruitment and activation of 
other kinases by the associated activated kinases, thus initiating the MIF signal transduction cascade, 
which results in the expression of genes required for activated macrophage functions. 
1.3.6 Role in B Cell Maturation 
The invariant chain also plays an important role in B cell maturation as invariant chain knockout mice 
show lower B cell proliferation in response to immunization compared to wild type mice (Shachar 
and Flavell, 1996).  Analysis of B cells isolated from these mice shows that the cells all have an 
immature phenotype, as indicated by the pattern of surface markers.  This inhibition of B cell 
maturation is caused by the absence of invariant chain as the removal of MHC class II does not result 
in a halt in the B all maturation process.  Further analysis shows that the amino terminal region of 
invariant chain, from residues 1 to 82 is capable of inducing B cell maturation, as mice expressing 
only this fragment show a normal B cell population (Matza et al, 2002a).  This region is able to 
interact with and activate the transcription factor NF-κB and its co-activator TAFII105 and this 
interaction is likely required for B cell maturation (Matza et al, 2001).   
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Mutation studies have subsequently shown that the cleavage of the transmembrane segment of the 
invariant chain is required for the activation of NF-κB (Matza et al, 2002b).  Recently a new strategy 
for the regulated release of proteins has been described (Hoppe et al, 2001).  In this mechanism, a 
transcription factor is part of a larger transmembrane protein.  The regulated cleavage of the larger 
protein results in the release of the transcription factor and this cleavage event relies on a signal to 
activate intramembrane cleavage proteases.  The regulated intramembrane proteolysis event occurs in 
two steps, beginning with the removal of the large extracellular domain followed by the cleavage of 
the transmembrane segment (Matza et al, 2003).  After the stepwise degradation of the invariant chain 
within the endosomal pathway, an unidentified protease cleaves the remaining membrane bound 
peptide to release the N-terminal fragment, which interacts with NF-κB to activate gene expression 
necessary for B cell maturation.  While the signal for the activation of the regulated intramembrane 
proteolysis of the invariant chain has not been identified, it may come from B cell receptor activation, 
as the activation of the BCR causes a reorganization of MHC class II vesicles (Siemasko et al, 1998).  
This may change the pattern of invariant chain degradation and activate an intramembrane cleavage 
protease.   
To prevent a prolonged activation of NF-κB, the invariant chain amino terminal fragment must be 
rapidly degraded.  The invariant chain contains the destruction box sequence R29X30X31L32 sequence, 
and the mutation of this sequence increases the life span of the invariant chain fragment (Matza et al, 
2002 b).  This sequence targets the protein for ubiquitin-dependent degradation by the proteasome, 
which ensures a short half life for active NF-κB.  This limits the length of time various genes are 
expressed for B cell maturation. 
1.4 Coordinated Regulation of MHC Class II and Invariant Chain Expression 
MHC class II dimers are constitutively expressed in macrophage, monocytes, dentritic cells and B 
cells.  Upon exposure to IFN-γ, expression of class II genes is up-regulated in these professional 
antigen presenting cells and can also be induced in other cell types.  This tissue specific constitutive 
and inducible expression of MHC class II genes is controlled by the MHC class II promoter and a 
number of transcription factors.  A schematic representation of MHC class II promoter region is 
shown in figure 1.3.  This region is highly conserved across the MHC class II genes and consists of 
three main elements, the W, X and Y boxes (Ting and Zhu, 1999).  The Y box binds NF-Y while the 
X box binds CREB and RFX (Boss and Jensen, 2003).  These transcription factors are constitutively  
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Figure 1.3: Transcriptional regulation of MHC class II antigen presentation pathway.  (A) A 
schematic representation of the promoter region of the human MHC class II gene HLA-DRA, 
invariant chain and HLA-DM is shown.  The W, X, Y and TATA box elements are common to all 
three genes, giving rise to coordinated constitutive and inducible tissue expression.  However, each 
promoter also has unique elements which allows for individual control of the expression of each gene.  
(B)  Schematic representation of the transcription factors involved in the control of expression from 
the class II promoter.  With the exception of the Oct region, these transcription factors are also 
involved in the control of the invariant chain and DM expression (Ting and Zhu, 1999).  















expressed and the complex acts as a scaffold to recruit additional transcription factors.  The master 
control of MHC class II expression is carried out by the class II transactivator (CIITA).  The 
expression pattern of this protein matches that of the MHC class II dimers, and genetic defects in the 
CIITA gene result in complete loss of MHC class II expression (Ting and Trowsdale, 2002).  
Regulation of CIITA expression is very complex as this gene contains four different promoter 
regions, with differential use of these promoters resulting in tissue-specific MHC class II expression.  
One of these promoters contains interferon-responsive elements, which is responsible for the up- 
regulation of MHC class II expression upon IFN-γ stimulation.  Other promoters are constitutively 
expressed in the antigen presenting cells.  Once the CIITA has bound to the transcription complex at 
the MHC class II promoter, it stabilizes the complex and recruits the general transcription factor 
TAFII32, a component of the TFIID complex (Ting and Trowsdale, 2002).  This facilitates the 
binding of RNA polymerase to the MHC class II promoter region and the subsequent transcription of 
the gene. 
In order for proper functioning of the MHC class II antigen presentation pathway, invariant chain 
and DM must be coordinately expressed with the MHC class II genes.  Analysis of the promoter 
region of both of these genes demonstrates the presence of the W, X and Y boxes, similar to those of 
the MHC class II promoter (Ting and Zhu, 1999).  This results in a coordinated expression pattern of 
invariant chain and DM with MHC class II by CIITA.  However, invariant chain must be present in 
excess of the MHC class II dimers to function properly as a chaperone.  It has been shown that 
invariant chain is expressed in mutant antigen presenting cells which have normal MHC class II 
genes, but are unable to express class II due to a mutated trans-acting factor, likely the CIITA (Long 
et al,1984).  As shown in figure 1.3, the invariant chain promoter contains addition elements, 
including the ICSBP, an element capable of responding directly to interferon stimulation (Barr and 
Saunders, 1991).  The conserved X, Y and W boxes allow for coordinated constitutive and induced 
expression of the invariant chain and MHC class II, while additional elements ensure that invariant 
chain is expressed at a higher level than MHC class II genes, to provide a large pool of invariant 
chain to mediate class II folding and transport.  
1.5 Immune System of Teleost Fish 
The preceding discussion of the immune system is based upon the known structure and function of 
the mammalian immune system.  While MHC receptors have been identified in all jawed vertebrates, 
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the immune system of humans and mice remain the most thoroughly studied.  However, various 
groups are working to elucidate the structure and function of the immune system in a number of 
different species.  A more thorough knowledge of various immune systems will provide insight into 
the evolution of the immune system and may also identify novel functions of known immune system 
effectors.  The following discussion will focus on the current understanding of the teleost immune 
system, in the context of the teleost MHC genes. 
1.5.1 MH Structure  
A major difference between mammalian and teleost immune systems occurs within the chromosomal 
organization of the MHC genes.  As described above, mammalian MHC genes, along with a number 
of genes involved in the MHC antigen loading pathways, are all encoded within the same region of a 
single chromosome, resulting in the linked inheritance of multiple MHC alleles by offspring.  In the 
case of teleost fish, the MHC genes are not linked in this fashion (Shand and Dixon, 2001, Sato et al, 
2000).  A single class I loci is not linked to class II loci and in addition, class II genes also are found 
within two or more unlinked loci.  This allows for offspring to inherit a combination of the various 
MHC alleles from each parent.  It has yet to be determined if there is any evolutionary advantage to 
this organization of the immune system.  Since the MHC genes are not found in a complex in teleost 
fish, they are instead referred to as the major histocompability (MH) genes. 
There are also many similarities between the mammalian and teleost immune systems, which have 
been shown mainly at the level of sequence comparison between species.  Multiple alleles of the MH 
class I and MH class II have been identified within single fish for a number of different teleost 
species (Shand and Dixon, 2001).  This is similar to the inheritance of multiple MHC class I heavy 
chain genes and MHC class II loci in humans.  In addition, teleosts also have a high sequence 
polymorphism for MH class I and class II genes (Shand and Dixon, 2001, Hasen et al, 1999).  Thus, 
the inheritance of multiple polymorphic alleles from each parent occurs in teleost fish as well as 
mammals. 
Finally, recent analysis has identified MH class II promoter elements and transcription factors with 
sequence similarity to mammalian genes.  In zebrafish, sequences with high similarity to the human 
X, Y and TATA box have been identified upstream of the MH class II α genes while sequences with 
high similarity to the X and Y box have been identified upstream of the MH class II β (Sultmann et 
al, 1993, Sultmann et al, 1994).  Furthermore, sequences with similarity to the transcription factor 
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RFX-B and its paralogue ANKRA2 have been identified in carp, zebrafish, Atlantic salmon and 
Japanese medaka (Long and Boss, 2005).  This indicates that while the MH genes are unlinked in 
teleost fish, they may be regulated in a similar fashion to mammalian MHC genes. 
1.5.2 Invariant Chain 
In addition to the identification of MH genes, invariant chain sequences have also been identified in a 
number of species, including zebrafish, Atlantic salmon, fugu, catfish, carp and rainbow trout (Yoder 
et al, 1999, Sakai et al, 2004, Fujiki et al, 2003).  The presence of the invariant chain gene indicates 
that antigen loading in the MH class II antigen presentation pathway may occur in a similar manner to 
the mammalian MHC class II pathway. 
Two genes, the invariant like proteins Iclp-1 and Iclp-2, have been identified in zebrafish (Yoder et 
al, 1999).  A schematic diagram of the proteins encoded by these genes is shown in figure 1.2.  Both 
encode a type II transmembrane protein containing a thyroglobulin domain as well as a 
transmembrane domain (Yoder et al, 1999).  In addition, Iclp-1 also has a truncated trimerization 
domain, which is absent in Iclp-2.  The highest sequence similarity between the two zebrafish genes 
and the mammalian invariant chain gene occurs within the transmembrane and thyroglobulin 
domains.  In addition, both contain putative endosomal targeting sequences in the amino-terminal 
cytoplasmic domain.  These features indicate that the role carried out by these domains may be 
conserved in the zebrafish immune system.  Since Iclp-2 is unable to trimerize, it is unlikely to 
facilitate MH class II trafficking, but may play a role in modulating protease activity, as described 
above for p41/p43.  Iclp-1 likely performs the chaperone functions for the MH class II antigen 
presentation pathway in zebrafish, although no functional analysis has been performed on these 
genes. 
Three invariant chain genes have also been identified in rainbow trout (Fujiki et al, 2003).  Two of 
these genes, S25-7 and INVX are homologues of mammalian p33 and p41, while the third gene, 14-1 
appears to be more closely related to zebrafish Iclp-2.  A schematic diagram of the proteins encoded 
by these genes is shown in figure 1.2.  The 14-1 sequence encodes a 21.3 kDa protein containing a 
thyroglobulin domain and transmembrane domain.  These regions exhibit high sequence similarity to 
invariant chain genes in other species, including human, mouse and chicken.  However, the absence 
of a trimerization domain indicates that this protein is not likely to act as a chaperone to facilitate MH 
class II trafficking, and similar to the case of Iclp-2, may be involved in modulating protease activity.  
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In addition, 14-1 encodes an endosomal targeting sequence in the cytoplasmic domain, which may 
allow co-localization with MH class II dimers in the endosomal pathway to control protease activity.   
INVX, the p33 homologue, encodes a 24.6 kDa protein containing a transmembrane domain and a 
trimerization domain while S25-7, the p41 homologue, encodes a 31.8 kDa protein containing a 
transmembrane domain, a trimerization domain and a thyroglobulin domain.  The transmembrane, 
trimerization and thyroglobulin domains of S25-7 and INVX show strong sequence similarity to 
tetrapod invariant chain sequences.  Both S25-7 and INVX contain two endosomal targeting signals 
in the cytoplasmic domain, which, along with the presence of a trimerization domain indicates that 
both of these proteins may be capable of trafficking to the endosomal pathway.  In addition, both S25-
7 and INVX sequences have very hydrophobic and proline rich CLIP domains.  Thus, the S25-7 and 
INVX may have the ability to bind to MH class II dimers to form a nonomeric structure, which can 
then be targeted to the endosomal pathway.  Furthermore, the thyroglobulin domain in S25-7 may 
also play a role in the modulation of protease activity, as described for p41. 
Each invariant chain is encoded by a single copy gene in rainbow trout and INVX is not 
alternatively spliced to give rise to S25-7, which is in contrast to the alternative splicing and 
alternative translational initiation associated with the mammalian invariant chain isoforms.  In 
addition, while all three trout invariant chain genes are constitutively expressed at the transcript level 
in peripheral blood leukocytes, gill and head kidney, S25-7 is found at the highest levels.  Within the 
mammalian system, in only p31 is constitutively expressed while p41 is upregulated upon IFN-γ 
stimulation (Albanesi et al, 1998).  The significance of this difference in expression pattern of 
invariant chain isoforms between the mammalian and teleost immune system is unknown.  
1.6 Purpose of Study 
The purpose of this research is to study the regulation of rainbow trout S25-7 and INVX genes in 
response to immune system stimulation.  Initial studies have indicated that there is a difference in the 
regulation of these genes compared to mammalian invariant chain regulation as both S25-7 and INVX 
are expressed in non-stimulated fish.  Both in vivo and in vitro methods will be used to measure 
changes in S25-7 and INVX transcript and protein levels in response to PMA stimulation of the 
immune system.  The results of this study will provide a more complete picture of the regulation of 
the teleost immune system and will allow further analysis of the results of the divergent evolution of 
teleost and mammalian immune systems.   
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A long term goal of this project is the production of more effective vaccination strategies for use in 
the aquaculture industry.  In general, vaccinations consist of the injection of either live attenuated 
pathogens or killed pathogens.  However, a new DNA vaccination strategy has recently been 
developed in which genes of antigenic proteins or peptides are cloned into an expression vector and 
this vector is injected into an individual.  The plasmid is taken up by cells at the injection site and the 
encoded peptide is expressed and presented in MHC for T cell activation.  In general, it is fairly easy 
to target antigenic peptides to the MHC class I antigen presentation pathway because all proteins 
expressed in the cytosol can be degraded and transported into the ER.  However, for a prolonged 
CD8+ T cell response, CD4+ T cells must also be activated because these cells synthesize and secrete 
IL-2, a cytokine required for T cell proliferation (Wang, 2001).  The challenge associated with 
activating a CD4+ T cell response lies in the targeting of antigenic peptide into the endosomal 
pathway.  This has been accomplished by manipulating an invariant chain sequence (van Bergen et al, 
1997, Barton et al, 1998, Fujii et al, 1998).  In this strategy, a full length invariant chain sequence is 
cloned into an expression plasmid and the CLIP region is replaced with a short antigenic sequence.  
The modified invariant chain protein can bind to MHC class II dimers in the ER and the complex is 
targeted to the endosomal pathway in the same way a wild type invariant chain protein would be.  The 
modified invariant chain is then processed but instead of CLIP remaining in the class II groove, the 
antigenic peptide is bound.  This complex then travels to the cell surface for presentation to CD4+ T 
cells.  By understanding the function of the teleost invariant chain proteins, it is possible to create a 
new invariant chain vaccination strategy to help eliminate infections in fish stocks.  





Materials and Methods 
2.1 Cloning a Truncated INVX Fragment 
2.1.1 Primer Design and PCR Conditions 
The open reading frame of INVX has previously been cloned into the pGEM T easy vector and this 
was used as a template to clone a truncated fragment of the INVX gene, lacking both the amino-
terminal intracellular domain as well as the transmembrane domain.  A truncated sequence was used 
to increase the protein expression level as previous work has shown low expression of transmembrane 
proteins.  The truncated fragment was amplified with a sense primer that binds 3’ to the 
transmembrane domain, as shown in figure 2.1 (5’ CGCCGGATCCCTGGTCTTGAACCAGAGG 
3’) and an antisense primer spanning the stop codon (5’ CGCCCTCGAGGCTGTGGTTACTCATTC 
3’).  These primers include a GC-clamp and a restriction enzyme site at the 5’ end, with a BamHI site 
in the sense primer and a XhoI site in the antisense primer.  The fragment was amplified under the 
following conditions: 5 minutes at 95°C followed by 30 cycles of 95°C for 30 seconds, 51°C for 30 
seconds, 72°C for 1 minute followed by a 5 minute extension at 72°C.  The PCR reaction was 
performed in the PTC-200 thermal cycler (MJ Research).  Amplification of an expected 467 base pair 
band was confirmed by electrophoresis on a 1% agarose gel stained with ethidium bromide and 
imaged on the Fluorchem 8000 chemiluminescent and visible imaging system (Alpha Innotech). 
2.1.2 Ligation into pRSETA 
The truncated INVX PCR fragment was digested for directional ligation into the pRSET A vector.  
The fragment was extracted by the addition of an equal volume of PCI (1:1 mixture of saturated 
phenol pH6.6 and CIAA, a 24:1 mixture of chloroform and isoamyl alcohol) followed by 
centrifugation at 13,000 rpm for 3 minutes in an IEC Mixromax centrifuge (Thermo Scientific).  An 
equal volume of CIAA was added to the upper layer and the solution was centrifuged at 13,000 rpm 
for 1 minute.  The DNA was precipitated by the addition of 1:10 volume of 3M sodium acetate and a 
2:5 volume of 100% ethanol followed by incubation at -80°C for 30 minutes and centrifugation at 
15,000 rpm for 15 minutes.  The pellet was washed once with 70% ethanol and re-suspended in 20 µL  
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Figure 2.1:  The position of the primers used to amplify truncated INVX DNA fragment.  A 467 
base pair truncated INVX fragment was amplified with a forward primer 3’ to the transmembrane 
domain.  Arrows represent primers. Abbreviations: TMD – transmembrane domain, CLIP – class II 
associated invariant chain peptide, TD – trimerization domain.     
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of de-ionized water.  The purified fragment was then digested with 1 unit each of BamHI and XhoI 
overnight at 37°C, followed by a PCI/CIAA extraction and sodium acetate/ethanol precipitation as 
described above.  The re-suspended product was separated on a 1.5% agarose gel run in 0.5 x TBE 
(45mM Tris-HCl, 90mM boric acid and 1mM EDTA pH8) and the 476 base pair fragment was cut 
out of the gel and purified with a GenElute agarose spin column (Sigma). 
The pRSET A vector, shown in figure 2.2, was also digested with 2 units each of BamHI and XhoI 
for 2 hours at 37°C.  The cut plasmid was then PCI/CIAA extracted, sodium acetate/ethanol 
precipitated, re-suspended in de-ionized water and gel purified as described above.  The concentration 
of the purified plasmid was measured with a Cary 50 Bio UV visible spectrophotometer (Varian) and 
was adjusted to 50ng/µL with de-ionized water. 
Ligation of the INVX fragment into pRSET A was performed overnight at 4°C.  Briefly, 3.5µL of 
the INVX PCR product was mixed with 1µL of digested pRSET A, along with 4.5µL of ligation 
buffer and 1µL of T4 DNA ligase from the pGEM T easy kit (Promega).  The reaction mixture was 
incubated overnight at 4°C on ice followed by one hour incubation at 14°C before transformation. 
2.1.3 Transformation of Rosetta cells 
The Rosetta (DE3) pLysS strain (Novagen) was chosen as a host to maximize recombinant protein 
expression.  The DE3 strains contain a chromosomal T7 RNA polymerase gene under the control of 
the lacUV5 promoter (Baneyx, 1999).  In these strains the lacUV5 promoter is repressed until the 
addition of isopropyl-β-D-1-thiogalactopyranoside (IPTG), which allows for strict control of 
recombinant protein expression.  The limited T7 RNA polymerase expression allows for faster 
bacterial growth as transcription from the pRSET A plasmid is prevented.  However, in the DE3 
strains, there is some leaky expression from the lacUV5 promoter which can result in slower cell 
growth.  In order to prevent the expression of low levels of T7 RNA polymerase, this strain contains 
the pLysS plasmid which encodes the T7 RNA polymerase inhibitor T7 lysozyme.  Upon IPTG 
induction of the lacUV5 promoter T7 RNA polymerase is expressed and its levels exceed that of T7 
lysozyme allowing for transcription from pRSET A.  Finally, the pLysS plasmid in the Rosetta strain 
also encodes several tRNAs for codons that are rarely used in E. coli, allowing for higher levels of 
expression of mammalian proteins. 
After incubation at 14°C for one hour, a 50µL aliquot of competent cells was added to the ligation 
reaction and this mixture was incubated on ice for 30 minutes.  To transform the cells, the mixture  
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Figure 2.2: pRSET A plasmid map.  The pRSET A plasmid has many features that make it useful 
as a protein expression vector.  It contains a T7 promoter which allows for tight control of 
recombinant protein expression in DE3 IPTG inducible host cells.  The vector encodes a ribosome 
binding sequence and an initiation ATG which allows for efficient translation initiation.  In addition, 
the vector encodes an N-terminal tag, consisting of a 6xHis tag, the T7 gene 10 sequence and the 
Xpress epitope tag.  This sequence is translated along with the gene of interest to result in a fusion 
protein that can easily be purified with metal-chelating resins.  In addition, the T7 gene 10 sequence 
increases the stability of the recombinant protein and the Xpress epitope can be used to detect the 
fusion protein by western blot analysis with an anti-Xpress antibody.  After the N-terminal tag 
sequence, there is an enterokinase cleavage site which allows cleavage of this tag from the fusion 
protein.  A multiple cloning site allows the insertion of the gene of interest and the T7 terminator 
sequence ensures efficient transcriptional termination.   
To allow for selection of transformed host cells, the plasmid also encodes the β-lactamase gene 
under the control of the bla promoter, resulting in host cell ampicillin resistance.  Finally, the plasmid 
contains the pUC origin for high copy number and growth in E. coli.  The pRSET A plasmid was 
chosen to give the proper reading frame of the insert     










was heat shocked at 42°C for 45s followed by the addition of SOC media (2% tryptone, 0.5% yeast 
extract, 8.55mM sodium chloride, 2.5mM potassium chloride, 10mM magnesium chloride and 10mM 
glucose).  The cells recovered for 30 minutes at 37°C before being plated on LB media (1% tryptone, 
0.5% yeast extract and 172mM sodium chloride) supplemented with 100µg/mL ampicillin and 
40µg/mL chloramphenicol (LB/amp/cam).  The transformed cells were incubated overnight at 37°C. 
2.1.4 Plasmid Isolation and Sequencing  
The tINVX : pRSET A plasmid was isolated from transformed cells and subjected to sequencing to 
confirm the cloning of a non-mutated truncated INVX (tINVX) sequence.  A single colony from the 
transformation plate was used to inoculate LB/amp/cam media and the bacteria were cultured 
overnight.  The next day the cells were centrifuged at 10,000 rpm for 3 minutes and the cell  pellet 
was re-suspended in 100 µL of solution I (50mM glucose, 25mM Tris-HCl pH8 and 10Mm EDTA 
pH8) followed by the addition of 200 µL of solution II (0.2N sodium hydroxide and 1% sodium 
dodecyl sulfate) to lyse the cells.  After five minute incubation on ice, the solution was neutralized by 
the addition of 150µL of solution III (3M potassium acetate and 11.5% acetic acid).  The mixture was 
then centrifuged at 15,000 rpm for 5 minutes to clear the protein-SDS complexes.  Intracellular RNA 
was degraded by the addition of 20 µg of ribonuclease A (RNase A) followed by incubation at 37°C 
for 30 minutes and contaminating proteins, RNA and chromosomal DNA were removed by 
PCI/CIAA extraction, as described.  Finally, the plasmid was precipitated with 2-propanol and the 
pellet was re-suspended in 20µL of de-ionized water.  The concentration of the plasmid was measured 
with the Cary 50 Bio UV spectrophotometer and the plasmid was diluted to 0.2µg/µL and submitted 
to the University of Waterloo molecular core facility for sequencing.  The sequencing was performed 
for both the forward and reverse direction and these were compared to the known INVX sequence 
(Fujiki et al¸ 2003) using Gene Runner v3.05.  The amino acid sequence was identical to the 
published sequence.       
2.2 Recombinant Truncated INVX Protein Expression 
2.2.1 Pilot Expression 
A small scale pilot induction experiment was performed to select high expressing, fast growing 
colonies and to determine the time required after induction for maximal levels of rtINVX.  Single 
colonies were inoculated into LB/amp/cam media and were grown overnight at 37°C.  The following 
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day, 500µL of the overnight culture was centrifuged at 4,000 rpm for 2 minutes and used to inoculate 
fresh LB/amp/cam media to an optical density, measured at 600nm (OD600), greater than 0.1, as 
measured on the VERSAmax tunable microplate reader (Molecular Devices).  These cultures were 
incubated at 37°C in the Gyrotary G10 shaker incubator (New Brunswick Scientific Company) and 
the OD600 was closely monitored.  When the OD600 was between 0.4 and 0.6, expression of rtINVX 
was induced by the addition of 1mM IPTG to the culture.  Before the addition of IPTG, 1mL of the 
culture was collected, centrifuged at 4,000rpm for 2 minutes and the pellet was stored at -20°C.  
Every hour after the IPTG induction, 1mL of culture was collected, centrifuged and stored at -20°C.  
Samples were collected for a total of 6 hours post-induction.    
After collecting rtINVX-expressing cells during the pilot induction, western blot analysis was 
performed on these samples to examine the levels of protein expression.  To lyse the cells, pellets 
were incubated in 8M urea buffer pH8 (8M urea, 100mM sodium phosphate and 10mM Tris-HCl) for 
1 hour at room temperature on the BD Clay Adams Nutator mixer (BD Diagnostics).  To denature the 
proteins for size separation on a polyacrylamide gel, 20µL of 5x Laemmli buffer (25% glycerol, 
125mM Tris-HCl pH 6.8, 10% SDS, 0.05% bromophenol blue and 2.5% β-mercaptoethanol) was 
added to each sample and samples were boiled for 5 minutes.  After allowing the samples to cool, 
6µL of each was loaded into a 12% SDS polyacrylamide gel.  The 12% resolving gel was made with 
30% acrylamide/biacrylamide 37.5:1 (Biorad) and 0.375M Tris-HCl pH 8.8, along with 0.1% SDS, 
0.05% ammonium persulfate and 0.05% TEMED (Sigma).  The 4% stacking gel was made with the 
same components with the substitution of 0.125M Tris-HCl pH 6.8 for 0.375M Tris-HCl pH8.8.  The 
electrophoresis was performed using the Mini Protein II gel apparatus (Bio-Rad) in a Tris glycine 
running buffer (0.2M glycine, 0.025M Tris, 0.1% SDS) at 130V until the dye front reached the 
bottom of the glass plates, which took approximately 2 hours. 
After electrophoresis was complete, the gel was removed from the glass plates and the protein was 
transferred onto a nitrocellulose membrane (Pall Corporation).  Briefly, the gel and membrane were 
sandwiched between two filter papers (Fisher) and two sponges and this was placed in the Transblot 
Cell (Bio-Rad) and transferred overnight at 22V.  Following the transfer, the membrane was removed 
and stained with Ponceau S stain (0.2% Ponceau S in 5% acetic acid) to examine transfer and analyze 
equal protein loading between samples.  After scanning with the AIO Printer A920 (Dell Computers), 
the membrane was de-stained in T-TBS pH8 (140mM sodium chloride, 2.5mM potassium chloride, 
2.5mM Tris and 0.05% Tween20). 
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To block unbound regions, the membrane was incubated in blocking buffer (5% skim milk in T-
TBS) for 2 hours at room temperature.  The express epitope encoded within the amino-terminal tag of 
rtINVX was detected by probing with the anti-express antibody (Invitrogen) at a 1:5,000 dilution in 
blocking buffer.  Binding of the primary antibody was detected by probing with the goat anti-mouse 
IgG alkaline phosphatase linked secondary antibody (Sigma) at a 1:30,000 dilution in blocking buffer.  
Both the primary and secondary antibodies were incubated with the membrane for 1 hour at room 
temperature.  To eliminate non-specific binding of either primary or secondary antibodies, a series of 
three 5 minute washes in T-TBS was repeated after both primary and secondary incubations.  After 
the final wash, the membrane was equilibrated in alkaline phosphatase buffer pH9.5 (100mM Tris, 
100mM sodium chloride and 5mM magnesium chloride) for 5 minutes and rtINVX was detected with 
bromochloroindolylphosphate (BCIP) / nitro blue tetrazolium (NBT) substrate (0.0165% BCIP and 
0.033% NBT in alkaline phosphatase buffer).  The membrane was incubated in the substrate in the 
dark until a purple band developed, at which time de-ionized water was added to stop the reaction.      
2.2.2 Full Scale Protein Induction 
A single colony was inoculated into 50mL of LB/amp/cam and incubated overnight at 37°C.  The 
culture was centrifuged at 4,000 rpm for 2 minutes in the IEC desktop centrifugre (Fisher Scientific) 
and used to inoculate 2L of fresh LB/amp/cam to an OD600 greater than 0.1.  This was incubated at 
37°C in the Gyrotary G10 shaker incubator until the OD600 was between 0.4 and 0.6 at which time 
protein expression was induced by the addition of 1mM IPTG.  Two hours after induction, the culture 
was centrifuged at 10,000 rpm for 10 minutes in the Sorval RC5B (DuPont) centrifuge.  The cell 
pellet was then lysed for protein purification, as described in the next section. 
2.2.3 Protein Purification 
The positive charge of the poly-histidine tag was exploited to isolate rtINVX protein by affinity 
purification using nickel resin.  The cell pellet was re-suspended in 5mL of lysis solution (25% 
sucrose, 50mM Tris-HCl pH8, 1mM EDTA, 1mM PMSF, 1mM DTT, 1% Triton X-100 and 0.1% 
lysozyme) and incubated on ice for 30 minutes.  Genomic DNA was degraded by the addition of 
30mM magnesium chloride and 150µg of deoxyribonuclease I (Sigma) with 30 minute incubation at 
room temperature on the Nutator mixer.  The volume of the lysate was then topped to 100 mL with 
8M urea buffer pH8 and incubated on the Nutator mixer for 2 hours at room temperature.  Cellular 
debris was cleared by centrifugation at 10,000 rpm for 20 minutes, followed by the addition of 2mL 
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Figure 2.3: Nickel Column Purification of rtINVX protein.  The rtINVX expressing cells were 
lysed under denaturing conditions with 8M urea buffer.  The recombinant fusion proteins have a 
positively charged 6xHis tag at the amino-terminus, which binds to negatively charged nickel resin to 
allow for protein purification.  After an overnight incubation with Ni-NTA resin, the unbound 
proteins were removed from the column.  Stepwise decreases in the pH of the 8M urea buffer allowed 
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of 50% Nickel –nitrilotriacetic acid resin (Qiagen) in 8M urea buffer pH8.  The lysate was incubated 
with the nickel resin overnight on the Nutator Mixer at room temperature to allow for rtINVX 
binding.   
To clear unbound proteins, the mixture was centrifuged at 4,000 rpm for 5 minutes and the 
supernatant, containing the unbound protein fraction, was removed.  The resin was washed once with 
10mL of 8M urea buffer pH8 and was re-suspended in 10mL of 8M urea buffer pH6.5.  The slurry 
was then poured into a column and the flow through was collected.  To elute non-specifically bound 
proteins, the resin continued to be washed with 8M urea buffer pH6.5 until no protein was detected in 
the column flow through, as determined by Bradford assay.  The Bradford assay was performed by 
combining 20µL of the column flow through with 180µL of Bradford reagent (10% coomassie 
brilliant blue in 8.5% phosphoric acid).  The colour of this reaction was compared by eye to the 
colour of a blank reaction in which 20µL of 8M urea buffer pH 6.5 was added to 180µL Bradford 
reagent.  The pH of the 8M urea buffer was decreased when the reactions appeared to be the same 
colour as this indicated the complete elution of non-specific protein.  Elution of rtINVX was achieved 
by the addition of 8M urea buffer pH5.9 to the column.  The resin was washed with 1mL volumes of 
this buffer until the Bradford assay showed no protein in the column elution.  Finally, the resin was 
washed with 8M urea buffer pH4.3 to elute any remaining protein bound to the nickel resin.  Protein 
elutions were stored at 4°C. 
Elutions from the nickel resin were separated on a 12% polyacrylamide gel and subjected to both 
western blotting and coomassie staining to examine the quality of the isolated protein.  Samples from 
the unbound protein fraction, pH8 and pH6.5 washes, along with pH5.9 elutions were analyzed by 
western blotting, as described above.  For coomassie staining, 16µL of each sample was mixed with 
4µL of 5x Laemmli buffer, boiled and separated at 130V as described for the western blot.  However, 
instead of transferring the proteins to a nitrocellulose membrane, the gel was stained in Coomassie 
blue G-250 (J. T. Chemical Co.) for one hour, de-stained in 45% methanol, 10% acetic acid and 
imaged with the Fluorchem 8000. 
The concentration of the rtINVX elutions were measured by the Bradford assay.  Briefly, 20µL of 
the sample was mixed with 180µL of Bradford reagent and the absorbance was read at 595nm on the 
VERSAmax tunable plate reader.  A standard curve was also generated by mixing 20µL of BSA 
standards at 1mg/mL, 0.6 mg/mL, 0.5 mg/mL, 0.4 mg/mL, 0.3 mg/mL, 0.2 mg/mL, 0.1 mg/mL and 
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0.05 mg/mL in 8M urea buffer pH8 with 180µL of Bradford reagent.  The standard curve was used to 
calculate the concentration of the elutions based on the absorbance from the Bradford assay. 
2.3 Development of a Polyclonal Rabbit Anti-rtINVX Antibody 
2.3.1 Preparation of Antigen for Immunization and Serum Collection 
In order to produce polyclonal antibodies, two female New Zealand White rabbits (Charles River 
Canada) were immunized with rtINVX.  The rtINVX-containing nickel column elutions were pooled 
together in dialysis tubing (Fisher) and concentrated using polyethylene glycol.  The sample was then 
dialyzed into 4M urea buffer pH8 for 3 hours at 4°C and the concentration was measured by Bradford 
assay, as described above.  A BSA standard curve was constructed as described above with the 
exception that the BSA was diluted in 4M urea buffer pH8.  Once the sample reached 1mg/mL, it was 
further dialyzed into 2M urea buffer for 3 hours at 4°C, into 1M urea buffer overnight at 4°C and 
finally into 1xPBS (140mM sodium chloride, 2.7mM potassium chloride, 4.3mM sodium phosphate 
and 1.5mM potassium phosphate) overnight at 4°C.  
To prepare the sample for immunization, 500µL of rtINVX was combined with 500µL of Freund’s 
complete adjuvant (Sigma) and 20µg of Keyhole Limpet Hemocyanin (Calbiochem).  This mixture 
was vortexed on high for 45 minutes and was taken up into a 1mL syringe.  This was performed in 
duplicate for the immunization of two animals.  The vaccine was injected intramuscularly at 4 sites by 
the animal care technician. 
In order to maximize the antibody production, these animals were boosted three times over 9 a 
week period at 3 week intervals.  The vaccine was prepared in the same manner as described above 
except that Freund’s incomplete adjuvant was substituted for the complete adjuvant and the amount 
of KLH was decreased by half for each subsequent boost.  Twelve weeks after the initial 
immunization the animals were exsangunated and the rtINVX antiserum was collected.  
2.3.2 ELISA: Determination of Antibody Titre  
Enzyme-linked immunosorbent assays were performed to monitor anti-rtINVX antibody titre during 
the rabbit immunizations.  Before the initial immunization and before each boost, approximately 
10mL of blood was collected from the ear canula of each rabbit.  The blood was left to clot for 2 
hours at room temperature followed by an overnight incubation at 4°C.  The blood was then 
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centrifuged at 3,000 g for 10 minutes at 4°C and the serum was transferred into a fresh tube and 
stored at -20°C until ELISA analysis was performed. 
A 96 well plate (Evergreen Scientific) was incubated overnight with 1µg of either rtINVX or KLH 
diluted in coating buffer pH9.6 (15mM sodium carbonate, 35mM sodium bicarbonate and 0.02% 
sodium azide) at room temperature to allow antigen binding.  The next morning the antigen 
suspensions were removed and 300µL of blocking solution (1%BSA in 1xT-TBS) was added, 
followed by incubation at 37°C for 1 hour.  After the blocking step, 100µL of the following serum 
dilution, made in blocking buffer, were added to the plate: 1/100 , 1/500 , 1/1,000 , 1/5,000 , 1/10,000 , 1/50,000 , 
1/100,000  and 1/500,000.  Analysis of each dilution was performed in triplicate.  To detect the serum 
antibodies 100µL of anti-rabbit IgG alkaline phosphatase conjugated antibody (Sigma), diluted to 
1:5,000 in blocking buffer was added to the plate.  Both primary and secondary antibody incubations 
were performed for 1 hour at room temperature.  After both the primary and secondary antibody 
incubations the plate was washed three times with T-TBS.  Bound secondary antibody was detected 
with the p-NPP alkaline phosphatase substrate from the Sigma FASTTM p-Nitrophenyl Phosphate 
tablet system.  Briefly, one of each tablet from the kit was dissolved in 20mL of Milli-Q water, and 
50µL of this substrate was added to each well.  After 30 minute incubation in the dark at room 
temperature, 50µL of 0.03M sodium hydroxide was added to stop the reaction and the absorbance 
was read at 405nm. 
2.3.3 Antibody Purification 
To reduce background noise when performing western blot analysis, the anti-rtINVX antibody was 
affinity purified from the antiserum.  The first step of the purification involved the binding of rtINVX 
to sulfolink resin (Pierce).  This resin has an iodoacetyl group which can bind to reduced cysteine 
residues on any protein.  To begin, 6mg of rtINVX, at a concentration of 0.5mg/mL, was dialyzed 
into coupling buffer pH8.5 (50mM Tris and 5mM EDTA).  Sulfolink resin was then washed with 
8mL of coupling buffering to remove the storage buffer (10mM EDTA, 0.05% sodium azide and 50% 
glycerol) and 3mL of rtINVX was added to column.  The protein was incubated with the resin at 
room temperature with rocking for 15 minutes and then overnight at 4°C.  The unbound protein was 
collected from the column and another 3mL of rtINVX was added and allowed to bind.  This was 




Figure 2.4: Affinity purification of anti-rtINVX antibody.  The rtINVX protein was linked to 
sulfolink resin by the reaction of a reduced rtINVX cysteine side chain with an iodoacetyl group on 
the resin.  After blocking any unbound iodoacetyl groups, crude antiserum was added to the column.  
After an overnight incubation unbound antibodies were removed from the column and non-specially 
bound antibodies were eliminated with sample buffer washes.  Finally, the anti-rtINVX antibody was 
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Coomassie staining was performed to examine the protein bound sulfolink resin.  Briefly, 100µL of 
resin was collected from the column, mixed with 20µL of 5x Laemmli buffer, boiled for 5 minutes 
and centrifuged.  The supernatant was loaded onto a 12% polyacrylamide gel along with samples 
from the column flow through and sample of 0.5mg/mL rtINVX.  Electrophoresis and staining were 
performed as described above.  Since the resin showed a high level of rtINVX binding, excess 
iodoacetyl residues were blocked by the addition of 16mg of cysteine to the column.  The column was 
incubated for 15 minutes at room temperature with rocking followed by 30 minutes without rocking 
to allow the resin to settle.  The cysteine was removed from the column and the resin was washed 
with 12mL of wash buffer (1M sodium chloride and 0.05% sodium azide).  Finally, the resin was 
washed with 1xPBS + 0.05% sodium azide and the column was stored at 4°C until needed for 
antibody purification. 
To purify anti-rtINVX antibodies, 1.5mL of crude serum was added to the column.  This was 
incubated with rocking for 15 minutes at room temperature followed by 30 minutes without rocking 
and overnight at 4°C.  The column flow through was collected and the resin was washed with 12mL 
of sample buffer pH8 (0.1M sodium phosphate and 5mM EDTA).  The antibody was eluted in 1mL 
volumes of 100mM glycine pH2.5.  A Bradford assay was performed to monitor antibody elution, as 
described above for protein purification, with the exception of 100mM glycine pH2.5 as the blank.  
The eluted antibody was neutralized with 100µL of 1M Tris-HCl pH7.5 + 0.05% azide and stored at  
-20°C until needed.  The column was neutralized with 1xPBS + 0.05% sodium azide and stored at 
4°C. 
2.4 In vivo Time Course 
2.4.1 PMA Immunostimulation and Tissue Collection 
Eighty rainbow trout ranging in size from 150g to 300g were obtained from Mimosa Springs trout 
farm in Guelph, Ontario.  These animals were maintained in 13°C water in the aquatic facility at the 
University of Waterloo for two months before starting the immunostimulation time course.  
Phorbol 12-myristate 13-acetate (PMA, Sigma) is a stimulator of protein kinase C (Nishizuka, 
1984).  This was used to stimulate an immune response because PKC is involved in a number of 
signal transduction cascades, including B and T cell receptor signaling cascades (Janeway et al, 
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2001).  Fish were anesthetized in ethyl 3-aminobenzoate methanesulfonate salt (MS-222, Sigma), 
weighed and injected intraparetioneally with 0.5µg PMA per gram body weight.  This concentration 
of PMA was chosen based on preliminary studies comparing the ability of a variety of PMA 
concentrations to induce an immune response.  Sixty fish were treated with PMA, placed in two tanks 
and sacrificed at regular time points.  At 8 hours, 48 hours and 120 hours after treatment, 9 fish were 
collected from tank 1 and at 24 and 96 hours after treatment 9 fish were collected from tank 2.  At the 
168 hour time point only 7 fish were collected as some fish died after the injection.  Since mineral oil 
was used as a carrier for the PMA, 9 fish were treated with mineral oil as a control and tissues were 
collected from these fish 168 hours after treatment. 
For tissue sampling, the fish were again anesthetized in MS-222.  Blood was collected from the 
caudal vein and 200 units of heparin (in 0.85% sodium chloride) was added to prevent clotting.  In 
addition, gill, spleen, head kidney and liver samples were collected from all fish.  These tissues were 
placed in sterile eppindorf tubes and flash frozen in liquid nitrogen and stored at -80°C until needed 
for analysis. 
The peripheral blood leukocytes were isolated from blood based on the differing density of 
leukocytes compared to erythrocytes.  Blood was centrifuged at 200g for 10 minutes at room 
temperature and the buffy coat was transferred into a new tube.  The volume was topped up to 25mL 
with L-15 media (Sigma) and 10mL of histopaque-1077 (Sigma) was layered at the bottom of the 
sample.  This was centrifuged for 1 hour at 400g and the leukocyte layer at the histopaque-L15 
interface was transferred into a new tube.  An equal volume of L-15 was added and the sample was 
centrifuged at 400 g for five minutes.  The pellet was re-suspended in 1mL of 1xPBS, transferred into 
an eppindorf tube and centrifuged at 400g for 1 minute.  The pellet was flash frozen in liquid nitrogen 
and stored at -80°C until needed for analysis. 
2.4.2 Total RNA Isolation 
Total RNA was isolated from 50mg tissue pieces.  Tissue was homogenized in 500µL of Trizol 
(Invitrogen) with a motorized pellet pestle and genomic DNA was sheared with a 23 gauge needle.  
An additional 500µL of Trizol was added and the mixture was incubated at room temperature for 5 
minutes, after which 200µL of chloroform (Fisher Scientific) was added.  This mixture was vortexed 
for 20 seconds, allowed to settle and centrifuged for 15 minutes at 12,000 g.  RNA was precipitated 
by the addition of 500µL of 2-propanol to the upper layer, followed by 10 minute incubation at room 
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temperature and centrifugation for 10 minutes at 12,000 g.  The RNA pellet was washed with 1mL of 
70% ethanol in DEPC-water and centrifuged for 5 minutes at 7,500 g.  The pellet was re-suspended in 
20µL - 80µL of DEPC-water (Fermentas first strand cDNA synthesis kit), depending on the pellet 
size, and heated at 70°C to aid dissolving.  The concentration of the RNA was measured at 260nm on 
the Cary UV 50 visible spectrophometer and was stored at -80°C until needed for analysis. 
2.4.3 Northern Blotting 
Three micrograms of total RNA was separated on an agarose gel and transferred to a nylon membrane 
for detection of S25-7 and INVX transcripts.  The RNA was denatured with 1 hour incubation at 
50°C in 6.75% glyoxal, 50% dimethyl sulfoxide and 20mM sodium phosphate pH7.  Following this 
incubation the mixture was quenched on ice for 3 minutes and 2µL of loading dye (50% glycerol, 
10mM sodium phosphate pH7, 0.25% bromophenol blue, 0.25% xylene cyanol) was added.  The 
entire sample was then loaded into a 1% agarose gel and separated in 10mM sodium phosphate pH7.  
To prevent RNA degradation the Mupid electrophoresis unit (Helix technologies) was treated with 
5% hydrogen peroxide and the running buffer was treated with diethyl pyrocarbonate (DEPC, Sigma).  
The samples were elctrophoresed at 50V until the bromophenol blue dye front reached approximately 
¼ from the bottom of the gel, which took approximately 90 minutes.  During the elctrophoresis 
100mL of running buffer was circulated from the cathode to the anode every 15 minutes to ensure 
constant pH.  After electrophoresis the gel was stained with 1µg/mL of ethidum bromide in 50mM 
sodium hydroxide, followed by neutralization in 0.2M Tris-HCl pH7.4.  The gel was visualized on 
the Fluorchem 8000 followed by incubated in 10xSSC (1.5M sodium chloride and 0.15M trisodium 
citrate dehydrate). 
After the electrophoresis, RNA was transferred onto a nylon membrane (Osmonics Inc).  A long 
piece of filter paper was soaked in 10xSSC and the ends were placed in a pool of 10xSSC.  This was 
used as the wick to draw up 10xSSC for RNA transfer.  The gel was placed onto a soaked filter paper 
and both were placed on top of the wick.  A nylon membrane cut to the exact size of the gel was 
soaked in de-ionized water, equilibrated in 10xSSC and placed on top of the gel.  To prevent buffer 
bypass plastic wrap was placed around the gel and another soaked filter paper, also cut to the size of 
the gel, was placed on top of the membrane.  A pipette was rolled across the filter paper to remove 
any air bubbles trapped between the gel and the membrane.  Finally, two more filter papers and a 
stack of paper towels, all cut to the size of the gel, were placed on top of the filter paper.  A weight 
was placed on top of the transfer apparatus and this was left overnight to allow for RNA transfer. 
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The next morning the transfer was disassembled and the gel was imaged on the Fluorochem 8000 
to ensure RNA transfer.  The membrane was soaked in 2xSSC and air dried for 30 minutes, followed 
by UV crosslinking on Fluorchem 8000.  The membrane was then stored at room temperature 
between two filter papers until probed. 
2.4.4 Preparation of a DIG-Labeled Probe 
Digoxigenin labeled DNA probes were used to detect S25-7 and INVX transcripts in the northern 
blots.  As a control, the 40S ribosomal protein S11 transcript was also detected and used to correct for 
any unequal RNA loading.  Plasmids encoding fragments of these genes were used as a template to 
amplify the DIG-labeled probes.  A cDNA fragment of S25-7 previously cloned into pcDNA3.1 was 
used as a template for S25-7 DIG probe synthesis.  A template for the INVX probe was constructed 
by amplifying a fragment of the INVX 3’ UTR from gill cDNA and cloning it into pGEM T-easy 
(Promega) with the following primers: INVX sense (5’ TCAACCACAGCACCTGATGG 3’) and 
INVX antisense (5’GGGATGGGAAAGTTTGGGTG ‘3).  A fragment of the S11 cDNA sequence 
was also amplified and cloned into pGEM T easy with the following primers: S11 sense (5’ 
AGCAGCCAACCATCTTCCAG 3’) and S11 antisense (5’ ACTCTCCGACGGTAACAATG 3’).  
Both INVX and S11 fragments were amplified under the following conditions: 95°C for 5 minutes, 
35 cycles of 95°C for 30 seconds, 55°C for 30 seconds, 72°C for 1 minute, followed by a 5 minute 
extension at 72°C.  The INVX and S11 fragments were separated on a 1% agarose gel, purified and 
ligated as described for pRSET A ligation, with the substitution of 50ng pGEM T-easy plasmid for 
pRSET A.  The ligation reaction was transformed into XL1-blue E. coli competent cells and plasmids 
were purified from white colonies and sequenced to verify the INVX and S11 inserts. 
The DIG labeled probes were synthesized with the DIG probe synthesis kit (Roche) which contains 
dUTP nucleotides bound to digoxigen molecules.  The DIG label is inserted into the PCR product and 
can be recognized by an antibody during northern blot detection.  Plasmids encoding gene fragments 
were used as a template for the probe reaction and the primers for S25-7 are as follows: S25-7 sense 
(5’ GGAGAAGCCCCCCT 3’) and S25-7 antisense (5’ATCATCCTGGGGAAAGCTGC 3’).  The 
primers used to clone INVX and S11 into pGEM T easy were also used for synthesis of the DIG-
labeled probes.  The probes were amplified under the following conditions: 95°C for 2 minutes, 35 
cycles of 95°C for 30 seconds, 55°C for 30 seconds, 72°C for 2 minutes followed by a 7 minutes 
extension time.  A control reaction, without DIG-dUTP, was run in parallel.  Both the labeled and 
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unlabeled fragments were separated on a 1.5% agarose gel and visualized with the Fluorchem 8000 to 
verify DIG labeling, indicated by a size difference between the labeled and unlabeled fragments. 
2.4.5 Detection of Northern Blot 
To detect INVX or S25-7 transcripts, the membrane was first soaked in 2xSCC and placed in 
hybridization buffer (4.65xSSC, 46.5% formamide, 46.5 mM sodium phosphate pH7, 1.9% blocking 
reagent, 0.1% sarkosyl and 6.5% SDS).  Pre-hybridization of the membrane was carried out at 50°C 
for 2 hours.  During this time the probe solution was prepared by the addition of 19µL of either the 
S25-7 and S11 probes or the INVX and S11 probes to 6mL of hybridization buffer.  This solution was 
boiled for 10 minutes, quenched on ice and added to the membrane.  The hybridization of the probe to 
the blot was performed overnight at 50°C with gentle rotation.  After hybridization, the membrane 
was washed for 5 minutes at 20°C with 2 x wash buffer (2xSSC with 0.1% SDS) followed by two 
washes at 65°C with 0.1 x wash buffer (0.1xSSC with 0.1% SDS).  The membrane was then 
incubated for 5 minutes in DIG buffer 1 (0.1M maleic acid and 0.15M sodium chloride).  The 
membrane was blocked with DIG buffer 2 (1% blocking reagent in DIG buffer 1) for 30 minutes and 
then probed with an anti-digoxigenin alkaline phosphatase conjugated antibody (Roche) at a 1:10,000 
dilution for 30 minutes.  The membrane was washed 5 times in DIG buffer 1 containing 0.03% 
Tween 20, followed by a 5 minute wash with DIG buffer 3 (0.1M Tris-HCl pH9.5, 0.1M sodium 
chloride and 50mM magnesium chloride).  The substrate CDPstar (Roche) was added to the 
membrane and the membrane was placed in a sealing bag and incubated for 15 minutes at 37°C. 
Due to differences in signal strength between S25-7 and INVX blots, different detection methods 
were utilized.  The S25-7 northern blots were detected on the Fluorchem 8000 using the 
chemiluminescence filter with an open iris and no light for 20 minutes under medium sensitivity.  The 
INVX northern blots were detected with x-ray film (Pierce).  The film was placed on the blot in an x-
ray cassette and this was left to expose for 10 minutes, 15 minutes and overnight at -80°C.  The film 
was developed with the CP1000 automatic film processor (AGFA) and the blots were scanned with 
the A920 printer (Dell Computers).   
2.4.6 Densitometry Analysis of the Northern Blot 
Densitometry analysis was performed to measure changes in S25-7 and INVX transcript levels.  The 
intensitys of the INVX, S25-7 and S11 signals were measured with the Total Lab 100 (Fotodyne Inc.) 
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analysis software and the ratio of S25-7 and INVX to S11 was calculated to correct for unequal 
sample loading.  An area of interest was created around all bands and automatic detection was used to 
create lanes, measure background and detect bands.  The bands were detected with a minimum slope 
of 100, as a measure of how pronounced the band was from the background, a noise reduction value 
of 5 to eliminate small local peaks and a percentage maximum peak of 3 to discard peaks that were 
less than this percentage of the largest detected peak.  The rolling ball background subtraction method 
was used with a radius of 200.  The program did not always automatically recognize all lanes and 
bands, in which case manual lane addition and band detection was performed.  Finally, in some cases 
the background of the membrane was very high and a smaller radius was used for the background.  
By calculating the ratio of the S25-7 and INVX band volumes to the S11 band volumes, changes in 
S25-7 and INVX transcript levels can be measured.  The average of the INVX/S11 and S25-7/S11 
ratios was calculated for each time point and the results were plotted along with error bars 
representing the standard deviation of these means. 
2.4.7 RT-PCR  
The amount of RNA isolated from peripheral blood leukocytes (PBLs) was to low to perform 
northern blot analysis, instead reverse transcriptase PCR was used to examine INVX and S25-7 
transcript levels.  The first strand cDNA synthesis kit (Fermentas) was used to synthesize cDNA from 
0.5µg of total RNA.  The RNA was incubated for at 70°C with a poly(dT)18 primer for 2 minutes to 
allow primer binding.  The reaction was quenched on ice for 3 minutes and the reverse transcriptase 
reaction mixture was added (5 x reaction buffer, 10mM dNTPs, RNase inhibitor and MMLV reverse 
transcriptase).  This was incubated at 37°C for 1 hour to allow cDNA synthesis followed by 5 minutes 
at 95°C.  The cDNA was stored at -20°C until needed. 
As a control for RT-PCR, the elongation factor EF-1α transcript was used to correct for unequal 
loading.  Amplification of PBL transcripts was performed with the following primers: INVX sense 
(5’ CAAACCCTGAGCCTCTGACC 3’), INVX antisense (5’ GTCTGGTTCACATCTCTTGG 3’), 
Ef1α sense (5’ GAGTGAGCGCACAGTAACAC 3’) and Ef1α antisense (5’ 
AAAGAGCCCTTGCCCATCTC 3’).  The primers used for S25-7 amplification are the same as 
described above for S25-7 DIG probe synthesis.  For amplification, 1µL of undiluted cDNA was 
amplified under the following conditions: 95°C for 5 minutes followed by 28 cycles or 29 cycles of 
95°C for 30 seconds, Tm for 30 seconds and 72°C for 1 minute followed by a 5 minute extension at 
72°C.  The Ef1α transcripts were amplified with 28 cycles at 57°C, S25-7 for 29 cycles at 57°C and 
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INVX for 29 cycles at 55°C.  PCR reactions were separated on a 1% agarose gel, stained with 
ethidium bromide and imaged with the Fluorchem 8000. 
RNA samples from all tissues collected from the first three sets were also analyzed for interleukin-
1β expression by RT-PCR.  The cDNA was synthesized as described above and 1µL of cDNA was 
amplified for either IL-1β or Ef-1α as a loading control.  The following primers were used: IL-1β 
sense primer (5’ CCTGATGAATGAGGCTATGG 3’) and IL-1β reverse primer (5’ 
TTCCTGAAACTGGCAGACTC 3’).  The PCR conditions for IL-1β amplification were as follows, 
95°C for 5 minutes followed by 35 cycles at 95°C for 30 seconds, 53°C for 30 seconds, 72°C for 1 
minute, followed by a 5 minute extension at 72°C.  These reactions were run out on a 1% agarose gel, 
stained with ethidium bromide and imaged with the Fluorchem 8000.  The control Ef1α was also 
amplified, with a Tm of 57°C and 27 cycles. 
Finally, to compare with northern blot results, all tissues from the first three sets were examined for 
INVX transcript level by RT-PCR.  Again, cDNA was synthesized as described above and a duplex 
PCR reaction was set up with amplification of 1µL of cDNA with both the INVX primers and Ef1α 
primers with the following conditions: 95°C for 5 minutes followed by 27 cycles of 95°C for 30 
seconds, 55°C for 30 seconds, 72°C for 1 minute followed by a 5 minute extension at 72°C.  These 
reactions were separated on a 1% agarose gel, stained with ethidium bromide and imaged on the 
Fluorchem 8000. 
To measure the change in INVX, S25-7 and IL-1β transcript levels, densitometry analysis was 
performed with the Total Lab 100 software, as described above.  The ratio of the volume of the 
INVX, S25-7 and IL-1β bands to the volume of the Ef-1α band was used to correct for unequal 
sample loading.   
2.4.8 Total Protein Isolation  
Total cellular protein was extracted from 100 – 200mg pieces of tissue for western blot analysis.  
Lysis buffer (1% non-idet P40, 50mM Tris-HCl pH7.4 and 0.15M sodium chloride) was added to 
tissue samples at a ratio of 2.5 µL/mg tissue and samples were kept on ice at all times.  To prevent 
protein degradation, the lysis buffer was supplemented with a number of protease inhibitors, 
including 2mM PMSF and a protease inhibitor cocktail (Sigma), consisting of AEBSF, EDTA, 
Bestatin, E-64, leupeptin and aprotinin.  This resulted in wide spread inhibition of serine, cysteine and 
metalloprotein protease inhibitors in tissues. 
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The tissues were lysed on ice with brief pulses of sonication after which cellular debris was cleared 
by centrifugation at 15,000 rpm for 10 minutes at 4°C.  The lysate was transfer to a new tube and the 
protein concentration was measured by a modified Bradford assay.  The lysate was diluted 1:5 in lysis 
buffer, and 2µL of this was diluted in 80µL of de-ionized water.  This dilution was used to prevent 
interference from the NP-40 detergent.  The Bradford was performed as described above and a BSA 
standard curve made in a 1:40 diluted NP-40 buffer was used to calculate protein concentration. 
2.4.9 Western Blot Analysis 
One hundred milligrams of total protein was separated in a 12% polyacrylamide gel and transferred 
overnight, as described above.  After ponceau staining, the membrane was blocked for 2 hours at 
room temperature and probed with either anti-rtINVX antibody at a 1:80 dilution or anti-rTg antibody 
at a 1:150 dilution in blocking buffer for 1 hour.  Following three 5 minute washes in T-TBS, the 
membrane was probed with anti-rabbit IgG horse radish peroxidase conjugated (Promega) at a 
1:2,000 dilution in blocking buffer for 1 hour.  After another three 5 minute T-TBS washes, 1mL of 
ECL plus substrate (Amersham) was added to the membrane and incubated for 5 minutes in the dark.  
The blot was detected on the Fluorchem 8000 using the chemiluminescence filter for 10 minutes on 
medium sensitivity. 
2.4.10 Densitometry Analysis for Western blotting 
The densitometry analysis of western blots was performed with the Total Lab 100 software, as 
described above.  Both S25-7 and INVX are detected as a doublet, in order to quantify the total 
amount of protein, the intensity of both bands in the doublet were added together.  As a control for 
equal sample loading, the intensity of a 50kDa band from the ponceau was measured.  The ratio of the 
S25-7 and INVX bands to this control band was calculated to measure changes in protein levels.  The 
50kDa band is common to all blots and was used for analysis because there is no antibody against a 
control protein with unchanging levels.  
2.5 In vitro Time Course 
The macrophage-like cell line RTS-11 was also stimulated with PMA to examine changes in S25-7 
and INVX levels.  This cell line was developed and is maintained by the Bols lab at the University of 
Waterloo and the cells were generously provided by Stephanie DeWitte-Orr.  The cells were plated at 
a concentration of 2x107 cells / well in 6 well tissue culture plates in L-15 media without fetal bovine 
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serum.  The cells were treated with 2µg/mL PMA or an equivalent volume of DMSO and incubated at 
18°C.  The cells were collected at the following time points: 8, 24, 48, 96, 120 and 168 hours post-
stimulation.  The control cells were also collected at 168 hours after treatment.  The cells were 
centrifuged at 4000 rpm and split into two equal fractions, one for western blotting and the other for 
RT-PCR and the cell pellets were stored at -80°C until analysis.  
RT-PCR was performed on the RTS-11 sample because it is difficult to extract enough RNA for a 
northern blot.  Total RNA isolation, cDNA synthesis and RT-PCR were performed on the RTS-11 
samples in the same manner as described above for the PMA in vivo study.   
To extract protein, the cell pellet was re-suspended in 100µL of the NP-40 lysis buffer 
supplemented with protease inhibitors and incubated on ice for 30 minutes.  The cellular debris was 
cleared by centrifugation at 15,000 rpm for 10 minutes at 4°C and a modified Bradford assay was 
performed, as described above.  Western blot analysis was performed in the same manner as 
described for the PMA in vivo study.  Densitometry analysis for RT-PCR and western blotting was 





3.1 Production of Polyclonal Anti-rtINVX Antibody 
3.1.1 Purification of Recombinant Truncated INVX Protein 
Previous attempts at expressing a full length recombinant INVX protein, as well as other 
transmembrane proteins, have been hindered by low expression levels.  To increase recombinant 
protein expression, a truncated INVX gene, lacking both the cytoplasmic and transmembrane 
domains, was cloned into pRSET A.  The tINVX : pRSET A plasmid was isolated from transformed 
cells and the insert sequence was compared to the published INVX sequence to ensure proper reading 
frame and to check for sequence mutations.  This comparison verified that the INVX insert encoded a 
truncated protein identical to the full length INVX, lacking only the amino-terminal cytoplasmic and 
transmembrane domains.  Subsequently, large scale expression of the recombinant truncated INVX 
(rtINVX) protein was performed and the 6xHis sequence in the amino-terminal tag of the fusion 
protein was used to purify rtINVX.  Nickel resin is negatively charged, allowing the positively 
charged 6xHis tag to bind at alkaline pH.  As the pH decreases, weakly bound proteins are eluted 
followed by the elution of rtINVX.  To verify size and purity of the rtINVX elutions, western blot and 
SDS-PAGE analysis was performed, as shown in figure 3.1.  Samples from the lysate, column flow 
through, pH8, pH6.5, pH5.9 and pH4.3 elutions were separated on a 12% SDS-PAGE gel and either 
stained with Coomassie blue or transferred onto a nitrocellulose membrane and probed with an anti-
Xpress antibody.  While rtINVX has an expected size of approximately 22.3 kDa, it migrates at an 
apparent size of approximately 30kDa.  This discrepancy is minor and likely caused by variation in 
the migration of the pre-stained SeeBlue (Invitrogen) standard bands, as the expected sizes of these 
bands are only an estimate.  The majority of the rtINVX protein is eluted in the pH5.9 wash, although 
some is lost in the pH6.5 wash.  The rtINVX protein appears as a doublet on both the SDS-PAGE and 
western blot, which may be caused by a partial degradation of the rtINVX protein by the host cell.  
The induction of protein expression was performed for 2 hours and it is possible that during this time 
a portion of the carboxy-terminus was cleaved by an E. coli protease.        
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Figure 3.1: Nickel affinity purification of rtINVX.  Lysates from host cells expressing rtINVX 
were incubated overnight with nickel resin to facilitate the binding of the 6xHis tag at the amino-
terminus of rtINVX to the negatively charged resin.  The column flow through, containing unbound 
protein was removed, sticky proteins were washed away and the rtINVX was eluted.  Samples from 
the purification were run on a 12% polyacrylamide gel and either stained with Coomassie blue or 
transferred onto a nitrocellulose membrane for western blot analysis with anti-Xpress antibody.  (A) 
Western blot analysis of the nickel column washes and elutions, including ponceau stain, to verify the 
identity of the isolated protein.  (B) Coomassie staining analysis of nickel column to ensure purity of 
isolated rtINVX.  Abbreviations: L – lysate, FT – flow through, numbers indicate the pH of the 8M 





































3.1.2 Rabbit Antibody Titre 
The pH5.9 elutions of rtINVX were combined, concentrated to 1mg/mL, dialyzed into 1xPBS, mixed 
with Freund’s complete adjuvant and used to vaccinate two rabbits.  The adjuvant forms an emulsion 
with rtINVX which delays the antigen release and aids phagocytosis by antigen presenting cells in the 
rabbits.  In addition, Freund’s complete adjuvant also contains heat-killed mycobacteria, which 
enhances the immune response, possibly by activating antigen presenting cells.  After the initial 
vaccination the rabbits were boosted three times at three week intervals with an emulsion of rtINVX 
and Freund’s incomplete adjuvant, which lacks the mycobacteria.  The repeated boosts maximize the 
anti-rtINVX antibody production.  The titre of anti-rtINVX antibody was monitored by enzyme-
linked immunosorbent assays (ELISA) during the vaccination procedure, as shown in figure 3.2.  The 
pre-immune serum, collected prior to the first immunization, shows very low levels of rtINVX 
reactive antibodies.  However, the levels of reactive antibody increase upon each subsequent boost, 
with the highest level found in the exsanguination serum.  The anti-rtINVX antibody in the 
exsanguination serum maintains reactivity up to a serum dilution of 1:500,000 and the highest level of 
reactivity is found in the 1:500 serum dilution.  While the 1:100 would be expected to have the 
highest reactivity, there is an inhibition of antigen binding in this dilution because of the high 
antibody concentration.  Although serums from both rabbits show high affinity for rtINVX, only one 
serum was used for all subsequent western blot analysis.  The ELISA analysis of anti-rtINVX 
antibody titre for this rabbit is shown in figure 3.2. 
3.2 Detection of an Immune Response in the in vivo PMA Time Course 
In order to examine the success of the PMA-induced immune system stimulation, transcript levels of 
the cytokine interleukin-1β (IL-1β) were measured.  This cytokine is produced and released by 
activated macrophage (Janeway et al, 2001) and is involved in the innate immune response.  It plays a 
role in the recruitment of the adaptive immune system by activating T cells.  IL-1β was chosen as an 
indicator of immune system activation because it is upregulated during an immune response.  Reverse 
transcriptase PCR was used to measure the level of IL-1β transcript to determine if the levels increase 
after PMA stimulation, indicating successful immune activation. 
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Figure 3.2: Anti-rtINVX antibody titre as measure by ELISA.  A small volume of serum was 
collected from each rabbit before immunization and before each subsequent boost.  Levels of rtINVX 
reactive antibodies in these sera, as well as in the exsanguination serum were measured by ELISA 
analysis.  Serum was diluted to 1:100, 1:500, 1:1000, 1:5000, 1:10000, 1:50000, 1:100000 and 
1:500000 and incubated with rtINVX.  Binding of rtINVX specific antibodies was detected with an 
anti-rabbit IgG alkaline phosphatase conjugated secondary antibody and p-NPP substrate.  The 
alkaline phosphatase enzyme cleaves the p-NPP substrate to give a coloured product that can be 
measured at 405nm.          







































Total RNA was isolated from gill, spleen, head kidney and liver tissues of 3 fish from each of the 
time points, 8, 24, 48, 96, 120 and 168 hours post-stimulation as well as from 3 untreated control fish.  
The samples were analyzed in sets, with one set representing a group of seven fish, one sacrificed at 
each time point.  Isolated RNA was reverse transcribed and the cDNA was PCR amplified with 
primers specific for IL-1β and Ef-1α.  Amplification of elongation factor Ef-1α is used as a control to 
correct for any unequal loading of template in the PCR reaction because the levels of Ef-1α remain 
constant during the PMA stimulation.  PCR amplification of IL-1β and Ef-1α were performed 
separately due to the difference in transcript levels, IL-1 β is present in very low levels and must be 
subjected to 35 cycles for detection while Ef-1α is present in much higher levels and is detected after 
27 cycles.  A duplex PCR amplifying both IL-1 β and Ef-1α would be inaccurate to use for 
densitometry analysis due to the extremely high levels of Ef-1α.  After amplification, the IL-1β and 
Ef-1α PCR products were separated on a 1% agarose gel and visualized under UV light.  
Densitometry analysis was then performed with Total Lab 100 software.  The intensity of the IL-1β 
band and the corresponding Ef-1α band were measured and the background was subtracted.  The ratio 
of the IL-1β intensity to the Ef-1α intensity was calculated and the average ratio for each time point 
was determined.  A comparison of these ratios across the time points allows for detection of an 
increase in IL-1β transcript levels, indicating immune system activation.  To determine if the change 
in transcript levels is significant, statistical analysis was performed.  A one-way ANOVA was 
performed to determine if there was a significant difference between the mean ratios for each time 
point and an LSD post hoc test was performed to determine which time points were significantly 
different from each other. 
3.2.1 Analysis of Interleukin-1β Transcript Levels in PMA Stimulated Gill 
Total RNA was isolated from gill tissue of 3 fish sacrificed at each of the time points, 8, 24, 48, 96, 
120 and 168 hours after PMA stimulation, as well as from 3 untreated control fish.  Reverse 
transcription was performed and cDNA was amplified separately for both IL-1β and Ef-1α.  
Amplification of IL-1β and the corresponding Ef-1α for the three fish sets analyzed are shown in 
Figure 3.3.  All three sets show two distinct peaks of IL-1β transcript, one at the 8 hour time point and 
another at the 120 hour time point.  Levels of IL-1β are decreased at the 24 hour time point in both set 
one and set two with the lowest levels at 48 hours.  IL-1β transcript then begins to increase at 96 
hours and reaches a maximum at 120 hours post-stimulation.  In set three, the IL-1β transcript 
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Figure 3.3:  RT-PCR analysis of IL-1β transcript levels in PMA stimulated gill.  Total RNA was 
isolated from gill tissue of three fish from each of the time points 8, 24, 48, 96, 120, and 168 hours 
post stimulation, as well as from three untreated controls.  The animals were grouped into sets for 
analysis, with one set consisting of seven fish, one from each time point and one untreated control.  
The RNA was reverse transcribed and the resulting cDNA was amplified for IL-1β as well as the 
control, elongation factor Ef-1α.  These reactions were performed separately due to the difference in 
transcript levels of IL-1β and Ef-1α, with IL-1β requiring 35 cycles for amplification while Ef-1α 
required 27 cycles.  Ef-1α is unaffected by the PMA stimulation and serves as a control to correct for 
any unequal sample loading during the RT-PCR procedure.  The reactions were separated on a 1% 
agarose gel, stained with ethidium bromide and visualized under UV light.  The RT-PCR results for 
all three gill sets analyzed are shown in this figure, along with the densitometry analysis.  The IL-1β 
amplification product is shown in the upper gel for each set while the Ef-1α amplification product is 
shown in the bottom gel.  The densitometry analysis shown in the bar graph represents the average 
IL-1β/Ef-1α ratio for set two and set three, with error bars representing the standard deviation of the 
means.  Set one was not included in the analysis because there is no IL-1β present in the untreated 
control fish.  The letters above the error bars represent the results of ANOVA and LSD post hoc 
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decreases at 48 hours and is absent at 96 hours, but similar to the other sets, shows a high level at 120 
hours post-stimulation.  In set one, there is no IL-1β transcript detected in the control fish, however, 
in both set two and set three, there is a low level of IL-1β present in the control samples.  
Densitometry analysis was performed on these sets to verify an increase in IL-1β transcript levels 
after stimulation.  The intensity of the IL-1β band and its corresponding Ef-1α band was measured for 
each time point and the ratio of the IL-1β volume to the Ef-1α volume was calculated.  Figure 3.3 
shows a bar graph representing the mean IL-1β / Ef-1α ratio for each time point, along with error bars 
representing the standard deviation of each average.  The graph clearly demonstrates that while there 
is a low level of IL-1β transcript present in the control sample of set two and set three, the transcript 
level is elevated at both the 8 hour and 120 hour time points.  In addition, this analysis also clearly 
demonstrates the decreased transcript levels at the 24 to 96 hour time points.  ANOVA analysis 
indicates that there is a significant difference in the means of the time points for gill IL-1β transcript 
level (p=0.034), while LSD post hoc test demonstrates that the transcript level at 8 hours and 120 
hours are significantly higher then the control (p=0.034 and p=0.024).  Also, transcript level at 8 
hours is significantly higher than 48 and 96 hours (p=0.007 and p=0.026).  Likewise, transcript level 
at 120 hours is significantly higher than 48 and 96 hour time points (p=0.05 and p=0.019).   Thus, an 
immune response has been activated in the gill of PMA treated fish.   
3.2.2 Analysis of Interleukin-1β Transcript Levels in PMA Stimulated Spleen 
As described above for gill, total RNA was isolated from spleen tissue of 3 fish from each of the time 
points, 8, 24, 48, 96, 120 and 168 hours post-stimulation as well as from 3 untreated control fish.  The 
RNA was reverse transcribed and both IL-1β and Ef-1α were amplified separately.  The amplification 
of these two transcripts are shown in figure 3.4 for all three sets analyzed.  The control samples and 
the 8 hour time points for all sets show an absence of IL-1β transcript, with an increase at the later 
time points of 96, 120 and 168 hours post-stimulation.  In set two, IL-1 β is also expressed transiently 
at the 24 hour time point.  Densitometry analysis was performed by calculating the ratio of the 
intensity of the IL-1β band to the corresponding Ef-1α band.  An average of this ratio was calculated 
for each time point and this is shown in figure 3.4, along with error bars, representing the standard 
deviation for each average.  The densitometry analysis shows that the level of IL- β transcript is 
elevated at 96 hours after PMA stimulation.  There is also transcript present at the 120 and 168 hour 
time points, but the error bars for these time points are very large.  This occurs because while IL-1 β 
transcript is present at these time points in all three sets, it is present at very different levels.  ANOVA 
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Figure 3.4: RT-PCR analysis of IL-1β transcript levels in PMA stimulated spleen.  Total RNA 
was isolated from spleen tissue of three fish from each time point 8, 24, 48, 96, 120 and 168 hours 
post-stimulation as well as from three untreated control fish.  The samples were analyzed in sets, as 
described above for gill IL-1β transcript analysis.  RNA was reverse transcribed and amplified 
separately for both IL-1β and the control Ef-1α.  PCR products were separated on a 1% agarose gel, 
stained with ethidium bromide and visualized under UV light.  Amplification of IL-1β transcript 
along with the corresponding Ef-1α for all three sets is shown in this figure, along with the 
densitometry analysis of these results.  The upper gel for each set is the IL-1β amplification product 
while the lower gel is the EF-1α amplification product.  The densitometry analysis is summarized in 
the bar graph, which represents the average IL-1β/Ef-1α ratio for each time point, with error bars 
representing the standard deviation of these means.  The letters above the error bars represent the 
results of ANOVA and LSD post hoc analysis, where ‘a’ is significantly different from ‘b’.  The three 
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analysis indicates that there is a significant difference in the means of each time point (p=0.046) 
while LSD post hoc analysis indicates that the 96 hour time point is significantly higher than control, 
8, 24 and 48 hour time points (p=0.006, p=0.006, p=0.008 and p=0.006).  Thus, at the later time 
points, there is an immune response occurring in the spleen.        
3.2.3  Analysis of Interleukin-1β Transcript Levels in PMA Stimulated Head Kidney 
Total RNA was also isolated from head kidney tissue of 3 fish at each of the time points, 8, 24, 48, 
96, 120 and 168 hours after PMA stimulation as well as from 3 untreated fish.  The RNA was reverse 
transcribed and cDNA was amplified separately to measure levels of IL-1β transcript and Ef-1α 
transcript.  Figure 3.5 shows the amplification of head kidney IL-1β, the corresponding Ef-1α, as well 
as the densitometry analysis of IL-1β transcript levels.  Similar to the results in spleen, the IL-1β 
transcript is absent in the head kidney of control fish as well as in the early time points, with an 
increase at the later time points, beginning at 96 hours and reaching maximal levels at 120 hours after 
PMA treatment.  While IL-1β transcript is clearly present in set two and set three at 96 and 168 hours 
post- stimulation, set one shows very low or no IL-1β at these time points.  This causes large standard 
deviation for the average intensity ratio at the 96 and 168 hour time points for head kidney, making it 
difficult to show a significant increase in transcript level.  ANOVA analysis indicates that there is no 
significant difference in the IL-1β transcript levels during PMA stimulation (p=0.163).  The error bar 
for the 120 hour time point is very small, and LSD post hoc testing gives a p value of 0.06.  Although 
this is not statistically significant, it is very close, and if the average IL-1β/Ef-1α ratio increased to a 
slightly higher value, it would have likely been a significant increase.  Thus, although the IL-1β 
transcript is clearly increasing after PMA stimulation, this increase is small, and cannot be shown to 
be statistically significant.  
3.2.4 Analysis of Interleukin-1β Transcript Levels in PMA Stimulated Liver 
The transcript level of IL-1β was also analyzed in total liver RNA.  As described above, RNA was 
isolated from 3 individuals at each of the time points 8, 24, 48, 96, 120 and 168 hours post-
stimulation as well as from 3 untreated control fish.  The RNA was reverse transcribed and cDNA 
was amplified separately with IL-1β and Ef-1α primers.  Since the liver is not an immune organ, it is 
not expected to express IL-1β.  As shown in figure 3.6, there is amplification of the Ef-1α control but 




Figure 3.5: RT-PCR analysis of IL-1β transcript levels in PMA stimulated head kidney.  Total 
RNA was isolated from head kidney of three fish from each of the time points 8, 24, 48, 96, 120 and 
168 hours post-stimulation as well as from three untreated control fish.  RNA was reverse transcribed 
and amplified for both IL-1β and Ef-1α, in separate PCR reactions, as described above for gill.  The 
resulting PCR products were separated on a 1% agarose gel, stained with ethidium bromide and 
visualized under UV light.  This figure shows the amplification of IL-1β in the upper gel for each set 
as well as the corresponding Ef-1α in the lower gel, for all three sets.  The densitometry analysis 
shown in the bar graph represents the average IL-1β/Ef-1α ratio for each time point, with error bars 
representing the standard deviation of each mean.  The three sets analyzed for head kidney are the 
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Figure 3.6: RT-PCR analysis of IL-1β transcript levels in PMA stimulated liver.  Total RNA was 
isolated from liver tissue of three fish from each of the time points 8, 24, 48, 96, 120 and 168 hours 
post-stimulation as well as from three untreated control fish.  RNA was reverse transcribed and 
amplified for IL-1β and Ef-1α in separation reactions, as described above for gill.  The resulting PCR 
products were separated on a 1% agarose gel, stained with ethidium bromide and visualized under 
UV light.  This figure shows the IL-1β amplification, in the upper gel of each set, as well as the 
corresponding Ef-1α amplification, in the lower gel, for all three sets.  There was no densitometry 
analysis performed on these results because there was no IL-1β detected.  These three sets correspond 
to the three sets analyzed for IL-1β transcript in spleen, gill and head kidney.   
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3.3 Analysis of Invariant Chain Transcript Levels in the PMA in vivo Time 
Course 
Both northern blotting and RT-PCR were used to analyze S25-7 and INVX transcript levels during a 
PMA stimulated immune response.  Total RNA was isolated from gill, spleen, head kidney, 
peripheral blood leukocytes and liver of six fish from each of the time points 8, 24, 48, 96, 120 and 
168 hours post-stimulation as well from six untreated control fish.  RT-PCR was performed to 
measure transcript levels in peripheral blood leukocytes due to the low level of isolated RNA.  RNA 
isolated from the other tissues was subjected to northern blot analysis.  For S25-7 transcript analysis, 
three RNA sets were separated on the same 1% agarose gel, while all six sets were separated on the 
same gel for INVX analysis.  Combining multiple sets on one membrane limits variability by 
maintaining constant electrophoresis, probing and detection conditions for all sets, allowing for more 
accurate comparison of results between sets.  After electrophoresis, the RNA was transferred onto a 
nylon membrane and probed with DIG-labeled probes for 40S ribosomal protein S11 transcript along 
with either S25-7 or INVX transcripts.  S11 is used as a loading control because transcript levels will 
not be affected by the PMA stimulation and its size is significantly different from S25-7 and INVX 
which allows both control and experimental bands to be detected on the same blot.  Again, this 
decreases the variability associated with comparison of two different blots.  Densitometry analysis 
was performed on all blots using the Total Lab 100 software.  Briefly, the intensity of the S25-7, 
INVX and S11 bands were measured and, after correcting for background, the ratio of the S25-7 or 
INVX signal to the corresponding S11 signal was calculated to correct for unequal RNA loading.  
The average ratio for each time point was calculated and these averages were analyzed by ANOVA 
and LSD post hoc testing to identify any significant changes in transcript levels.  
3.3.1 Analysis of Invariant Chain Transcript Levels in PMA Stimulated Gill   
As described above, total RNA was isolated from gill tissue of six fish from the time points 8, 24, 48, 
96, 120 and 168 hours post-stimulation as well as from six untreated control fish and probed for both 
S25-7 and INVX.  Representative S25-7 and INVX blots, along with densitometry analysis are shown 
in figure 3.7.  A UV image of the 18S and 28S ribosomal RNA is also included for both sets of blots 
to show the quality of RNA isolation as well as equal sample loading.  The signals for all three probes 
used are very different, with S25-7 giving a much more intense signal than S11, while S11 gives a 
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much more intense signal than INVX.  The INVX signal was so low that x-ray film was used for 
detection.  Since there is a constant amount of S11 transcript in both blots, these results indicate that 
the S25-7 transcript is present at a higher level in gill than the INVX transcript.  As shown by 
densitometry analysis, there appears to be very little variation in the transcript level of S25-7 during 
the time course.  The ANOVA analysis confirmed this result with a p value of 0.407.  In the case of 
INVX, there may be a slight increase in transcript levels between control and 8 hours post-
stimulation, with a subsequent decrease at later time points, such that after 8 hours there appears to be 
no difference between control and treated samples.  However, ANOVA analysis indicates the 
difference in INVX transcript levels between control and 8 hours is not significant (p=0.255), which 
is likely due to the large error bar associated with the mean INVX/S11 ratio of the 8 hour time point.  
The difference in signal strength from the INVX and S11 probe resulted in a saturation of the S11 
signal in many samples, as seen in figure 3.7, specifically in set one results.  This makes it difficult to 
accurately measure the intensity of these signals to compare with INVX.   
To verify the northern blot results, RT-PCR was also performed on gill RNA to confirm that 
INVX levels remain constant during the immune response.  Figure 3.8 shows RT-PCR analysis 
performed on three sets of gill RNA along with the densitometry analysis.  For this analysis, a duplex 
PCR was performed in which both INVX and the control transcript Ef-1α were amplified under the 
same conditions.  ANOVA analysis of RT-PCR results confirm that there is no change in gill INVX 
transcript levels during immune system stimulation, even at the 8 hour time point (p=0.931).  This 
analysis also confirms the large variability between samples within each time point, as shown by the 
large error bars, indicating that the variability within each time point is not due to the northern blot 
technique.  The large variation in transcript levels between fish within the same time point makes it 
difficult to determine if there are any global changes in transcript level, however, since the means are 
all quite similar, it appears that both S25-7 and INVX transcript levels remain unchanged in gill tissue 
during an immune response.     
3.3.2 Analysis of Invariant Chain Transcript Levels in PMA Stimulated Spleen 
Again, as described above, total RNA was isolated from spleen tissue of six fish at each of the time 
points 8, 24, 48, 96, 120 and 168 hours post-stimulation as well as from six untreated control fish and 
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Figure 3.7: Northern blot analysis of S25-7 and INVX transcript levels in PMA stimulated gill.  
Total RNA was isolated from gill tissue of six fish sacrificed at each of the time points 8, 24, 48, 96, 
120 and 168 hours post stimulation, as well as from six untreated control fish.  RNA was separated on 
a 1% agarose gel, stained with ethidium bromide, visualized under UV light, transferred onto a nylon 
membrane and probed for either S25-7 or INVX with DIG-labeled probes.  In addition, the blots were 
also probed for the 40S ribosomal protein S11 transcript.  This transcript remains unchanged during 
PMA stimulation and serves as a loading control.  A representative blot for both S25-7 and INVX is 
shown in this figure, along with densitometry analysis for both transcripts.  To analyze changes in 
transcript levels, densitometry analysis was performed by measuring the intensity of the INVX, S25-7 
and S11 bands.  A ratio of INVX or S25-7 to the corresponding S11 signal was calculated and the 
average of ratio for each time point was plotted, along with error bars representing the standard 
deviation for each mean.  The additional sets used for densitometry analysis are shown in appendix A, 
figure A.1.  The sets used for S25-7 and INVX northern blot analysis are corresponding, such that set 
1 in the S25-7 northern blot consists of the same fish as set 1 in the INVX northern blot.    
(A)  Northern blot analysis of S25-7 transcript levels in PMA stimulated gill.  In the case of S25-
7 analysis, three sets of RNA were separated on the same gel, transferred onto a nylon membrane, 
probed with DIG-labeled S25-7 and S11 probes and detected on the Flurochem 8000 imager.  The 
upper band of the blot is the S25-7 transcript while the lower band is the S11 transcript.  The UV 
image of the RNA gel is presented below the blot to show integrity of the 18S and 28S ribosomal 
RNA.  Finally, the average S25-7/S11 ratio for each time point of all six sets, along with error bars, 
representing the standard deviation of each mean, is shown in the bar graph. 
(B)  Northern blot analysis of INVX transcript levels in PMA stimulated gill.  For the analysis of 
INVX, all six sets of RNA were electrophesed on the same gel, transferred onto a nylon membrane, 
probed with DIG-labeled INVX and S11 probes and detected with x-ray film.  The upper band of the 
blot is the INVX transcript while the lower band is the S11 transcript.  The UV image of the RNA gel 
is shown below the blot, demonstrating 18S and 28S ribosomal RNA integrity.  Finally, the bar graph 
represents the average INVX/S11 ratio for each time point, for five sets (set six was excluded from 
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Figure 3.8: RT-PCR analysis of INVX transcript levels in PMA stimulated gill.  Total RNA was 
isolated from gill tissue of three fish sacrificed at each of the time points 8, 24, 48, 96, 120 and 168 
hours post stimulation as well as from three untreated control fish.  This RNA was reverse transcribed 
and subjected to a duplex PCR reaction in which both INVX and Ef-1α were amplified with 27 cycles 
in a thermocycler.  The duplex PCR was performed to eliminate variations in PCR reaction, 
electrophoresis and visualization conditions between INVX and the corresponding Ef-1α control.  
The PCR products were separated on a 1% agarose gel, stained with ethidium bromide and visualized 
under UV light.  Amplification of the three sets analyzed are shown in this figure, along with the 
densitometry analysis.  The bar graph represents the average ratio of INVX/Ef-1α for each time point, 
with error bars representing the standard deviation of the means.  The three sets analyzed by RT-PCR 












































Figure 3.9: Northern blot analysis of S25-7 and INVX transcript levels in PMA stimulated 
spleen.  Total RNA was isolated from spleen tissue of six fish from each of the time points 8, 24, 48, 
96, 120 and 168 hours post stimulation as well as from six untreated control fish.  RNA was separated 
on a 1% agarose gel, stained with ethidium bromide, visualized under UV light and transferred to a 
nylon membrane.  The membrane was then probed with DIG-labeled probes for either S25-7 and S11 
or INVX and S11.  To analyze changes in transcript levels, densitometry analysis was performed by 
measuring the intensity of the INVX, S25-7 and S11 bands.  A ratio of INVX or S25-7 to the 
corresponding S11 signal was calculated and the average of ratio for each time point was plotted, 
along with error bars representing the standard deviation for each mean.  The additional sets used for 
densitometry analysis are shown in appendix A, figure A.2.   The sets shown in this figure correspond 
to the sets analyzed for gill northern blotting. 
(A)  Northern blot analysis of S25-7 transcript levels in PMA stimulated spleen.   As described 
above, three sets of RNA were separated on the same gel and transferred onto a nylon membrane for 
S25-7 and S11 probing.  The bands were detected with the Fluorchem 8000.  The upper band in the 
blot represents the S25-7 transcript while the lower band represents the S11 transcript.  The UV 
image of the 18S and 28S ribosomal RNA is shown below the blot.  Finally, the average S25-7/S11 
ratio of each time point for all six sets is shown in the plot, along with error bars representing the 
standard deviation for these means. 
(B)  Northern blot analysis of INVX transcript levels in PMA stimulated spleen.  As described 
above, all six sets of RNA were separated on the same gel and transferred onto a nylon membrane.  
The blot was probed for INVX and S11 and was detected with x-ray film.  The upper band in the blot 
is the INVX transcript while the lower band is the S11 transcript.  The UV image of the 18S and 28S 
ribosomal RNA is shown below the blot.  Finally, the average INVX/S11 ratio of each time point for 
five sets is shown in the bar graph.  Set three has been excluded from the analysis due to low RNA 
levels.  The error bars for each time point represents the standard deviation of the means of the 
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Figure 3.10: RT-PCR analysis of INVX transcript levels in PMA stimulated spleen.  Total RNA 
was isolated from spleen tissue of three fish sacrificed at each of the time points 8, 24, 48, 96, 120 
and 168 hours post stimulation as well as from three untreated control fish.  The RNA was reverse 
transcribed and amplified for both INVX and Ef-1α in a duplex PCR reaction.  The transcripts were 
amplified with 27 cycles and the products were separated on a 1% agarose gel, stained with ethidium 
bromide and visualized under UV light.  The results of this amplification are shown in this figure.  
The upper band is the amplified INVX fragment while the lower band is the Ef-1α fragment.  
Densitometry analysis of INVX levels was performed and unequal template loading was corrected for 
by calculating the ratio of INVX signal to Ef-1α signal.  The average of the ratio for each time point 
is shown in the bar graph, with error bars representing the standard deviation of the means for each 
time point.  The average of all three sets was taken for the densitometry analysis.  The three sets 
analyzed by RT-PCR for INVX transcript corresponds to the three sets shown in figure 3.9 for spleen 














































probed for S25-7 and INVX.  Representative S25-7 and INVX blots, along with densitometry 
analysis and a UV image of the 18S and 28S rRNA are shown in figure 3.9.  The transcript levels of 
S25-7 are again much higher in spleen than the levels of INVX transcript, similar to the case for gill.  
However, the levels of S25-7 appear to be lower in spleen than in gill, as shown by the S25-7/S11 
ratio values in the two tissues.  In contrast, INVX transcript appears to be at a similar low level in 
both spleen and gill and while INVX bands are seen more clearly in gill, the S11 control bands are 
not as saturated in spleen.  This gives rise to similar ratio values even though the bands are seen more 
clearly in gill.  Similar to gill, the S25-7 transcript levels appear to remain constant in the spleen 
during immune system stimulation, with perhaps a slight increase at 8 hours, followed by a slight 
decrease at 96 hours.  However, as was the case for gill, the large variability within each time point 
causes large error bars, making it difficult to show statistical significance for these changes (ANOVA: 
p=0.314).  Similarly, it appears that the INVX transcript may increase at 8 hours, but is insignificant 
due to the extremely large error bars associated with the 8 hour time point (ANOVA: p=0.314).  It is 
very difficult to analyze the INVX transcript levels in spleen by northern blotting due to the 
extremely large error bars associated with the 8, 24 and 168 hour time points.  These errors are due to 
difficulty in comparing the extremely low signal from the INVX transcript with the large signal from 
the S11 transcript.   
To analyze the low levels of INVX, RT-PCR was also performed on spleen RNA, as described 
above for gill.  The results, shown in figure 3.10, indicate that INVX transcript levels remain quite 
constant during the time course.  However, in contrast to the northern blot results, there does not 
appear to be any increase in INVX transcript levels at 8 hours, as the control has a higher average 
INVX/S11 ratio, although the large error bar associated with the control makes comparisons difficult.  
It is possible that there may be a slight decrease at 24 hours post-stimulation, but this is also not 
statistically significant (ANOVA: p=0.894).  Taken together, it appears that the transcript levels of 
both S25-7 and INVX in the spleen remain fairly constant during immune system stimulation.      
3.3.3 Analysis of Invariant Chain Transcript Levels in PMA Stimulated Head Kidney 
As described above, total RNA was isolated from head kidney of six fish from each of the time points 
8, 24, 48, 96, 120 and 168 hours post stimulation as well as from 6 untreated control fish.  The RNA 
was separated, transferred onto a nylon membrane and probed for S25-7 and INVX.  Representative 
blots for both S25-7 and INVX, along with densitometry analysis and a UV image of 
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Figure 3.11: Northern blot analysis of S25-7 and INVX transcript levels in PMA stimulated 
head kidney.  Total RNA was isolated from head kidney tissue from six fish sacrificed at each of the 
time points 8, 24, 48, 96, 120 and 168 hours post stimulation as well as from six untreated control 
fish.  The RNA was separated on a 1% agarose gel, stained with ethidium bromide, visualized under 
UV light and transferred onto a nylon membrane.  The membrane was then probed with DIG-labeled 
probes for either S25-7 and S11 or INVX and S11.  Densitometry analysis was performed to examine 
transcript levels by measuring the signal from each band.  To correct for any unequal RNA loading, 
the ratio of S25-7 signal to S11 signal or INVX signal to S11 signal was calculated.  The average 
ratio for each time point was plotted along with error bars representing the standard deviation of each 
mean.  The sets shown in this figure correspond to the sets analyzed for gill and spleen northern 
blotting. 
(A)  Northern blot analysis of S25-7 transcript levels in PMA stimulated head kidney.  As 
described for gill, three sets of RNA were separated on the same gel and transferred onto a nylon 
membrane.  The membrane was probed for both S25-7 and S11 and the bands were detected with the 
Fluorchem 8000.  The upper band of the blot is the S25-7 transcript while the lower band is the S11 
control band.  The 18S and 28S ribosomal RNA are shown in the UV image, just below the blot.  
Finally, the densitometry analysis of S25-7 transcript levels in head kidney is represented by the bar 
graph.  The average S25-7/S11 ratio for each time point is plotted, along with error bars representing 
the standard deviation of the means.  The letters represent the results of ANOVA and LSD post hoc 
analysis, where ‘a’ is significantly different from ‘b’ and ‘c’ is significantly different from ‘d’.  The 
additional sets used for densitometry analysis are shown in appendix A, figure A.3. 
(B) Northern blot analysis of INVX transcript levels in PMA stimulated head kidney.  As 
described for gill, all six sets of RNA were separated on the same gel and transferred onto a nylon 
membrane.  The membrane was probed for both INVX and S11 and was detected with x-ray film.  
The INVX transcript is not detected in this tissue, only the lower S11 band can be seen.  The UV 
image of the 18S and 28S ribosomal RNA is shown below the blot.  Densitometry analysis was not 
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Figure 3.12: RT-PCR analysis of INVX transcript levels in PMA stimulated head kidney.  Total 
RNA was isolated from head kidney tissue of three fish sacrificed at each of the time points 8, 24, 48, 
96, 120 and 168 hours post stimulation as well as from three untreated control fish.  The RNA was 
reverse transcribed and subjected to duplex PCR reaction to amplify both INVX and Ef-1α.  The PCR 
products were separated on a 1% agarose gel, stained with ethidium bromide and visualized under 
UV light.  The results of the amplification, along with densitometry analysis are shown in this figure.  
The upper band is the amplified INVX transcript and the lower band is the Ef-1α band.  Densitometry 
analysis of INVX levels was performed and unequal template loading was corrected for by 
calculating the ratio of INVX signal to Ef-1α signal.  The average of the ratio for each time point is 
shown in the bar graph, with error bars representing the standard deviation of the means for each time 
point.  All three sets were included in the densitometry analysis.  The sets used for RT-PCR analysis 
of INVX transcript levels correspond to the sets used for northern blot analysis of INVX transcript in 














































the 18S and 28S rRNA are shown in figure 3.11.  Again, as indicated by the decreased pixel ratio 
values, the levels of S25-7 transcript appear to be lower in head kidney than in both spleen and gill.  
Likewise, INVX transcript cannot be detected by northern blot analysis, and was subsequently 
analyzed by RT-PCR.  This demonstrates that INVX transcript is present at a lower level in head 
kidney than S25-7 transcript and also is present at lower levels than found in spleen or gill.  From the 
densitometry analysis, it appears that S25-7 transcript levels may be increasing slightly at the 8 hour 
time point, but similar to gill and spleen results, this increase is not statistically significant due to the 
large error bars associated with the S25-7/S11 means.  However, the late time points, 96, 120 and 168 
hours all have very small error bars and all appear to be lower than the control and early time points, 
indicating that S25-7 transcript levels may be decreasing during immune stimulation within head 
kidney.  ANOVA analysis verifies that there is a significant difference in the means of this time 
course (p=0.001) while LSD post hoc testing indicates that the 96, 120 and 168 hour time points are 
significantly lower than the control time point (p=0.001, p=0.002 and p=0.036).  Furthermore, the 24, 
48, 96, 120 and 168 hour time points are all significantly lower than the 8 hour time point (p=0.019, 
p=0.019, p=0.000, p=0.001, and p=0.012).  Although the error bars for the 8 hour time point appears 
to overlap with the error bar for the 24 and 48 hour time points, LSD post-hoc testing indicates that 
these time points are significantly different.  This is because the analysis was performed for the entire 
set and was not a pair-wise comparison.  Thus, although the level of S25-7 transcript is low in head 
kidney tissue, the transcript appears to be decreasing upon immune system stimulation.   
To measure INVX transcript levels, RT-PCR analysis was performed with a duplex reaction to 
amplify both INVX and Ef-1α, as described above for both gill and spleen.  The results of this 
amplification for the three sets analyzed are shown in figure 3.12.  The densitometry analysis 
indicates that INVX transcript levels remains constant during immune system stimulation in head 
kidney, as confirmed by ANOVA analysis (p=0.903). 
3.3.4 Analysis of Invariant Chain Transcript Levels in PMA Stimulated Liver 
As a negative control, liver was also analyzed for S25-7 and INVX transcript expression, as this is not 
an immune tissue and is not expected to express INVX or S25-7.  As described above, total RNA was 
isolated from liver tissue of six fish from each of the time points 8, 24, 48, 96, 120 and 168 hours 
post-stimulation as well as from six untreated control fish.  The RNA was separated and transferred 
onto a nylon membrane and probed separately for S25-7 and INVX.  Representative blots for both 
S25-7 and INVX, along with densitometry analysis and a UV image of the 18S and 28S rRNA are  
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Figure 3.13: Northern blot analysis of S25-7 and INVX transcript levels in PMA stimulated 
liver.  Total RNA was isolated from liver tissue of six fish sacrificed at each of the time points 8, 24, 
48, 96, 120 and 168 hours post stimulation as well as from six untreated control fish.  The RNA was 
separated on a 1% agarose gel, stained with ethidium bromide, visualized under UV light and 
transferred onto nylon membrane.  The RNA was then probed with either DIG-labeled S25-7 and S11 
probes or INVX and S11 probes.  A representative blot for both S25-7 and INVX are shown in this 
figure.  The sets used for both S25-7 and INVX northern blotting correspond to the sets used for head 
kidney, spleen and gill northern blot analysis.   
(A)  Northern blot analysis of S25-7 transcript levels in PMA stimulated liver.  As described 
above, three sets of RNA were separated on the same gel and transferred onto a nylon membrane.  
The membrane was probed for both S25-7 and S11 and the bands were detected on the Fluorchem 
8000.  The upper band in the blot is the S25-7 transcript while the lower band is the S11 transcript.  
The 18S and 28S bands are shown in the UV image of the RNA, under the blot.  Finally, 
densitometry analysis was performed to analyze S25-7 transcript levels.  The ratio of S25-7 signal to 
S11 signal was calculated and the average ratio for each point was plotted, along with error bars 
representing the standard deviation for each mean.  All six sets were used for densitometry analysis.  
The additional sets are shown in appendix A, figure A.4. 
(B)  Northern blot analysis of INVX transcript levels in PMA stimulated liver.  As described 
above, all six sets were separated on the same gel and transferred onto a nylon membrane.  The 
membrane was probed for both INVX and S11 and the bands were detected with x-ray film.  INVX 
transcript was not detected in liver RNA, only the lower S11 transcript can be seen.  The 18S and 28S 
ribosomal RNA is shown in the UV image below the blot.  No densitometry analysis was performed 
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Figure 3.14: RT-PCR analysis of INVX transcript levels in PMA stimulated liver.  Total RNA 
was isolated from liver tissue of three fish sacrificed at each of the time points 8, 24, 48, 96, 120 and 
168 hours post stimulation as well as from three untreated control fish.  The RNA was reverse 
transcribed and subjected to a duplex PCR to amplify both INVX and Ef-1α.  The PCR products were 
separated on a 1% agarose gel, stained with ethidium bromide and visualized under UV light.  
Amplification of the three sets analyzed are shown in this figure, along with the densitometry 
analysis.  The upper band in each gel is the INVX transcript while the lower band in the Ef-1α 
transcript.  The ratio of INVX signal to Ef-1α signal was calculated for all time points, and the 
average INVX/Ef-1α for each time point was plotted along with error bars representing the standard 
deviation for each mean.  The sets analyzed for INVX transcript by RT-PCR correspond to the sets 
















































shown in figure 3.13.  As expected, there was no INVX signal; however, there was a very low signal 
from S25-7.  The S25-7/S11 ratio was much lower than the other tissues analyzed, and is quite 
variable within each time point, as indicated by the large error bars relative to the small means.  
ANOVA analysis indicates that there is no significant difference between S25-7 transcript levels at 
each of the time points examined (p=0.370).  The likely source of this signal is leukocytes within 
liver tissue.  Indeed, when RT-PCR was performed on liver RNA to analyze INVX levels, a low level 
was also detected.  As shown in figure 3.14, the level of INVX transcript is also very low with large 
variability within each time point.  ANOVA analysis also confirms that there is no significant change 
in INVX transcript levels in the liver during immune system stimulation (p=0.705).  Since the signals 
for both S25-7 and INVX are likely due to leukocytes within the liver, these results also indirectly 
demonstrate a higher level of S25-7 transcript in leukocytes than INVX, as INVX cannot be detected 
by northern blotting while S25-7 can. 
3.3.5 Analysis of Invariant Chain Transcript Levels in PMA Stimulated Peripheral 
Blood Leukocytes 
Total RNA was isolated from peripheral blood leukocytes of six fish from each of the time points 
8, 24, 48, 96, 120 and 168 hours post-stimulation as well as from six untreated control fish.  The level 
of isolated RNA was too low to perform northern blot analysis.  Instead, RT-PCR was performed to 
measure S25-7 and INVX transcript levels.  Although RNA was isolated from six sets, only four sets 
showed non-degraded RNA, and thus only 4 sets were included for the analysis.  A separate PCR 
reaction was performed for INVX, S25-7 and the control Ef-1α, each reaction was run on a 1% 
agarose gel and visualized under UV light.  A representative gel for INVX, S25-7 and Ef-1α RT-PCR 
results are shown in figure 3.15, along with densitometry analysis.  The other three sets used for 
densitometry analysis are shown in appendix A.  Densitometry analysis of RT-PCR results indicates 
that S25-7 and INVX are present at similar levels in leukocytes.  While there was a marked difference 
in S25-7 and INVX transcript levels in the other tissues analyzed, it is likely that the separate PCR 
reactions makes it difficult to compare these transcript levels in peripheral blood leukocytes.  If a 
duplex PCR reaction with INVX and Ef-1α as well as S25-7 and Ef-1α had been performed, it would 
have been much easier to compare the levels of S25-7 and INVX, as there would be no variability of 
PCR conditions or gel loading and visualizing between the invariant chain transcript and the control 
transcript.  However, the amplified S25-7 and Ef-1α band are very close in size and cannot be 
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Figure 3.15: RT-PCR analysis of S25-7 and INVX transcript levels in PMA stimulated 
peripheral blood leukocytes.  Total RNA was isolated from peripheral blood leukocytes collected 
from six fish sacrificed at each of the time points 8, 24, 48, 96, 120 and 168 hours post stimulation as 
well as from six untreated control fish.  The RNA was reverse transcribed and amplified separately 
for INVX, S25-7 and Ef-1α.  The PCR products were separated on a 1% agarose gel, stained with 
ethidium bromide and visualized under UV light.  Due to RNA degradation in some samples, only 
four sets could be analyzed for invariant chain transcript levels.  A representative image for INVX, 
S25-7 and Ef-1α is shown in this figure, along with densitometry analysis for both S25-7 and INVX 
transcripts.  The upper gel is the INVX PCR product, the middle gel is S25-7 and the lower gel is Ef-
1α.  Densitometry analysis was performed by calculating the ratio of INVX or S25-7 signal to the 
corresponding Ef-1α signal.  The average ratio for S25-7 and INVX for the four set analyzed were 
plotted, along with error bars representing the standard deviation for each mean.  The additional three 
sets used for the densitometry analysis are shown in appendix A, figure A.5.   
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resolved from each other on an agarose gel.  Thus, it cannot be conclusively determined if S25-7 and 
INVX are present at different levels in peripheral blood leukocytes.   
Both S25-7 and INVX appear to increase slightly at 8 hours post-stimulation, followed by a 
decrease at 24 and 48 hours and a subsequent increase at 96 hours.  However, as was the case for the 
northern blot analysis, there is great variability between individuals within each time point, resulting 
in large error bars, making it very difficult to show significant differences across time points.  
ANOVA analysis indicates that there is no significant difference in the levels of either S25-7 or 
INVX (p=0.093 and p=0.244) transcript in peripheral blood leukocytes during immune system 
stimulation. 
3.4 Analysis of Invariant Chain Protein Expression in the PMA in vivo Time 
Course 
Total cellular protein was isolated from gill, spleen, head kidney and liver of six fish from each of the 
time points 8, 24, 48, 96, 120 and 168 hours post-stimulation as well as from six untreated control 
fish.  The S25-7 and INVX protein level was analyzed by western blot analysis.  For each blot, one 
set of one tissue was run on a 12% polyacrylamide gel and transferred onto a nitrocellulose 
membrane.  Western blotting was performed to analyze both S25-7 and INVX protein levels in all 
tissues for all six sets.  However, due to poor western blot results, only four sets were used for protein 
expression analysis in gill and spleen.  As described above for northern blot analysis, densitometry 
analysis was also performed on the western blots to measure changes in protein levels.  However, in 
this case there is no antibody against a control protein that will remain unaffected during the immune 
system stimulation.  Instead, a 50 kDa protein found on the ponceau stained membranes was used as a 
control.  Further complicating the densitometry analysis is the fact that both S25-7 and INVX migrate 
as doublets.  In order to quantify the signals for these proteins, the signal from both bands of the 
doublet was added together, and the ratio of this value to the corresponding 50 kDa band was 
calculated to control for unequal protein loading.  ANOVA analysis and LSD post hoc tests were 
performed to identify statistically significant changes in S25-7 and INVX proteins levels during 
immune system stimulation. 
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3.4.1 Analysis of Invariant Chain Protein Levels in PMA Stimulated Gill 
Protein was isolated from gill tissue of four fish from each time point 8, 24, 48, 96, 120 and 168 as 
well as from four untreated control fish and subjected to western blot analysis for S25-7 and INVX 
protein expression levels.  Representative western blots, along with the corresponding ponceau 
staining of the nitrocellulose membrane to show equal sample loading, as well as densitometry 
analysis for both S25-7 and INVX are shown in figure 3.16.  The other three sets of blots are shown 
in appendix A.  In the case of S25-7, it appears the protein level may increase slightly between 
control and the 8 and 24 hour time points, but this increase is not statistically significant due to the 
large error bars associated with the average S25-7 / 50 kDa ratio for each time point (ANOVA: 
p=0.778).  The large variability of S25-7 protein levels between individual fish can be clearly seen 
within the control fish.  In two of the sets analyzed, the level of S25-7 is very low in the control 
sample, while in the two other sets S25-7 levels are quite high.  It is difficult to determine any change 
in protein levels between treatment and control when the variability within the untreated controls is so 
high.  INVX protein levels in gill are similar to S25-7, indicating that the difference in transcript level 
of these two genes may not be reflected in the level of expressed protein.  INVX also appears to 
increase slightly between the untreated control and the 8 hour time point, with this increase being 
larger than the one seen for S25-7.  However, as is the case for S25-7, the large error bars and the 
variability within the control fish make it difficult to show a significant increase (ANOVA: p=0.184).  
Thus, while there may appear to be a very slight increase in both S25-7 and INVX protein levels at 8 
hours after immune system stimulation, this increase is not statistically significant and may be due to 
random variability between fish and not dependent on the immune system stimulation.  From these 
results, it appears that S25-7 and INVX protein levels in the gill remain fairly constant during 
immune system stimulation.  Interestingly, both invariant chain proteins show degradation at the 168 
hour time point.  This may be evidence of the stepwise degradation of the invariant chain as it travels 
through the cell for class II antigen loading. 
3.4.2 Analysis of Invariant Chain Protein Levels in PMA Stimulated Spleen 
Protein was isolated from spleen tissue of four fish from each of the time points 8, 24, 48, 96, 120 and 
168 hours post-stimulation as well as from four untreated control fish.  The protein was denatured and 
run as single sets for SDS-PAGE and western blot analysis of S25-7 and INVX protein expression.  
Representative western blots for both S25-7 and INVX, along with ponceau staining as well as 
densitometry analysis are shown in figure 3.17.  The expression of both S25-7 and INVX are 
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Figure 3.16: Western blot analysis of S25-7 and INVX protein levels in PMA stimulated gill.  
Total protein was isolated from gill tissue of six fish sacrificed at each of the time points 8, 24, 48, 96, 
120 and 168 hours post stimulation as well as from six untreated control fish.  The protein was 
denatured, 100µg of each sample was separated on a 12% polyacrylamide gel and transferred onto a 
nitrocellulose membrane.  The membrane was ponceau stained to check for equal protein loading and 
probed with either anti-rtINVX antibody or anti-rTg antibody, followed by anti-rabbit IgG HRP 
conjugated antibody.  The protein was detected by the addition of the ECL-plus substrate followed by 
visualization with the Fluorchem 8000 imager.  The blots were then subjected to densitometry 
analysis.  Since there is no antibody against a housekeeping protein, the 50kDa protein seen on the 
ponceau stain was used as a control.  The intensity of this band was measured, and used to correct for 
unequal protein loading.  Both S25-7 and INVX migrate as doublets in the western blot, thus, for the 
densitometry analysis the intensity of both bands of the doublet was added together.  The ratio of this 
value to the 50kDa signal was calculated and the average ratio for each time point was plotted on a 
bar graph, with error bars representing the standard deviation for each mean.  Due to difficulty 
detecting blots, only four sets were used for the densitometry analysis.  The additional three sets used 
are shown in appendix A, figure A.6. 
(A)  Western blot analysis of S25-7 protein levels in PMA stimulated gill.  The doublet of S25-7 
protein is shown in the blot, migrating just above 36kDa.  The ponceau stain of this membrane is 
shown just below the western blot.  The densitometry analysis of S25-7 protein levels is shown, with 
the average S25-7/50kDa ratio for each time point plotted in a bar graph along with the error bars. 
(B)  Western blot analysis of INVX protein levels in PMA stimulated gill.  The doublet of INVX 
protein is shown in the blot, migrating slightly above 36 kDa.  The ponceau stain of this membrane is 
shown just below the western blot.  The densitometry analysis is represented by a bar graph of the 
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Figure 3.17: Western blot analysis of S25-7 and INVX protein levels in PMA stimulated spleen.  
Protein was isolated from spleen tissue of six fish sacrificed at each of the time points 8, 24, 48, 96, 
120, and 168 hours post stimulation as well as from six untreated control fish.  The protein was 
denatured, 100µg of each sample was separated on a 12% polyacrylamide gel and transferred onto a 
nitrocellulose membrane.  The membrane was the ponceau stained to visualize total cellular proteins.  
The membrane was then probed with either anti-rtINVX antibody or anti-rTg antibody followed by 
anti-rabbit IgG HRP conjugated antibody.  The blot was detected by incubation with the ECL-plus 
substrate followed by detection on the Fluorchem 8000 imager.  The blots were subjected to 
densitometry analysis in the same way as described above for gill western blot analysis.  Again, only 
four sets were used for densitometry analysis due to difficulties analyzing blots with the Total Lab 
100 software.  The additional blots used for densitometry analysis is shown in appendix A, figure 
A.6. 
(A)  Western blot analysis of S25-7 protein levels in PMA stimulated spleen.  The doublet of 
S25-7 protein is shown in the blot running just above 36kDa.  The ponceau stain of this membrane is 
shown below the blot.  The densitometry analysis consisting of a bar graph representing the average 
S25-7/50kDa ratio for each time point, along with error bars representing the standard deviation for 
each time point is shown below the ponceau stain. 
(B)  Western blot analysis of INVX protein levels in PMA stimulated spleen.  The doublet of 
INVX protein is shown in the blot running slightly above 36kDa.  The ponceau stain of this 
membrane is shown below the blot.  The densitometry analysis, consisting of a bar graph representing 
the average INVX/50kDa ratio for each time point, along with error bars representing the standard 
deviation for each time point is shown below the ponceau stain.     
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extremely variable within the spleen.  All four sets show one or two time points with a very high level 
of S25-7 and INVX, for the representative blots, these time points are control and 8 hours for INVX 
and control, 8, 48 and 96 hours for S25-7.  The other time points have very low or undetectable S25-7 
and INVX.  The ponceau staining of the membranes show approximately equal sample loading, 
indicating that this large variability in protein expression is not due to errors in sample loading.  This 
pattern is consistent for all spleen blots, as shown in appendix A, figure A.7.  As a control, six 
untreated fish were sacrificed and analyzed for S25-7 and INVX, and again, the levels of the protein 
vary from undetectable to very high, with INVX:50KDa densitometry values ranging 1.17 to 10.73 
and S25-7:50KDa densitometry ratios ranging from 1.17 to 34.32 (data not shown).  Thus, it is 
impossible to draw conclusions about any changes in spleen S25-7 and INVX protein levels during an 
immune response due to the large degree of variability of spleen S25-7 and INVX protein expression 
between fish.   
3.4.3 Analysis of Invariant Chain Protein Levels in PMA Stimulated Head Kidney 
Total cellular protein was isolated from head kidney tissue of six fish from each of the time points 8, 
24, 48, 96, 120 and 168 hours post-stimulation as well as from six untreated control fish.  S25-7 and 
INVX protein levels were analyzed by western blotting.  Each set was separated on a 12% 
polyacrylamide gel, transferred to a nitrocellulose membrane and probed for either INVX or S25-7.  
Representative blots for both S25-7 and INVX, along with ponceau staining of the membrane are 
shown in figure 3.18.  Neither INVX nor S25-7 could be detected in head kidney by western blot 
analysis, thus no densitometry analysis was performed.  Although transcript for both genes could be 
detected at low levels in head kidney, either there is no translation of the transcripts, or the protein is 
present at such low levels that it is undetectable with the western blotting methods used. 
3.4.4 Analysis of Invariant Chain Protein Levels in PMA Stimulated Liver 
Protein was also isolated from liver tissue of six fish from each of the time points 8, 24, 48, 96, 120 
and 168 hours post-stimulation, as well as from six untreated control fish and analyzed by western 
blot analysis for S25-7 and INVX protein expression.  Representative blots for both S25-7 and INVX, 
along with the corresponding ponceau stain are shown in figure 3.19.  Neither INVX nor S25-7 was 
detected in liver tissue and no densitometry analysis was performed.  Again, although there was a 
small amount transcript detected for both S25-7 and INVX, either these are not translated or the 
amount of protein translated is too small to be detected by the western blotting method.  
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Figure 3.18: Western blot analysis of S25-7 and INVX protein levels in PMA stimulated head 
kidney.  Total protein was isolated from head kidney tissue of six fish sacrificed at each of the time 
points 8, 24, 48, 96, 120 and 168 hours post stimulation as well as from six untreated control fish.  
The protein was denatured, 100µg of each sample was separated on a 12% polyacrylamide gel and 
transferred onto a nitrocellulose membrane.  The membrane was ponceau stained to visualize 
integrity of separated protein and to verify equal sample loading.  The blot was then probed with 
either anti-rtINVX antibody or anti-rTg antibody followed by anti-rabbit IgG HRP conjugated 
antibody.  The blot was detected by incubation with the substrate ECL-plus followed by visualization 
with the Fluorchem 8000.  Since neither S25-7 nor INVX were detected in this tissue, no 
densitometry analysis was performed. 
(A)  Western blot analysis of S25-7 protein levels in PMA stimulated head kidney.  The western 
blot is shown, with no detectable bands, along with the ponceau staining of this blot. 
(B)  Western blot analysis of INVX protein levels in PMA stimulated head kidney.  The western 
blot is shown, with no detectable bands, along with the ponceau staining of this blot.  
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Figure 3.19: Western blot analysis of S25-7 and INVX protein levels in PMA stimulated liver. 
Total protein was isolated from liver tissue of six fish sacrificed at each of the time points 8, 24, 48, 
96, 120 and 168 hours post stimulation as well as from six untreated control fish.  The protein was 
denatured, 100µg of each sample was separated on a 12% polyacrylamide gel and transferred onto a 
nitrocellulose membrane.  The membrane was ponceau stained to visualize integrity of separated 
protein and to verify equal sample loading.  The blot was then probed with either anti-rtINVX 
antibody or anti-rTg antibody followed by anti-rabbit IgG HRP conjugated antibody.  The blot was 
detected by incubation with the substrate ECL-plus followed by visualization with the Fluorchem 
8000.  Since neither S25-7 nor INVX were detected in this tissue, no densitometry analysis was 
performed. 
(A)  Western blot analysis of S25-7 protein levels in PMA stimulated liver.  The western blot is 
shown, with no detectable bands, along with the ponceau staining of this blot. 
(B)  Western blot analysis of INVX protein levels in PMA stimulated liver.  The western blot is 
shown, with no detectable bands, along with the ponceau staining of this blot.   































3.5 Analysis of Invariant Chain Expression in the Macrophage-Like Cell Line 
RTS11 
In addition to the in vivo time course, an in vitro time course was also performed to analyze S25-7 
and INVX expression in the macrophage-like cell line RTS11.  These cells were plated at a 
concentration of 2x107 cells per well and treated with 2µg PMA per 1mL of media.  Cells were 
incubated at 18°C and samples were collected at each of the time points 8, 24, 48, 96, 120 and 168 
hours post-stimulation.  In addition, a DMSO-treated control was also collected after 168 hours of 
incubation.  The collected cells for each time point were split in two aliquots and used for both 
western blot and RT-PCR analysis. 
3.5.1 Analysis of Invariant Chain Transcript Levels in PMA Stimulated RTS11 
Total RNA was isolated from cells collected at each of the time points 8, 24, 48, 96, 120 and 168 
hours post-stimulation as well as from the DMSO-treated control.  The RNA was reverse transcribed 
and amplified with primers specific for INVX, S25-7 and Ef-1α.  These PCR reactions were 
performed separately and run on separate 1% agarose gels.  To control for unequal sample loading, 
densitometry analysis was performed for both S25-7 and INVX by calculating the ratio of INVX / Ef-
1α and S25-7 / Ef-1α.  The in vitro time course was performed in triplicate.  Representative results for 
all three PCR reactions as well as densitometry analysis for both S25-7 and INVX transcript 
expression is shown in figure 3.20.  As described above for peripheral blood leukocyte analysis, the 
use of separate PCR reactions for INVX, S25-7 and Ef-1α makes it difficult to compare expression 
levels of S25-7 and INVX.   
Similar to the results of the in vivo time course, there appears to be very little change in the levels 
of S25-7 transcript after stimulation, with only a slight decrease at 48 hours, which is not statistically 
significant, as confirmed by ANOVA analysis (p=0.713).  INVX transcript levels appear to be at the 
highest level in the control samples, with a continual decrease from 8 hours to 24 hours followed by 
an increase at 96, 120 and 168 hours after stimulation.  In the case of INVX, ANOVA analysis 
indicates that there is a significant change in transcript levels (p=0.021), while LSD post hoc analysis 
indicates that INVX transcript in the control sample is significantly higher than 48, 96 and 120 hour 
time points (p=0.001, p=0.004 and p=0.037).  Furthermore, INVX transcript level the 8 hour time  
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Figure 3.20: RT-PCR analysis of S25-7 and INVX transcript levels in the macrophage-like cell 
line RTS11.  Cells were plated at a concentration of 2x107 cells / well, treated with 2µg/mL PMA and 
incubated at 18°C.  Samples were then collected at each of the time points 8, 24, 48, 96, 120, and 168 
hours post stimulation.  In addition, a control well was treated with DMSO and collected after 168 
hours.  The collected cells were split in half, such that approximately 107 cells were analyzed for 
invariant chain transcript and 107 cells analyzed for invariant chain protein levels for each time point.  
The time course was performed in triplicate. 
For transcript analysis, total RNA was isolated from cells of each time point and the RNA was 
reverse transcribed.  The resulting cDNA was then amplified separately for INVX, S25-7 and Ef-1α.  
The PCR products were separated on a 1% agarose gel, stained with ethidium bromide and visualized 
under UV light.  A representative set of PCR products are shown in this figure along with the 
densitometry analysis for both S25-7 and INVX.  The bar graphs represent the average INVX/Ef-1α 
and S25-7/Ef-1α ratios for each time point, with error bars representing the standard deviation for 
each mean.  The letters represent the results of ANOVA and LSD post hoc testing, where ‘a’ is 
significantly different from ‘b’, ‘c’ is significantly different from ‘d’ and ‘e’ is significantly different 
from ‘f’.  The additional sets used for densitometry analysis are shown in appendix A, figure A.8.
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point is significantly higher than 48 hour time point (p=0.022).  Finally, the 168 hour time point is 
significantly higher than the 48 and 96 hour time points (p=0.017 and p=0.044).  Although the 8 hour 
and 168 hour time points have very similar values, only the 168 hour time point is significantly 
different from the 96 hour time point.  Similar to the results in head kidney, this is due to the 
comparison of the entire time course instead of a pair-wise comparison.  These results demonstrate 
that while S25-7 transcript levels appear to remain unchanged during PMA stimulation, INVX 
transcript decreases upon stimulation and then increases again at the later time points. 
3.5.2 Analysis of Invariant Chain Protein Levels in PMA Stimulated RTS11 
Total protein was isolated from cells collected at 8, 24, 48, 96, 120, and 168 hours post-stimulation as 
well as from DMSO-treated control cells.  This protein was separated on a 12% polyacrylamide gel, 
transferred onto a nitrocellulose membrane and probed for either INVX or S25-7.  Representative 
blots for both S25-7 and INVX, along with ponceau staining of these blots as well as densitometry 
analysis is shown in figure 3.21.  Again, as found with the in vivo time course western blotting, there 
is a great deal of variability within each time point.  However, for INVX, only 3 replicates were 
analyzed while only 2 replicates were analyzed for the S25-7 western blot densitometry.  If more 
samples had been analyzed, it is likely that the error bars would be decreased in size.  Comparison of 
the ratios of S25-7 / 50 kDa and INVX / 50 kDa indicate that S25-7 appears to be present in a higher 
amount than INVX.  S25-7 appears to be present in high levels in the control samples, which 
corresponds to the high levels of transcript in these samples.  The levels appear to decrease at the 24 
and 48 hour time points, although the large error bars indicate that this decrease is not significant.  
INVX protein levels appear to remain constant during the time course.  ANOVA analysis indicates 
that there is no significant change in the levels of S25-7 or INVX protein during PMA stimulation 
(p=0.230 and p=0.883).  
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Figure 3.21: Western blot analysis of S25-7 and INVX protein levels in the macrophage-like cell 
line RTS11.  Total protein was isolated from 107 RTS11 cells collected at each of the time points 8, 
24, 48, 96, 120 and 168 hours after PMA stimulation as well as from a DMSO treated control.  The 
protein was denatured, 100µg of each sample was separated on a 12% polyacrylamide gel and 
transferred onto a nitrocellulose membrane.  The membrane was ponceau stained to verify protein 
integrity as well as equal sample loading across the membrane.  The blot was then probed with either 
anti-rtINVX antibody or anti-rTg antibody, followed by anti-rabbit IgG HRP conjugated antibody.  
The blot was incubated with ECL-plus substrate followed by detection with the Fluorchem 8000 
imager.  Densitometry analysis was performed on these blots in a similar manner to that described 
above for gill western blot anlaysis.  The sum of the S25-7 and INVX doublet bands were calculated 
and the ratio of this sum to the 50kDa band on the ponceau was determined.  The additional blots 
used for this densitometry analysis is shown in appendix  A, figure A.9.    
(A)  Western blot analysis of S25-7 protein levels in PMA stimulated RTS11 cells.  The doublet 
in the blot running just above 36kDa represents the S25-7 protein.  The ponceau staining of this 
membrane is shown below the blot.  The densitometry analysis of S25-7 protein levels is also shown, 
where each bar represents the average S25-7 / 50kDa ratio for each time point, with error bars 
representing the standard deviation for each mean.  The densitometry analysis is the average of two 
S25-7 blots. 
(B) Western blot analysis of INVX protein levels in PMA stimulated RTS11 cells.  The doublet 
in the blot running slightly above 36kDa represents the INVX protein.  The ponceau staining of this 
membrane is shown below the blot.  The densitometry analysis of INVX protein levels is also shown, 
where each bar represents the average INVX / 50kDa ratio for each time point, with error bars 
representing the standard deviation for each mean.  The densitometry analysis is an average of three 















































































4.1 Overview of Experimental Results 
The purpose of this research was to simulate an immune response and study the resulting effect on the 
expression of the rainbow trout invariant chain genes S25-7 and INVX.  The immune system was 
activated both in vivo, by treating live animals with PMA as well as in vitro, by similarly stimulating 
the macrophage-like cell line RTS11.  To identify successful immune system activation in vivo, the 
transcript levels of the cytokine IL-1β were examined because this gene is expressed by activated 
macrophage (Janeway et al, 2001).  The level of IL-1β transcript increased significantly upon PMA 
treatment in both gill and spleen, with an immediate increase at 8 hours post-treatment in gill tissue.  
These levels decreased from 24 hours to 96 hours post-treatment but increased again at 120 hours.  In 
the spleen, IL-1β transcript was not detected at early time points, but was elevated at later time points, 
with the highest levels found at 96 hours post-stimulation.  Similar to spleen, the IL-1β transcript was 
also absent at early time points in head kidney, with an increase beginning approximately 96 hours 
post-stimulation.  However, this increase was lower than the increase in both gill and spleen, and was 
not statistically significant.  Regardless, these results demonstrate the presence of activated 
macrophage in the immune organs of PMA-stimulated fish, indicating successful immune activation.  
The level of IL-1β was not examined in RTS11 because previous studies show that PMA treatment 
induces RTS11 activation, as shown by the induction of homotypic aggregation, a characteristic of 
activated immune cells (DeWitte-Orr et al, 2007).  
After demonstrating the ability of PMA to induce immune system activation in vivo, the 
expression of S25-7 and INVX was examined.  Northern blot analysis indicates that S25-7 transcript 
is present in all tissues examined, including gill, spleen, head kidney, peripheral blood leukocytes and 
liver.  However, the level of S25-7 varies greatly in these tissues, with the highest level being found 
in gill.  Of the immune tissues, head kidney shows the lowest levels of S25-7 transcript.  In addition, 
the liver, a non-immune tissue, also shows very low S25-7 transcript levels, although this is likely 
caused by leukocytes present in the liver from circulating blood.  It is difficult to make comparisons 
between of the level of S25-7 transcript found in peripheral blood leukocytes and the expression in 
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other tissues because S25-7 transcript was detected by RT-PCR analysis in leukocytes, which cannot 
be compared to the northern blot results.  Although all tissues examined differ in the level of S25-7 
expressed, there appears to be very little change in this transcript during immune system activation in 
most tissues.  Gill, spleen, liver and peripheral blood leukocytes show no significant change in the 
S25-7 transcript level after PMA treatment.  However, an exception occurs within head kidney, as 
S25-7 is significantly decreased at the later time points, beginning 24 hours post-stimulation. 
Similarly, INVX transcript is detected in all tissues analyzed with the highest levels found in gill 
and spleen tissue, while head kidney shows the lowest expression level of the immune tissues.  
Furthermore, there is a small amount of INVX transcript detected in the liver tissue of some 
individuals, and as explained above, is likely due to blood leukocytes circulating through this tissue.  
INVX transcript is present in all of these tissues at a much lower level than S25-7 transcript and could 
only be detected in head kidney and liver by RT-PCR.  However, similar to S25-7, INVX transcript 
levels remain constant during immune system activation in all tissues analyzed. 
In contrast to transcript levels, protein levels of S25-7 and INVX appear to be very similar within 
the same tissue.  Both proteins appear to be expressed at similar levels in gill tissue, and while these 
proteins seem to be slightly increased after PMA stimulation, it is not significant.  In addition, both 
proteins are present in spleen, although the levels vary greatly between similarly treated individuals.  
The large variation of S25-7 and INVX expression even within untreated controls make it difficult to 
separate PMA induced protein up-regulation from the natural variation of the fish used for this study.  
However, for each individual analyzed, the levels of S25-7 and INVX protein are very similar within 
spleen tissue.  Neither INVX nor S25-7 protein is detected in head kidney or liver tissue, which 
corresponds with the very low transcript levels in these tissues.      
The PMA induced activation of RTS11 causes no change in the transcript levels of S25-7, as 
shown by RT-PCR analysis.  In contrast, INVX transcript decreases 48 hours after PMA stimulation 
with a subsequent increase at 168 hours post-stimulation.  In contrast to the in vivo results, S25-7 
protein appears to be at a higher level than INVX protein in the RST11 cells.  Both S25-7 and INVX 
protein levels remains unchanged upon immune system activation. 
4.2 Implications for the Teleost Immune System 
The expression pattern of invariant chain, at both the transcript and protein level, provides valuable 
insight into immune functions carried out within various organs of rainbow trout, as the presence of 
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these proteins indicates an ability to present antigens via the MH class II antigen presentation 
pathway.  To begin, peripheral blood leukocytes consist of a mixture of various immune cells, 
including B cells and macrophage circulating in the blood stream (Shanchez et al, 1995; Kollner et al, 
2001).  In addition, although dendritic cells have not yet been identified in teleosts, a sequence similar 
to the dendritic cell surface marker CD83 has recently been identified in rainbow trout, indicating the 
presence of this cell type in the teleost immune system (Ohta et al, 2004).  B cells, macrophage and 
dendritic cells are thought to be the antigen presenting cells of the teleost immune system and as such, 
are expected to express both MH class II and invariant chain.  The detection of invariant chain 
transcript, along with MH class II transcript and protein, in this cell population indicates the presence 
of circulating cells capable of presenting extracellular antigen to activate a CD4+ T cell response 
(Nath et al, 2006).   
The rainbow trout invariant chain genes show the highest level of expression in gill tissue, at both 
transcript and protein level.  The gills represent an entry site for any pathogens located in the water, 
thus, to prevent infection, this site must be constantly monitored by the immune system.  Although 
very little is known about the immune system effector cells found in gill tissue, much more is known 
about the mammalian lungs, a corresponding site of pathogen entry.  The lungs contain a high number 
of alveolar macrophage, capable of non-specific removal of foreign material (Martin et al, 2005).  
These cells endocytose and degrade foreign pathogens, and can present antigenic fragments to 
activate memory T cells located within the lungs (Woodland and Scott, 2005).  In addition, there is 
also a population of dendritic cells found within the connective tissue surrounding the blood vessels 
of the lungs (Lambrecht et al, 2001).  These cells have an immature phenotype and are capable of 
rapid endocytosis and degradation of antigens.  These cells play an essential role in the activation of 
an adaptive immune response.  Upon infection of the rat lung, additional dendritic cells are recruited 
by a number of chemokines secreted by activated lung epithelial cells.  Dendritic cells are directly 
activated by pathogens through the binding of the TLR on the dendritic cell surface.  This causes a 
number of changes in the dendritic cell, including the up-regulation of CD80 and CD86, which are 
required for T cell activation, as well as the up-regulation of receptors for chemokines synthesized in 
secondary lymph organs (Lambrecht et al, 2001).  Furthermore, mature dendritic cells down-regulate 
receptors for chemokines expressed at sites of infection.  In this way antigen loaded dendritic cells 
can migrate from the site of infection to the lymph tissue, where they activate circulating T cells, and 
these activated cells in turn migrate to the site of infection. 
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Previous work has shown that MH class II α and β are present in the gill tissue of rainbow trout, 
with both transcript and protein being detected (Nath et al, 2006).  This, together with the detection of 
S25-7 and INVX, indicate that the gill contains immune cells capable of processing and presenting 
extracellular antigen.  In contrast to other tissues examined, S25-7 and INVX are constitutively 
expressed in gill as both proteins were detected in the gill tissue of all analyzed individuals.  This 
indicates that antigen presentation occurs continuously in this tissue, allowing for constant immune 
surveillance.  Although the cells carrying out this surveillance have not yet been identified, it likely 
performed by macrophage and dendritic cells, similar to the mammalian lung.  Analysis of the 
expression pattern of the recently cloned rainbow trout CD83 homologue demonstrates the presence 
of this transcript in gill tissue, indicating the presence of a dendritic cell population (Ohta et al, 2004).  
Furthermore, indirect evidence of a macrophage population in gill tissue comes from the detection of 
inducible nitric oxide synthetase transcript in rainbow trout gill, as this enzyme is produced 
predominately by macrophage (Campos-Perez et al, 2000).  Also, the detection of a rapid up-
regulation of IL-1β transcript demonstrates the presence of activated macrophage within the gill.  It is 
likely that gill macrophage are primarily responsible for non-specific elimination of foreign 
pathogens while dendritic cells process antigens for the activation of T cells.  In teleosts, CD8+ T cells 
have been identified and a CD4 homologue has recently been cloned, indicating the existence of 
CD4+ T cells in these fish (Laing et al, 2006, Fischer et al, 2003).  The CD8 and CD4 transcript are 
undetected in non-stimulated gill tissue, indicating that, similar to the human lung, antigen loaded 
dendritic cells leave the gill and migrate to a secondary lymphoid tissue to activate circulating T cells 
(Fischer et al, 2003, Moore et al, 2005). Once activated, T cells likely migrate back to the site of 
infection in the gill.  After treating rainbow trout with a DNA vaccine against infectious 
hematopoietic necrosis virus (IHNV), both TCR-β and CD8-α transcript are detected in gill tissue 
(Purcell et al, 2006).  Unfortunately, there has been no corresponding study of CD4 transcript upon 
immune system stimulation.  Although the migration of dendritic cell out of the gill would be 
expected to result in a decrease of invariant chain, it is likely that additional dendritic cells, B cells or 
macrophage are simultaneously migrating to the site of infection, resulting in a constant level of 
invariant chain.       
Once antigen has been captured at the initial site of infection, antigen presenting cells must interact 
with lymphocytes in order to activate an adaptive immune response.  This interaction occurs within 
the secondary lymphoid organs.  The spleen is one such organ in both mammals and fish (Brendolan 
et al, 2007).  The spleen consists of red pulp, which is responsible for the destruction of erythrocytes, 
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and white pulp, which is the location of lymphocyte activation.  In the human spleen, the white pulp 
compartment consists of a T cell zone and a B cell zone, or follicle (Mebius and Krall, 2005).  The 
follicle is surrounded by a marginal zone and the entire compartment is surrounded by a perifollicular 
zone.  The perifollicular zone is a blood filled site due to open spleenic circulation and is the entry 
site for all antigens, antigen presenting cells and lymphocytes from the circulation.  In defense against 
blood borne pathogens, the perifollicular zone has a population of macrophage.  In addition, this zone 
also contains endothelial like fibroblasts which secrete a number of chemokines to attract 
lymphocytes from the blood (Crivellato et al, 2004).  Upon infection, antigen loaded dendritic cells 
migrate through the blood from the site of infection and enter the spleen.  These cells activate a 
population of memory B cells found in the marginal zone, resulting in the rapid production of IgM 
antibodies.  The dendritic cells then migrate into the B and T cells zones.  Both CD8+ and CD4+ T 
cells are activated in the T cell zone, with the activated CD8+ T cell leaving the spleen to migrate to 
the site of infection.  The activated CD4+ T cells migrate to the periphery of the T cell zone to help 
activate B cells at the periphery of the B cell follicle.  Thus the spleen is an important immune organ, 
required to co-localize various immune effectors cells to induce an adaptive immune response to 
eliminate pathogen infection. 
In teleosts, the spleen is also composed of red and white pulp, although the white pulp is poorly 
developed (Press and Evensen, 1999).  The white pulp consists of two compartments, the 
melanomacrophage compartment, which is responsible for erythrocyte destruction and the ellipsoid 
compartment, which contains macrophage that are responsible for degrading blood borne pathogens.  
Both of these compartments are capable of retaining antigen, which may allow for the activation of 
lymphocytes attracted from circulation.  The rainbow trout CD83 homologue transcript is detected in 
spleen, indicating that dendritic cells may also be involved in the activation lymphocytes in the teleost 
spleen (Ohta et al, 2004).  Similarly, while T cells have not been identified within the spleen, the 
CD8α and β transcript, as well as the CD4 transcript have been detected in rainbow trout spleen 
(Moore et al, 2005, Laing et al, 2006).  In addition, two populations of Ig-bearing cells have been 
identified in the spleen of rainbow trout, likely representing the B cells (Sanchez et al, 1995).  Thus, it 
appears that the teleost spleen contains the same populations of cells as the mammalian spleen, and is 
likewise capable of activating an adaptive immune response.  The presence of macrophage, B cells, 
and most likely, dendritic cells within the spleen indicates that the invariant chain proteins should also 
be found here.  Furthermore, examination of the spleen-derived macrophage like cell line RTS11 
demonstrates the presence of S25-7 and INVX, at both the transcript and protein level, indicating the 
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presence of antigen presenting macrophage within spleen.  Finally, in this study, northern blot 
analysis indicates that all fish studied expressed both S25-7 and INVX transcript in the spleen tissue.  
However, there was a great variability in the detection of these proteins within the spleen.  Although 
all fish express the invariant chain transcripts, the variation at the protein level indicates that there 
may be a different rate of invariant chain translation or proteolysis within the spleen antigen 
presenting cells between individuals.  Some fish have no detectable invariant chain protein, but this 
may be due to an inability to detect weak signals on a blot with very strong signals.  It is possible that 
a lower intensity band may be detected by a longer exposure time or by increasing the amount of 
primary or secondary antibody.  However, other samples with high signal intensity would be 
supersaturated under these detection conditions and the high intensity signal would overshadow the 
low signal.  It is unclear how the variation in invariant chain protein level may affect antigen 
presentation. 
In teleost fish, the major function of the head kidney is blood cell differentiation, similar to the role 
played by the mammalian bone marrow (Press and Evensen, 1999).  The hematopoietic stem cell 
population of the bone marrow is capable of differentiating into either the common lymphoid 
progenitor, which gives rise to B cells, T cells and NK cells, or the common myeloid progenitor, 
which gives rise to platelets, erythrocytes, monocytes, neutrophils, eosinophils or basophils 
(Kaushansky, 2006).  A complex array of factors control this differentiation pathway to ensure the 
maintenance or up-regulation of specific cell populations.  After differentiation in the bone marrow, 
cells enter the bloodstream and migrate throughout the body to carry out effector functions.   
Immature T cells migrate from the bone marrow to the thymus, where cellular maturation continues 
as positive and negative selection produce a T cell population capable of recognizing self MHC 
dimers but incapable of recognizing self antigens (Janeway et al, 2001).  In teleosts, B cell 
maturation, including negative selection of non-self reactive B cells, occurs entirely within the bone 
marrow.  Once differentiation and selection has occurred, mature B and T cells migrate through the 
bloodstream and the lymphatic system, frequently entering secondary immune tissues, such as the 
spleen or lymph nodes.  As described above, lymphoid cells are activated in these tissues by loaded 
antigen presenting cells and these activated cells then migrate to the site of infection to eliminate 
pathogen.   
In the mammalian immune system, the process of differentiation and negative selection of non-self 
reactive cells occurs in a physically distinct location from the activation of mature cells.  In contrast, 
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both lymphoid differentiation and activation is thought to occur in head kidney (Kaattari and Irwin, 
1985).  However, the absence of invariant chain proteins together with the very low levels of 
transcript indicate that MH class II antigen presentation may not be occurring in this tissue.  
Likewise, although MH class II transcript is detected in the head kidney, it is also present at a lower 
level than spleen or gill (Nath et al, 2006).  Invariant chain and MH class II transcripts may be 
expressed at a low level by differentiating immune cells, but the absence of invariant chain protein 
indicates that no antigen presentation, and thus, no lymphoid activation is occurring within this tissue.    
As a result, it appears that the teleost head kidney may be performing only hematopoietic functions, 
similar to mammalian bone marrow, and the physical separation of differentiation and activation may 
be similar in both mammalian and teleost immune systems.  This separation may be important for 
controlling the factors cell populations are subjected to, as differentiating cells should not be exposed 
to antigen presenting cells and activation cytokines before negative selection removes self-reactive 
cells.    
Neither teleost nor mammalian liver are thought to be involved in the immune response.  Although 
a very low level of invariant chain transcript is detected, it is likely due to circulating leukocytes that 
have entered the liver.  As expected, no invariant chain proteins are detected, which indicates no MH 
class II antigen presentation is occurring in this tissue. 
4.3 Regulation of Invariant Chain During an Immune Response  
The mammalian invariant chain has been shown to be up-regulated at both the transcript and protein 
level in response to IFN-γ treatment in a number of cell types, including macrophage, endothelial 
cells, fibroblasts and keratinocytes (Paulnock-King et al, 1985, Collins et al, 1984, Albanesi et al, 
1998).  This provides indirect evidence for the up-regulation of invariant chain during an immune 
response as IFN-γ is synthesized and secreted from a number of activated immune effector cells, 
including CD8+ and CD4+ T cells as well as natural killer cells (Janeway et al, 2001).  The increased 
invariant chain expression after IFN-γ stimulation is due to an up-regulation of the transcription factor 
CIITA, which increases the transcription rate of the MHC class II and the accessory genes (Ting and 
Zhu, 1999).  In addition, invariant chain is also directly up-regulated by the binding of IFN-γ to the 
IFN responsive element in the invariant chain promoter region (Barr and Saunders, 1991).  This up-
regulation of the MHC class II genes allows for an increased rate of antigen presentation during an 
immune response (Collins et al, 1984). 
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In contrast, the teleost invariant chain homologues were not up-regulated during an immune 
response.  In gill and spleen, the major sites of antigen presentation, there was no change in INVX or 
S25-7 transcript or protein levels, although the up-regulation of the IL-1β transcript demonstrated the 
induction of an immune response.  This may indicate that the teleost invariant chains are 
constitutively expressed at a high level, which would allow for a rapid response to pathogenic 
challenge.  However, this would also require a high expression of MH class II.  Unfortunately, the 
response of MH class II to an artificial immune challenge has not been studied, making it difficult to 
determine the relationship between MH class II and invariant chain expression.  If MH class II 
remains unchanged during an immune response, it is likely that both invariant chain and MH class II 
are expressed at a constitutive level, allowing rapid response to pathogenic challenge, as there is no 
lag time required for the transcription and translation of these genes.  However, if MH class II is up-
regulated, it leads to the question of how a steady level of invariant chain is able to chaperone the 
increasing level of MH class II dimers.  
Two studies have been performed recently in which teleosts were subjected to a live pathogen 
challenge.  Rainbow trout were challenged with the infectious hematopoietic necrosis virus (IHNV) 
and Japanese flounder were challenged with the intracellular bacteria Edwardsiella tarda (Matsuyama 
et al, 2007, Hansen and LePatra, 2002).  In both cases MH class II transcript were significantly 
decreased after infection.  Interestingly, infected Japanese flounder also showed a significant down-
regulation of invariant chain transcript.  The interpretation of these results in terms of the regulation 
of MH class II genes after infection is difficult because these pathogens may have evolved the ability 
to down-regulate MH class II as an immune system evasion mechanism, which may not occur for all 
pathogens.  However, the down-regulation of both invariant chain and MH class II may indicate a co-
regulatory expression pattern between these two genes, as occurs in the mammalian immune system.  
Furthermore, this may provide indirect evidence that both MH class II and the associated invariant 
chains are constitutively expressed in specific immune tissues, and while immune system stimulation 
does not cause an up-regulation of these genes, some pathogens may have evolved the ability to 
down-regulate these genes, likely by interfering with a transcription factor that may be required for 
coordinated expression.   
Furthermore, in this study, the results of IL-1β transcript analysis demonstrate an initial expression 
peak at the 8 hour time point followed by a reduction at the 24 to 48 hour time points with a second 
increase at 120 hours post stimulation. This pattern is also seen in the invariant chain results, although 
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statistical analysis does not show a significant change. When rainbow trout were infected with IHNV, 
the MH class II transcript was decreased at 72 hours post infection but returned to control levels by 
192 hours post infection (Hansen and La Patra, 2002). In addition, exposure to cold temperatures also 
caused a downregulation of MH class II (Nath et al, 2006). When rainbow trout were kept at 2°C for 
5 days, MH class II was downregulated at both the transcript and protein level which was maintained 
after 10 days at the low temperature. Furthermore, incubation of rainbow trout leukocytes with the 
stress hormone cortisol caused a decrease in IL-1β transcript (Zou et al, 2000). The down-regulation 
of IL-1B likely causes an inhibition of the innate immune response, which is seen by a decrease of 
MH class II within innate antigen presenting cells. However, activation of the adaptive immune 
response causes the upregulation of MH class II at the later time points.  Taken together, these results 
indicate that after immune system stimulation, there is a transient down-regulation of IL-1β, MH class 
II and invariant chain, which is overcome at later time points. 
Another major difference between the regulation of teleost and mammalian invariant chain can be 
seen in the comparison of the homologues p41 and S25-7.  In mammals, p33 is constitutively 
expressed, while p41 is induced upon IFN-γ stimulation (Albanesi et al, 1998).  However, not only is 
S25-7 transcript expressed in non-stimulated tissues, it is expressed at a higher level than INVX.  This 
high level of S25-7 expression indicates that it is likely performing the majority of the invariant chain 
functions during an immune response, similar to the up-regulated p41.  The thyroglobulin domain of 
S25-7 likely carries out the same protease inhibition roles as the p41 thyroglobulin domain and this 
inhibition may increase the half life of the MH class II dimer and invariant chain as it travels through 
the endosomal pathway, leading to an increased presentation of antigen at the cell surface.  Although 
S25-7 transcript is present at higher levels than INVX, western blot analysis indicates that both 
appear to be present at the same protein level, which may be due to a different rate of translation 
between the two transcripts.  However, no conclusive comment can be made about the protein levels 
of the two invariant chain isoforms because comparison of western blots is not reliable without an 
internal standard.  To determine conclusively if there is a difference in the protein levels of S25-7 and 
INVX, both need to be detected on the same blot, or an antibody to a housekeeping protein should be 
used to probe both S25-7 and INVX blots, similar to the S11 probe in the northern blots.  
In contrast to results shown in other tissues, S25-7 transcript level in head kidney is significantly 
decreased during immune system activation.  However, since neither INVX nor S25-7 protein is 
detected in head kidney and the transcript is very low to begin with, the purpose of this down-
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regulation is unclear, as no antigen presentation occurs within this tissue.  In addition, RTS11 INVX 
transcript level also decreases after PMA stimulation, although levels return to untreated control 
levels by the last time point analyzed.  The effect of this down-regulation is also unclear because 
there is no corresponding down-regulation at the INVX protein level.  Furthermore, stable S25-7 
transcript and protein levels indicate antigen presentation can still occur.  It is interesting that in these 
two cases of down-regulation, only one invariant chain isoform is affected.  This indicates that 
different factors are responsible for controlling the expression of these two genes.  As described 
above, the promoter regions of MHC class II genes and invariant chain contain some similar elements 
while the invariant chain promoter also has unique elements, allowing for independent expression of 
invariant chain.  A similar situation likely occurs within the promoter regions of S25-7 and INVX, in 
which there are some common elements and some unique elements, giving rise to both coordinated 
and independent regulation of expression.  This is an alternative method of control compared to the 
mammalian invariant chain in which the expression of p33 and p41 is controlled at the post-
transcriptional level by alternative splicing.  In contrast, the separate invariant chain genes in rainbow 
trout are controlled at the transcriptional level by unique promoter elements. 
4.4 The Challenge of Individual Variability 
A major challenge with using animals to study the immune system lies within the variability of gene 
expression between individuals.  In this study, all fish have a different genetic background, resulting 
in variability in the expression level of S25-7 and INVX.  Spleen samples collected from non-
stimulated fish vary from no expression of either invariant chain protein to high expression of both, 
with corrected INVX signals ranging from 1.17 to 10.73 and corrected S25-7 signals ranging from 
1.17 to 34.32.  Furthermore, this same pattern can be seen in the untreated control samples of the 
PMA time course.  In gill western blot analysis, the corrected INVX signal of the untreated control 
samples varies from 1.9 to 9.13, while the time point means vary from 3.95 to 12.46.  Similarly, the 
corrected S25-7 signal of the control samples varies from 3.07 to 20.04, while the time point means 
vary from 8.35 to 15.59.  Finally, the corrected S25-7 transcript signal of untreated controls varies 
from 5.74 to 20.54 while the time point means vary from 7.64 to 12.81.  These results demonstrate 
that the level of protein and transcript varies almost as much, and in some cases more so, within each 
group than between groups.  This makes it difficult to determine if changes across time are due to 
immune system stimulation or simply due to individual variability.  
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There are two possible solutions to the problem of individual variability.  First off, the analysis of 
invariant chain expression could be confined to peripheral blood leukocytes.  In this case, blood 
samples could be collected from the same fish at various time points, allowing an analysis of the 
immune response within one individual over a specific time period after an immune challenge.  In this 
way, even if each individual showed different levels of invariant chain, a general pattern of response 
from each individual over time could demonstrate any changes in expression.  A major problem 
associated with this method of immune system analysis is the stress to the animals from repeated 
sample collections.  Studies of the stress response in rainbow trout demonstrate decreased peripheral 
white blood cells after extended net confinement (Ruane et al, 1999).  Thus, the repeated catch and 
anesthetization of the fish would likely affect the immune system response.  In addition, to analyze 
both protein and transcript level, a significant amount of blood would have to be collected.  This 
would require a long time lapse between each time point and would not allow for the analysis of the 
immune response over a short period of time.   
A second solution to the problem of individual variability would be to utilize cell lines for immune 
system analysis.  This would eliminate the variability in the genetic background, resulting in a 
consistent expression of invariant chain.  Thus, changes in invariant chain expression would be due 
solely to the activation of an immune response.  Furthermore, cell lines are not susceptible to a stress 
response, are easier to maintain and prevent the need to sacrifice live animals.  In addition, since the 
function and regulation of the immune response in teleost is only beginning to be elucidated, cell lines 
will allow for a more simplified analysis of immune effector cell responses.  Once the immune system 
has become more defined, whole animal studies would be useful to understand how the system works 
as a whole in vivo, including how various cells work together and how cells migrate to various sites 
within the animal during an immune response.  However, for the initial studies, it is very difficult to 
understand the basic functions of the immune system in such a complex setting.  
4.5 Future Research 
The results from this study represent a preliminary glimpse at the regulation of invariant chain.  A 
great deal of work is still required for a more complete understanding of teleost invariant chain 
regulation and function.  The regulation of invariant chain expression is likely carried out at a number 
of levels, including post-translational, post-transcriptional and transcriptional.  However, in the 
mammalian immune system, the majority of work has focused on the translational control of invariant 
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chain.  To determine if the teleost invariant chain genes are controlled in a similar manner, it would 
be useful to analyze promoter regions and proteins capable of binding to these regions.  To begin, the 
promoter regions of all invariant chain genes could be cloned and sequenced.  The promoter regions 
of both S25-7 and INVX could be compared to the promoter region of mammalian invariant chain to 
look for conserved regions.  Furthermore, the promoter sequences could be compared between S25-7 
and INVX, as well as with the promoter region of MH class II genes to look for similar sequences, 
which may indicate a co-regulation of these genes.  Once a region of interest has been identified, 
further analysis could be performed to confirm promoter capabilities.  To begin, the putative promoter 
elements could be subjected to gel mobility shift analysis and DNase footprinting to demonstrate the 
ability of protein factors to bind these regions as well as to identify the precise protein binding 
sequences.  Furthermore, reporter assays could be performed to determine the ability of the putative 
promoter region to activate expression of a reporter gene within various cell lines and mutational 
analysis of this promoter region would provide information regarding essential nucleotides required 
for transcription initiation. 
Once the promoter elements have been identified, yeast one-hybrid analysis could be performed to 
identify proteins capable of interacting with these sequences.  In this strategy, a rainbow trout cDNA 
library could be cloned into a vector, upstream of a transcriptional activation domain sequence.  This 
vector would be transfected into cells containing a reporter gene downstream of the invariant chain 
promoter region.  By identifying which clones can activate transcription, the sequence of invariant 
chain transcription factors can be identified.  The functions of these identified factors could then be 
examined in vitro, by knocking out the endogenous protein with siRNA and examining the resulting 
expression of either the invariant chain genes themselves, or the expression of a reporter construct.  In 
addition, a search could be performed for homologous sequences of transcription factors known to be 
involved in mammalian invariant chain expression.  These sequences could be used in yeast one-
hybrid analysis to confirm interaction with the invariant chain promoter region, and could be co-
expressed along with an invariant chain reporter construct to determine if there is an up-regulation of 
reporter gene expression.   
Furthermore, to examine the regulation of invariant chain during an immune response, cell lines 
could be stimulated with a variety of cytokines and the effect on invariant chain expression could be 
analyzed.  The sequences of IFNγ and TNF have recently been cloned from rainbow trout (Zou et al, 
2005, Zou et al, 2003).  These genes could be recombinantly expressed and used to stimulate a cell 
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line to determine the effects on invariant chain expression.  Furthermore, teleost homologous of other 
mammalian cytokines known to be involved in the immune response could be similarly cloned, 
expressed and used to stimulate immune cell lines to examine the effect on invariant chain 
expression.  Finally, immune cell lines could also be exposed to live fish pathogens to determine the 
response of invariant chain.  This would provide a simplified picture of invariant chain regulation 
within specific cell types. 
In addition to understanding the regulatory control of invariant chain expression, an understanding 
of its function within the MH class II antigen presentation pathway is essential.  To begin, the ability 
of invariant chain to bind MH class II dimers could be demonstrated by co-immunoprecipitation of 
either the invariant chain proteins or MH class II.  To determine if invariant chain is capable of 
directing transport of the MH class II dimer, a non-immune cell line could be transfected with an 
expression vector encoding both MH class II α and β chains.  Flow cytometry could be performed to 
determine the amount of MH class II dimers present at the cell surface and subcellular fractionation 
along with western blot analysis could determine the intracellular location of MH class II.  This same 
cell line could then be co-transfected with the invariant chain sequence and the same analysis of MH 
class II localization could be performed.  The results of Ii- and Ii+ cells could then be compared to 
determine if invariant chain has an effect on the MH class II transport path and surface expression. 
A number of mutational studies of the rainbow trout invariant chain would also lead to a more 
complete understanding of the function of these proteins.  Further analysis of the transportation ability 
of invariant chain could be performed by mutating the putative endosomal targeting sequences and 
looking at the intracellular localization of these mutated proteins.  Furthermore, to determine if 
trimerization is important for targeting, the putative trimerization domain could be mutated and the 
intracellular localization of invariant chain could be examined.  The invariant chain lacking the 
trimerization domain could also be expressed along with MH class II to determine the effect on MH 
class II transport.  Finally, the putative CLIP region could also be mutated or deleted and the ability 
of the mutant invariant chain to interact with MH class II could be examined by co-
immunoprecipitation.  This would indicate the exact residues involved in peptide binding groove 
interaction. 
Finally, yeast two-hybrid analysis could be performed to identify proteins capable of interacting 
with invariant chain.  Similar to the yeast one-hybrid, a cDNA library from rainbow trout could be 
cloned upstream of a transcriptional activator while the region of interest from invariant chain could 
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be cloned upstream of a DNA binding domain.  The expression of the reporter gene will indicate 
which cDNA sequences encode proteins capable of interacting with invariant chain.  These sequences 
could then be analyzed for similarity to known mammalian proteins.  This could be performed with 
the thyroglobulin domain, in an attempt to identify an interaction with a protease, similar to the 
interaction of the p41 thyroglobulin domain and cathepsin L.  In addition, the cytosolic region of 
invariant chain could be analyzed for any protein interactions, as it is known to interact with NF-κB 
in the mammalian immune system.  Finally, the macrophage inhibitory factor (MIF) has been 
sequenced from rainbow trout (Jin and Shoa, unpublished).  This could also be used in the yeast two 
hybrid assay with various regions of the invariant chain to identify an interaction between invariant 
chain and MIF.  Furthermore, if an interaction between MIF and invariant chain is shown to occur, 
yeast two hybrid may be used to identify other proteins that invariant chain is capable of interacting 
with to facilitate the MIF signaling cascade within macrophage. 
Lastly, in a step towards DNA vaccination, a modified invariant chain vector could be synthesized 
in which the CLIP region is replaced with a known antigenic peptide.  An immune cell line could be 
transfected with this vector, incubated for a sufficient time to allow expression and processing of the 
invariant chain, after which surface MH class II proteins could be isolated and levels of antigenic 
peptide could be measured.  This could be compared with surface expression of the antigen when 
cells are incubated with the antigenic peptide alone, or transfected with a vector encoding just the 
antigenic peptide.  If the modified invariant chain vector increases surface antigen, it could then be 
used in vivo in combination with vaccines targeting the MH class I antigen presentation pathway to 
analyze the ability of DNA vaccines to elicit a sustained protective immunity against a number of 
different pathogens.   
4.6 Conclusions 
The expression pattern of invariant chain transcript and protein provides insight into the immune 
functions carried out within the various tissues of rainbow trout.  The majority of MH class II antigen 
presentation occurs primarily within the gill and spleen in rainbow trout.  The gill represents a site of 
constant immunosurveillance, as it is a primary site of antigen entry while the spleen functions as a 
secondary immune tissue in which antigen presenting cells can interact with and activate B cells and 
T cells of the adaptive immune response.  The lack of detectable invariant chain protein within the 
head kidney indicates that this tissue is not functioning as a secondary immune tissue.   Furthermore, 
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INVX and S25-7 are differentially regulated at the transcriptional level, allowing for unique control 
of each gene, similar to the use of alternative splicing of mammalian invariant chain to produce either 
p33 or p41.   Finally, these results also indicate that invariant chain expression is not up-regulated 
during an immune system response, in contrast to the up-regulation of the homologous mammalian 
genes.  Thus, it appears that the teleost immune system has evolved a unique method of immune 
system regulation upon pathogenic challenge.       
     
Appendix A 
Figures 
Figure A.1:  Northern blot analysis of S25-7 and INVX transcript levels in PMA stimulated gill, 
additional sets.  Total RNA was isolated from gill tissue, separated and transferred onto a nylon 
membrane.  The membrane was probed for either (A) S25-7 and S11 or (B) INVX and S11.  The 
densitometry analysis of these sets is included in the average S25-7/S11 and INVX/S11 pixel ratio 
shown in figure 3.7.  The blot for S25-7 is a separate membrane from the blot shown in figure 3.7 
while INVX is the bottom half of the same membrane shown in figure 3.7. 
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Figure A.2: Northern blot analysis of S25-7 and INVX transcript levels in PMA stimulated 
spleen, additional sets.  Total RNA was isolated from spleen tissue, separated and transferred onto a 
nylon membrane.  The membrane was probed for either (A) S25-7 and S11 or (B) INVX and S11.  
The densitometry analysis of these sets is included in the average S25-7/S11 and INVX/S11 pixel 
ratio shown in figure 3.9.  The blot for S25-7 is a separate membrane from the blot shown in figure 
3.9A while INVX is the bottom half of the same membrane shown in figure 3.9B. 
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Figure A.3: Northern blot analysis of S25-7 transcript levels in PMA stimulated head kidney, 
additional sets. Total RNA was isolated from head kidney tissue, separated, transferred onto a nylon 
membrane and probed for S25-7 and S11.  The densitometry analysis of these sets is included in the 
average S25-7/S11 pixel ratio shown in figure 3.13.  The blot for S25-7 is a separate membrane from 
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Figure A.4: Northern blot analysis of S25-7 transcript levels in PMA stimulated liver, 
additional sets. Total RNA was isolated from liver tissue, separated, transferred onto a nylon 
membrane and probed for S25-7 and S11.  The densitometry analysis of these sets is included in the 
average S25-7/S11 pixel ratio shown in figure 3.13.  The blot for S25-7 is a separate membrane from 
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Figure A.5: RT-PCR analysis of S25-7 and INVX transcript levels in PMA stimulated PBLs, 
additional sets.  Total RNA was isolated from four sets of PBLs.  This RNA was reverse transcribed 
and amplified for INVX, S25-7 and Ef-1α.  The PCR reactions were performed separately and 
separated on separate 1% agarose gels.  The UV images of the additional PBL sets used for 
































Figure A.6: Western blot analysis of S25-7 and INVX protein levels in PMA stimulated gill, 
additional sets.  Protein was isolated from gill tissue of six sets of fish, although only four sets were 
used for densitometry analysis.  The protein was analyzed by western blotting with either anti-rtINVX 
antibody or anti-rTg antibody, followed by anti-rabbit IgG HRP conjugated antibody.  The additional 







































C 8h 24h 48h 96h 120h 168h
36








Figure A.7: Western blot analysis of S25-7 and INVX protein levels in PMA stimulated spleen, 
additional sets.  Protein was isolated from spleen tissue of six sets of fish, although only four sets 
were used for densitometry analysis.  The protein was analyzed by western blotting with either anti-
rtINVX antibody or anti-rTg antibody, followed by anti-rabbit IgG HRP conjugated antibody.  The 



















































Figure A.8: RT-PCR analysis of S25-7 and INVX transcript levels in PMA stimulated RTS11, 
additional sets.  Total RNA was isolated from three replicates of an RTS11 time course, reverse 
transcribed and amplified for INVX, S25-7 and Ef-1α.  The PCR reactions were performed separately 
and separated on separate 1% agarose gels.  The UV image of the additional RTS11 sets used for 
densitometry analysis in figure 3.20 is shown below. 
 




















Figure A.9: Western blot analysis of S25-7 and INVX protein levels in PMA stimulated RTS11, 
additional sets.  Protein was isolated from three replicates of an RTS11 time course. The protein was 
analyzed by western blotting with either anti-rtINVX antibody or anti-rTg antibody, followed by anti-
rabbit IgG HRP conjugated antibody.  The additional sets used for the S25-7 and INVX densitometry 
analysis shown in figure 3.21 are shown below. 
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Table B.1: Densitometry analysis for RT-PCR analysis of IL-1β transcript level in PMA 
stimulated gill.  The corrected intensity for the IL-1β band as well as the corresponding Ef-1α band 
is listed in the table.  The ratio of IL-1β/Ef-1α for each sample and the average ratio for each time 
point along with the standard deviation of each average are shown. 
 
  Control 8h 24h 48h 96h 120h 168h 
Set 2 IL-1β 1041569 6136599 1722720 0 3399725 5539378 2861160 
 Ef1α 5797194 4537203 4621456 3290412 4153138 4199831 3884870 
 IL/E 0.179668 1.352507 0.372766 0 0.818592 1.318953 0.736488 
         
Set 3 IL-1β 4958159 9041557 10018578 3737134 0 10233636 5716026 
 Ef1α 6266396 5113571 9079721 4927889 4440567 5100691 5169024 
 IL/E 0.79123 1.768149 1.103402 0.758364 0 2.006323 1.105823 
         
 Avg IL/E 0.485 1.560 0.738 0.379 0.409 1.663 0.921 




Table B.2:  Densitometry analysis for RT-PCR analysis of IL-1β transcript level in PMA 
stimulated spleen.  The corrected intensity for the IL-1β band as well as the corresponding Ef-1α 
band is listed in the table.  The ratio of IL-1β/Ef-1α for each sample and the average ratio for each 
time point along with the standard deviation of each average are shown. 
 
  Control 8h 24h 48h 96h 120h 168h 
Set 1 IL-1β 0 0 0 0 1472691 2407652 0 
 Ef1α 5803340 7663336 8106870 6713371 8904626 6801315 3980902 
 IL/E 0 0 0 0 0.165385 0.353998 0 
         
Set 2 IL-1β 0 0 561527.3 0 3122690 203823 0 
 Ef1α 6457439 4706813 6848286 5793612 5929417 8365632 5700087 
 IL/E 0 0 0.081995 0 0.526644 0.024364 0 
         
Set 3 IL-1β 0 0 0 0 4096447 2417998 6184867 
 Ef1α 7267659 14716220 13039309 6029999 4754531 14305411 10692877 
 IL/E 0 0 0 0 0.861588 0.169027 0.57841 
         
 Avg IL/E 0.000 0.000 0.027 0.000 0.518 0.182 0.193 




Table B.3: Densitometry analysis for RT-PCR analysis of IL-1β transcript level in PMA 
stimulated head kidney.  The corrected intensity for the IL-1β band as well as the corresponding Ef-
1α band is listed in the table.  The ratio of IL-1β/Ef-1α for each sample and the average ratio for each 
time point along with the standard deviation of each average are shown. 
 
  Control 8h 24h 48h 96h 120h 168h 
Set 1 IL-1β 0 0 0 307469.5 1334126 2428969 0 
 Ef1α 5475829 7117126 5345413 6700807 6296603 7008797 5548820 
 IL/E 0 0 0 0.045885 0.21188 0.34656 0 
         
Set 2 IL-1β 0 0 0 0 2911309 1713789 0 
 Ef1α 5837247 5838845 6537015 6701408 4313660 5946107 5045697 
 IL/E 0 0 0 0 0.674905 0.28822 0 
         
Set 3 IL-1β 0 0 0 0 0 1857199 3026010 
 Ef1α 5969791 5832765 3886834 4534722 5669924 5987727 4896484 
  0 0 0 0 0 0.310168 0.617996 
         
 Avg IL/E 0 0 0 0.015 0.296 0.315 0.206 





Table B.4 Densitometry analysis for northern blot analysis of S25-7 transcript level in PMA 
stimulated gill.  The corrected intensity for the S25-7 band as well as the corresponding S11 band for 
all samples analyzed is listed in the table.  The ratio of S25-7/S11 for each sample and the average 
ratio for each time point along with the standard deviation of each average are shown. 
 
  Control 8h 24h 48h 96h 120h 168h 
Set 1 S25-7 61074.5 72653 42867 21611 40460 21752 44869.5 
 S11 7051 5694 5174.5 7137 6008 2446 5505 
 S25-7/S11 8.661821 12.75957 8.284279 3.028023 6.734354 8.892886 8.150681 
         
Set 2 S25-7 41506.5 63307 52799 43012 23441.5 25205 19471 
 S11 2020 4529 3390 4417.5 5459.5 3897 5634 
 S25-7/S11 20.54777 13.97814 15.57493 9.736729 4.293708 6.467796 3.455982 
         
Set 3 S25-7 32376 43382 39374 28821 23431.5 23002 40206.5 
 S11 5637 3027 3921.5 3731 5302.5 1279 4141 
 S25-7/S11 5.743481 14.33168 10.04055 7.724739 4.418953 17.98436 9.70937 
         
Set 4 S25-7 36271.5 43646.5 43557.5 47683.5 49542 39769 44724 
 S11 3241.5 6193 5993 5121 6433 4239 5702 
 S25-7/S11 11.18973 7.047715 7.268063 9.311365 7.701228 9.381694 7.843564 
         
Set 5 S25-7 32339 55079.5 51837.5 47380.5 44949.5 38598 22470 
 S11 4373 6443 4666 6337 3207 2278.5 822.5 
 S25-7/S11 7.395152 8.548735 11.10962 7.476803 14.01606 16.94009 27.31915 
         
Set 6 S25-7 40595 28191.5 19998 23980 19591 18353.5 27387.5 
 S11 3194 4511 4774.5 2785.5 2289 1068 1442 
 S25-7/S11 12.70977 6.249501 4.188501 8.608867 8.558759 17.18493 18.99272 
         
 Avg S25-7/S11 11.041 10.486 9.411 7.648 7.621 12.809 12.579 




Table B.5:  Densitometry analysis for northern blot analysis of S25-7 transcript level in PMA 
stimulated spleen.  The corrected intensity for the S25-7 band as well as the corresponding S11 band 
for all samples analyzed is listed in the table.  The ratio of S25-7/S11 for each sample and the average 
ratio for each time point along with the standard deviation of each average are shown 
 
  Control 8h 24h 48h 96h 120h 168h 
Set 1 S25-7 43961 43430 43709 34549 52258 28737 16703 
 S11 6369 6318 9613.5 7300 9753 7593.5 2214.5 
 S25-7/S11 6.902339 6.874011 4.546627 4.73274 5.358146 3.784421 7.54256 
         
Set 2 S25-7 52094 45669 28542 38328 13406 23300 25889.5 
 S11 12460 6545 2836 9946 3424.5 3458 9231 
 S25-7/S11 4.180899 6.977693 10.06417 3.853609 3.914732 6.737999 2.804626 
         
Set 3 S25-7 26394 25363 17234.5 26831 19599 12593 10679 
 S11 6104 2252 2851 3777.5 6500 3173 1899 
 S25-7/S11 4.32405 11.26243 6.045072 7.102846 3.015231 3.968799 5.623486 
         
Set 4 S25-7 63465 29520 20825 25374 24345 31138.5 21148 
 S11 12026 8273.5 5747.2 8223.5 8303 10801.5 5611 
 S25-7/S11 5.277316 3.568018 3.623504 3.085548 2.932073 2.882794 3.769025 
         
Set 5 S25-7 39763 31932 33183 42213 21960 30074.5 31992.43 
 S11 11093.5 6277 8161 9651 12595 8306.5 4758 
 S25-7/S11 3.584351 5.087144 4.066046 4.373951 1.743549 3.620598 6.723924 
         
Set 6 S25-7 44478.5 47451.5 22627 29770.5 23993 12564 20470.5 
 S11 10378 16072 3975 14496.5 4830.5 4758 9739 
 S25-7/S11 4.285845 2.952433 5.692327 2.053634 4.966981 2.640605 2.10191 
         
 Avg S25-7/S11 4.759133 6.120289 5.672958 4.200388 3.655119 3.939203 4.760922 




Table B.6:  Densitometry analysis for northern blot analysis of S25-7 transcript level in PMA 
stimulated head kidney.  The corrected intensity for the S25-7 band as well as the corresponding 
S11 band for all samples analyzed is listed in the table.  The ratio of S25-7/S11 for each sample and 
the average ratio for each time point along with the standard deviation of each average are shown. 
 
  Control 8h 24h 48h 96h 120h 168h 
Set 1 S25-7 56440 65020 34913 48447 46841 28793.5 41564 
 S11 47282 63994.5 37170 35919 46251 36626 28855 
 S/S11 1.193689 1.016025 0.939279 1.348785 1.012756 0.786149 1.440444 
         
Set 2 S25-7 41747.5 30997 43939 26152 15862.1 31129 17192 
 S11 20955.5 24729 24852.5 18913 20521.5 27431.5 18645 
 S/S11 1.992198 1.253468 1.767991 1.382753 0.77295 1.13479 0.92207 
         
Set 3 S25-7 44627.5 47276 27512 33888 34562.5 21194.5 46611 
 S11 21410 21784 33949.22 25069 38290 23090 25521 
 S/S11 2.084423 2.170217 0.810387 1.351789 0.902651 0.917908 1.826378 
         
         
Set 4 S25-7 32908 36568 38977.5 22611 7811.74 10493.5 10151.85 
 S11 18897 23091 22748.5 18682.5 9464 13390.5 10695.5 
 S/S11 1.74144 1.583647 1.71341 1.210277 0.825416 0.783653 0.94917 
         
Set 5 S25-7 15916 25204.5 9059 19593.5 7991.6 10123.29 9850.8 
 S11 13853.5 8134 6819.24 10641 10968 10460.5 10864.91 
 S/S11 1.148879 3.09866 1.328447 1.841321 0.728629 0.967763 0.906662 
         
Set 6 S25-7 17085 29258 10377 4846.5 10027.76 8561.56 4523 
 S11 7032 13258.5 11011.5 13088 13358.41 10086 3956 
 S/S11 2.429608 2.206735 0.942378 0.370301 0.75067 0.848856 1.143327 
         
 Avg S25-7/S11 1.773 2.296 1.328 1.141 0.768 0.867 1.000 




Table B.7:  Densitometry analysis for northern blot analysis of S25-7 transcript level in PMA 
stimulated liver.  The corrected intensity for the S25-7 band as well as the corresponding S11 band is 
listed in the table.  The ratio of S25-7/S11 for each sample and the average ratio for each time point 
along with the standard deviation of each average are shown. 
 
  Control 8h 24h 48h 96h 120h 168h 
Set 1 S25-7 5505 7800.5 5477 4763 6134 3841 5151 
 S11 23454 30630 23047.5 29105 30206 21405 14457 
 S25-7/S11 0.234715 0.254669 0.23764 0.163649 0.203072 0.179444 0.356298 
         
Set 2 S25-7 3418 1492.19 4249.66 5999.5 5429 5397 3538 
 S11 14249 13891 15114 17319.5 15638 16666 11851 
 S25-7/S11 0.239876 0.107421 0.281174 0.346401 0.347167 0.323833 0.29854 
         
Set 3 S25-7 3801 7097 5272 1035 191 0 0 
 S11 9651 20129 27787.5 21756 14563 12669 7555 
 S25-7/S11 0.393845 0.352576 0.189726 0.047573 0.013115 0 0 
         
Set 4 S25-7 3227 675 4148 4128 1205 0 3214 
 S11 14405 13298 34779 34029 29907 15542 19454 
 S25-7/S11 0.224019 0.05076 0.119267 0.121308 0.040292 0 0.16521 
         
Set 5 S25-7 556 5632 4025 3566 1239 235 1280 
 S11 10957 20387 10738 14964 16865 18117 19573 
 S25-7/S11 0.050744 0.276254 0.374837 0.238305 0.073466 0.012971 0.065396 
         
Set 6 S25-7 5810 5737 3146 230 0 245 0 
 S11 25366 24763 34431 18398 10544 13614 12826 
 S25-7/S11 0.229047 0.231676 0.091371 0.012501 0 0.017996 0 
         
 Avg S25-7/S11 0.229 0.212 0.216 0.155 0.113 0.089 0.148 




Table B.8:  Densitometry analysis for northern blot analysis of INVX transcript level in PMA 
stimulated gill.  The corrected intensity for the INVX band as well as the corresponding S11 band for 
all samples analyzed is listed in the table.  The ratio of INVX/S11 for each sample and the average 
ratio for each time point along with the standard deviation of each average are shown. 
 
  Control 8h 24h 48h 96h 120h 168h 
Set 1 INVX 1204619 1638831 529528.1 296334 1215372 219245.2 557717 
 S11 11855273 12487489 11645011 7034147 10660934 1893373 9330635 
 INVX/S11 0.10161 0.131238 0.045473 0.042128 0.114002 0.115796 0.059773 
         
Set 2 INVX 771368.1 1285036 3042473 664216.5 452888 654742 569722.8 
 S11 6999406 9512237 14511253 5235107 7220916 6748375 5630448 
 INVX/S11 0.110205 0.135093 0.209663 0.126877 0.062719 0.097022 0.101186 
         
Set 3 INVX 717184.1 1275896 110517 444225.9 258347.7 329229 375425.1 
 S11 7065818 5361763 7255308 5964688 6501396 6732971 8761975 
 INVX/S11 0.101501 0.237962 0.015233 0.074476 0.039737 0.048898 0.042847 
         
Set 4 INVX 677593.9 912586 197111 575907.3 706737.3 701844 724997.1 
 S11 5401270 11460074 2381253 2861142 9504661 5338081 7780797 
 INVX/S11 0.125451 0.079632 0.082776 0.201286 0.074357 0.131479 0.093178 
         
Set 5 INVX 740814.5 1878443 568190.1 908131 929282 1210419 767834.6 
 S11 8269132 10910129 4892447 11416121 8697078 8989596 9854748 
 INVX/S11 0.089588 0.172174 0.116136 0.079548 0.10685 0.134647 0.077915 
         
 Avg INVX/S11 0.106 0.151 0.094 0.105 0.080 0.106 0.075 




Table B.9:  Densitometry analysis for northern blot analysis of INVX transcript level in PMA 
stimulated spleen.  The corrected intensity for the INVX band as well as the corresponding S11 band 
for all samples analyzed is listed in the table.  The ratio of INVX/S11 for each sample and the average 
ratio for each time point along with the standard deviation of each average are shown. 
 
  Control 8h 24h 48h 96h 120h 168h 
Set 1 INVX 273465.6 52795.43 439351.1 211206.7 451727.1 385434 373378.2 
 S11 3024717 1585574 2148420 1278191 2539613 2287924 671724.5 
 INVX/S11 0.09041 0.033297 0.2045 0.165239 0.177872 0.168465 0.55585 
         
Set 2 INVX 493332.4 998732.1 592692.5 484424.2 198409 92862 1336255 
 S11 2694379 1791979 631457 4045215 1167348 848258 2431870 
 INVX/S11 0.183097 0.557335 0.938611 0.119752 0.169966 0.109474 0.549476 
         
Set 4 INVX 1021822 496612 467719.2 333827.2 349669 338744 407280.4 
 S11 8432063 3433389 1820522 1566684 2878284 4310218 2692440 
 INVX/S11 0.121183 0.144642 0.256915 0.213079 0.121485 0.078591 0.151268 
         
Set 5 INVX 292653.3 464694.7 811953 685070.3 1501092 2322644 1185060 
 S11 4678186 2808366 4123041 1659268 9008377 10076709 5406323 
 INVX/S11 0.062557 0.165468 0.196931 0.412875 0.166633 0.230496 0.219199 
         
Set 6 INVX 1629497 1734091 576889.6 801965 589157.7 652738.7 441268 
 S11 9178445 8017214 1912394 12149083 2105986 2467958 5146212 
 INVX/S11 0.177535 0.216296 0.301658 0.06601 0.279754 0.264485 0.085746 
         
 Avg INVX/S11 0.127 0.223 0.380 0.195 0.183 0.170 0.312 




Table B.10:  Densitometry analysis for RT-PCR analysis of INVX transcript level in PMA 
stimulated gill.  The corrected intensity for the INVX band as well as the corresponding Ef-1α band 
is listed in the table.  The ratio of INVX/Ef-1α for each sample and the average ratio for each time 
point along with the standard deviation of each average are shown. 
 
  Control 8h 24h 48h 96h 120h 168h 
Set 1 INVX 13116842 16183073 6449169 11906954 13063446 13249923 12002006 
 Ef1α 15192460 20324441 11132489 20012399 14014548 18087168 15042363 
 INVX/Ef1α 0.863378 0.796237 0.579311 0.594979 0.932135 0.732559 0.79788 
         
Set 2 INVX 12098262 6888496 5608070 5073344 3610632 6232246 5970277 
 Ef1α 14796640 18253164 17448579 10081381 11728441 16093551 11526772 
 INVX/Ef1α 0.817636 0.377386 0.321406 0.503239 0.307853 0.387251 0.517949 
         
Set 3 INVX 21727546 13491312 11878298 11725531 7557823 11899050 11997952 
 Ef1α 15291788 7838304 12107799 9165555 6572797 10392320 10481147 
 INVX/Ef1α 1.420864 1.721203 0.981045 1.279304 1.149864 1.144985 1.144717 
         
 Avg INVX/Ef1α 1.034 0.965 0.627 0.793 0.797 0.755 0.820 




Table B.11: Densitometry analysis for RT-PCR analysis of INVX transcript level in PMA 
stimulated spleen.  The corrected intensity for the INVX band as well as the corresponding Ef-1α 
band is listed in the table.  The ratio of INVX/Ef-1α for each sample and the average ratio for each 
time point along with the standard deviation of each average are shown. 
 
  Control 8h 24h 48h 96h 120h 168h 
Set 1 INVX 8291045 11384165 6680067 9251647 7635968 6708432 5607507 
 Ef1α 11910936 12973347 12552360 13208541 11301054 9882337 5470997 
 INVX/Ef1α 0.696087 0.877504 0.532176 0.700429 0.675686 0.678831 1.024952 
         
Set 2 INVX 21259805 14326302 12892980 7993317 9452385 11048100 14547544 
 Ef1α 12173121 13258963 17927428 9248247 16724852 23260604 15978297 
 INVX/Ef1α 1.746455 1.080499 0.719176 0.864306 0.56517 0.47497 0.910456 
         
Set 3 INVX 12788665 8347107 6118785 7560332 7050828 4442668 4410610 
 Ef1α 10400920 5275237 4181303 7348156 2516299 3062843 1972916 
 INVX/Ef1α 1.229571 1.582319 1.463368 1.028875 2.802063 1.450504 2.23558 
         
 Avg INVX/Ef1α 1.224 1.180 0.905 0.865 1.348 0.868 1.390 




Table B.12:  Densitometry analysis for RT-PCR analysis of INVX transcript level in PMA 
stimulated head kidney.  The corrected intensity for the INVX band as well as the corresponding Ef-
1α band is listed in the table.  The ratio of INVX/Ef-1α for each sample and the average ratio for each 
time point along with the standard deviation of each average are shown. 
 
  Control 8h 24h 48h 96h 120h 168h 
Set 1 INVX 6381630 6529410 3218100 2725306 3836026 2846703 6094214 
 Ef1α 15380286 22109683 9904066 11469209 19434194 13198850 15866414 
 INVX/Ef1α 0.414923 0.295319 0.324927 0.237619 0.197385 0.215678 0.384095 
         
Set 2 INVX 11131553 12606648 13244145 8500355 10209114 11467859 6659781 
 Ef1α 19642216 20642669 22245028 21813610 16144385 21741552 17472075 
 INVX/Ef1α 0.566716 0.610708 0.595375 0.389681 0.632363 0.527463 0.381167 
         
Set 3 INVX 4480476 6427798 2875314 4384466 3991896 3616002 4765196 
 Ef1α 8438391 8267087 6261917 7055607 7753010 7937105 9888673 
 INVX/Ef1α 0.530963 0.777517 0.459175 0.621416 0.514883 0.455582 0.481884 
         
 Avg INVX/Ef1α 0.504 0.561 0.460 0.416 0.448 0.400 0.416 




Table B.13:  Densitometry analysis for RT-PCR analysis of INVX transcript level in PMA 
stimulated liver.  The corrected intensity for the INVX band as well as the corresponding Ef-1α band 
is listed in the table.  The ratio of INVX/Ef-1α for each sample and the average ratio for each time 
point along with the standard deviation of each average are shown. 
 
  Control 8h 24h 48h 96h 120h 168h 
Set 1 INVX 0 1371603 0 0 0 0 0 
 Ef1α 9859990 12155960 9534139 11071815 8311759 7614829 6688179 
 INVX/Ef1α 0 0.112834 0 0 0 0 0 
         
Set 2 INVX 3045983 3171581 2329545 0 3680165 3347928 4400390 
 Ef1α 14892518 15426960 9552115 12705103 13720983 11820171 9820636 
 INVX/Ef1α 0.204531 0.205587 0.243877 0 0.268214 0.283239 0.448076 
         
Set 3 INVX 2011314 2084362 0 0 0 0 1759364 
 Ef1α 10302934 10149239 5719179 11967671 7355119 11566288 13512202 
 INVX/Ef1α 0.195218 0.205371 0 0 0 0 0.130206 
         
 Avg INVX/Ef1α 0.133 0.175 0.081 0.000 0.089 0.094 0.193 




Table B.14:  Densitometry analysis for RT-PCR analysis of INVX transcript level in PMA 
stimulated PBL.  The corrected intensity for the S25-7, INVX band as well as the corresponding Ef-
1α band is listed in the table.  The ratio of INVX/Ef-1α and S25-7/Ef-1α for each sample and the 
average ratio for each time point along with the standard deviation of each average are shown. 
 
  Control 8h 24h 48h 96h 120h 168h 
Set 1 INVX 12278078 9351550 9238318 11273417 17941586 10957467 14848362 
 S25-7 11340531 10330174 11589962 10937334 12235440 7674857 11250602 
 Ef1α 10965276 5127190 8571023 13692649 7629619 7654858 10949359 
 INVX/Ef1α 1.119724 1.823913 1.077855 0.823319 2.35157 1.43144 1.356094 
 S25-7/Ef1α 1.034222 2.014783 1.352226 0.798774 1.603676 1.002613 1.027512 
Set 3 INVX 26300741 19501419 16318759 3935877 19175590 14611985 19634501 
 S25-7 20741185 16466706 13381386 5784559 12758218 10951208 14647332 
 Ef1α 19469591 14471294 13351444 7801827 14802429 14766547 10296050 
 INVX/Ef1α 1.350863 1.347593 1.222247 0.504482 1.295435 0.989533 1.906994 
 S25-7/Ef1α 1.065312 1.137888 1.002243 0.741436 0.8619 0.741623 1.422617 
Set 4 INVX 16583450 12879603 9348481 7159478 12510489 13794570 20397065 
 S25-7 13975777 10892470 6116648 4652328 9107396 9646095 14666359 
 Ef1α 21553251 8687316 6432383 6889375 8668917 11011757 18428416 
 INVX/Ef1α 0.769418 1.482576 1.453346 1.039206 1.443143 1.252713 1.106827 
 S25-7/Ef1α 0.64843 1.253836 0.950915 0.67529 1.050581 0.875981 0.795856 
Set 6 INVX 17062293 9093226 14032445 19595850 14976805 13561567 18019553 
 S25-7 17400769 13375706 16470058 17444860 11711543 13342670 18773357 
 Ef1α 14057935 12902851 13178686 15856262 10904656 10760257 14039864 
 INVX/Ef1α 1.213713 0.704745 1.064783 1.235843 1.373432 1.260339 1.283456 
 S25-7/Ef1a 1.23779 1.036647 1.24975 1.100187 1.073995 1.239995 1.337147 
         
 Avg INVX/Ef1α 1.113 1.340 1.205 0.901 1.616 1.234 1.413 
 St Dev 0.248 0.468 0.181 0.313 0.494 0.182 0.345 
         
 Avg S25-7/Ef1α 0.996 1.361 1.139 0.829 1.148 0.965 1.146 




Table B.15:  Densitometry analysis for Western blot analysis of S25-7 protein level in PMA 
stimulated gill.  Western blot analysis was performed on four sets of gill tissue.  The S25-7 protein 
migrates as a doublet in western blot analysis, the S25-7_1 and S25-7_2 represent the corrected 
intensity for the upper and lower bands of the doublet.  The corrected intensity of the 50kDa band in 
the ponceau stain is also shown and a ratio of the sum of the S25-7 bands to the 50kDa band is shown 
(Ratio B:P).  Finally, the average S25-7/50kDa for each time point, along with the standard deviation 
for each, is shown at the bottom of the table. 
 
  Control 8h 24h 48h 96h 120h 168h 
Set 1 S25-7_1 6386702 4488196 4799727 13291612 11998297 7440181 11697595 
 S25-7_2 1191134 798508.7 749617.9 2837217 2975654 2413988 4985681 
 Sum 7.58E+06 5.29E+06 5.55E+06 1.61E+07 1.50E+07 9.85E+06 1.67E+07 
 Ponceau 2467418 2164116 2714578 1598280 2314402 2789012 2093072 
 Ratio B:P 3.07 2.44 2.04 10.09 6.47 3.53 7.97 
Set 2 S25-7_1 9260060 14009986 15399030 16251988 14844345 18708859 21887339 
 S25-7_2 1988499 4836461 5257705 4832752 3865585 6892995  
 Sum 1.12E+07 1.88E+07 2.07E+07 2.11E+07 1.87E+07 2.56E+07 2.19E+07 
 Ponceau 2690012 1498625 1474151 1558043 1785011 1313421 1500364 
 Ratio B:P 4.18 12.58 14.01 13.53 10.48 19.49 14.59 
Set 3 S25-7_1 13260819 18850200 20350069 17129269 10387458 17434571 18412618 
 S25-7_2 5259948 9502389 5893817 5526874 2389580 7763188 4094973 
 Sum 1.85E+07 2.84E+07 2.62E+07 2.27E+07 1.28E+07 2.52E+07 2.25E+07 
 Ponceau 3029301 1804044 1249328 2096624 2488209 2170708 949062.9 
 Ratio B:P 6.11387 15.71613 21.00641 10.80601 5.13503 11.60808 23.71560 
Set 4 S25-7_1 23871853 21995830 23781302 25879763 23655739 21653328 20700222 
 S25-7_2 13763031 15135069 20491505 18051913 13533540 11667332 13482271 
 Sum 3.76E+07 3.71E+07 4.43E+07 4.39E+07 3.72E+07 3.33E+07 3.42E+07 
 Ponceau 1877603 2103291 1868034 1792940 1887770 2129252 2126190 
 Ratio B:P 20.0441 17.6537 23.7002 24.5026 19.7001 15.6490 16.0769 
         
 Avg B:P 8.35 12.10 15.19 14.73 10.45 12.57 15.59 




Table B.16:  Densitometry analysis for Western blot analysis of S25-7 protein level in PMA 
stimulated spleen.  Western blot analysis was performed on four sets of spleen tissue.  The S25-7 
protein migrates as a doublet in western blot analysis, the S25-7_1 and S25-7_2 represent the 
corrected intensity for the upper and lower bands of the doublet.  The corrected intensity of the 50kDa 
band in the ponceau stain is also shown and a ratio of the sum of the S25-7 bands to the 50kDa band 
is shown (Ratio B:P).  Finally, the average S25-7/50kDa for each time point, along with the standard 
deviation for each, is shown at the bottom of the table. 
 
  Control 8 24 48 96 120 168 
Set 1 S25-7_1 22112122 24048001 2479184 13674706 6851555 493685.9 3587799 
 S25-7_2 0 0 2014664 2437832 1525796 0 0 
 Sum 22112122 24048001 4493848 16112537 8377351 493685.9 3587799 
 Ponceau 4650990 2294717 1936047 1770045 2394214 2503051 1844504 
 Ratio B:P 4.754283 10.47973 2.321146 9.102896 3.498999 0.197234 1.945129 
Set 2 S25-7_1 1714290 25278513 1120053 2921085 7817702 814809.1 546579.9 
 S25-7_2 2098012 0 0 0 2426091 0 1020179 
 Sum 3812302 25278513 1120053 2921085 10243793 814809.1 1566759 
 Ponceau 1418869 1821340 1216727 814284.9 1471538 1555698 1917999 
 Ratio B:P 2.686859 13.87907 0.920546 3.587302 6.961283 0.523758 0.816872 
Set 3 S25-7_1 2872840 29908581 9686591 16107566 6183260 6404500 15674287 
 S25-7_2 8732133 0 0 11010702 10328789 3157588 0 
 Sum 11604973 29908581 9686591 27118268 16512049 9562088 15674287 
 Ponceau 1890346 1239473 1087962 993271.6 1280840 1159146 1814852 
 Ratio B:P 6.139075 24.13009 8.90343 27.30197 12.89158 8.249255 8.636675 
Set 4 S25-7_1 8200916 2856899 479288.1 2572266 2125340 431540.6 330560.7 
 S25-7_2 0 0 820313.4 0 0 1011062 0 
 Sum 8200916 2856899 1299601 2572266 2125340 1442602 330560.7 
 Ponceau 3428744 3498548 3746557 2193836 1338357 2173468 2216912 
 Ratio B:P 2.391814 0.816596 0.346879 1.172497 1.588022 0.663733 0.149109 
         
 Avg B:P 3.993 12.326 3.123 10.291 6.235 2.408 2.887 




Table B.17:  Densitometry analysis for Western blot analysis of INVX protein level in PMA 
stimulated gill.  Western blot analysis was performed on four sets of gill tissue.  The INVX protein 
migrates as a doublet or triplet in western blot analysis, the INVX_1, INVX_2 and INVX_3 represent 
the corrected intensity for the upper and lower bands of the doublet.  The corrected intensity of the 
50kDa band in the ponceau stain is also shown and a ratio of the sum of the INVX bands to the 
50kDa band is shown (Ratio B:P).  Finally, the average INVX/50kDa for each time point, along with 
the standard deviation for each, is shown at the bottom of the table. 
 
  Control 8h 24h 48h 96h 120h 168h 
Set 1 INVX_1 9471306 4996817 2338256 9159438 7085246 6921288 27284675 
 INVX_2 8434117 8420798 2585998 12611300 9191597 10922038 0 
 INVX_3 0 0 5847380 6647854 0 0 0 
 Sum 1.79E+07 1.34E+07 1.08E+07 2.84E+07 1.63E+07 1.78E+07 2.73E+07 
 Ponceau 1961918 2241406 2194428 1377526 1181006 1437877 1760403 
 Ratio B:P 9.13 5.99 4.91 20.63 13.78 12.41 15.50 
Set 2 INVX_1 4486261 15122744 10091327 8737615 6940461 8655682 3208322 
 INVX_2 2443502 15890664 10451293 6170868 9434778 10344054 2358669 
 INVX_3 0 0 0 0 0 0 4358558 
 Sum 6.93E+06 3.10E+07 2.05E+07 1.49E+07 1.64E+07 1.90E+07 9.93E+06 
 Ponceau 3400280 1621180 1521451 1614725 2259484 1677400 1653446 
 Ratio B:P 2.04 19.13 13.50 9.23 7.25 11.33 6.00 
Set 3 INVX_1 6717621 7464497 10159831 5075980 2148043 4558961 8291831 
 INVX_2 0 15245691 20103534 6560194 1591362 14541643 7066016 
 INVX_3 0 0 0 3562339 0 0 0 
 Sum 6.72E+06 2.27E+07 3.03E+07 1.52E+07 3.74E+06 1.91E+07 1.54E+07 
 Ponceau 2451159 2044603 1753080 2208933 2439674 1859991 988161.5 
 Ratio B:P 2.74 11.11 17.26 6.88 1.53 10.27 15.54 
Set 4 INVX_1 1287535 3496949 5343226 9548070 4178750 4519410 7048133 
 INVX_2 2189280 3370409 6954363 2145323 5728738 6173405 4429439 
 Sum 3.48E+06 6.87E+06 1.23E+07 1.17E+07 9.91E+06 1.07E+07 1.15E+07 
 Ponceau 1829425 1466759 1124086 884165.4 963792.2 703774 896882.2 
 Ratio B:P 1.90 4.68 10.94 13.23 10.28 15.19 12.80 
         
 Avg B:P 3.95 10.23 11.65 12.49 8.21 12.30 12.46 
 St Dev 3.469627 6.551646 5.192471 6.024363 5.191188 2.117833 4.492258 
 
 150 
Table B.18:  Densitometry analysis for Western blot analysis of INVX protein level in PMA 
stimulated spleen.  Western blot analysis was performed on four sets of spleen tissue.  The INVX 
protein migrates as a doublet in western blot analysis, the INVX_1 and INVX_2 represent the 
corrected intensity for the upper and lower bands of the doublet.  The corrected intensity of the 50kDa 
band in the ponceau stain is also shown and a ratio of the sum of the INVX bands to the 50kDa band 
is shown (Ratio B:P).  Finally, the average INVX/50kDa for each time point, along with the standard 
deviation for each, is shown at the bottom of the table. 
 
  Control 8h 24h 48h 96h 120h 168h 
Set 1 INVX_1 13536954 4087483 0 0 0 0 0 
 INVX_2 22898050 8897641 0 0 0 0 0 
 Sum 36435004 12985124 0 0 0 0 0 
 Ponceau 2409076 1304556 1404269 1141416 1737189 1916466 2038584 
 Ratio B:P 15.12406 9.95367 0 0 0 0 0 
Set 2 INVX_1 299699.7 27555258 356043.1 5132668 3164355 2338534 2140404 
 INVX_2 1068210  2121551     
 Sum 1367910 27555258 2477594 5132668 3164355 2338534 2140404 
 Ponceau 1205481 1942968 1097733 1972950 1915756 1395714 1815843 
 Ratio B:P 1.134741 14.18204 2.25701 2.60152 1.651752 1.67551 1.178738 
Set 3 INVX_1 445893.7 17679643 3300255 17678632 8437821 265369.5 574745.6 
 INVX_2 2499743     3364231 3256492 
 Sum 2945637 17679643 3300255 17678632 8437821 3629601 3831237 
 Ponceau 2772355 1239245 1578284 1493492 1693972 2312441 2666162 
 Ratio B:P 1.062503 14.26646 2.09104 11.83711 4.981086 1.569597 1.436986 
Set 4 INVX_1 1525862 182149.3 0 180572.8 233074 0 258051.2 
 INVX_2 2717058 747182.4 0 0 568776.8 0 0 
 Sum 4242920 929331.7 0 180572.8 801850.7 0 258051.2 
 Ponceau 2553576 2120536 2476337 2576459 1960165 2236291 2385560 
 Ratio B:P 1.66156 0.438253 0 0.070086 0.409073 0 0.108172 
         
 Avg B:P 4.746 9.710 1.087 3.627 1.760 0.811 0.681 




Table B.19:  Densitometry analysis for RT-PCR analysis of INVX transcript level in PMA 
stimulated RTS11.  The corrected intensity for the S25-7, INVX band as well as the corresponding 
Ef-1α band is listed in the table.  The ratio of INVX/Ef-1α and S25-7/Ef-1α for each sample and the 
average ratio for each time point along with the standard deviation of each average are shown. 
 
  Control 8h 24h 48h 96h 120h 168h 
Set 1 INVX 19025806 12629827 10643073 4544289 8430951 11365087 11418943 
 S25-7 17142471 15714796 15170387 9301579 13548318 19139384 14120886 
 Ef1α 13812667 10780858 10318873 8493475 10159106 10790358 11635673 
 INVX/Ef1α 1.377417 1.171505 1.031418 0.535033 0.829891 1.053263 0.981374 
 S25-7/Ef1α 1.241069 1.457657 1.470159 1.095144 1.333613 1.773749 1.213586 
         
Set 2 INVX 17587749 11016102 5463220 4364767 2318306 6823268 6015167 
 S25-7 26008558 21364800 19572850 13264714 10754900 23338325 16997931 
 Ef1α 13480148 13001302 9123052 11500540 6525857 11214839 8943512 
 INVX/Ef1α 1.304715 0.847308 0.598837 0.379527 0.355249 0.608414 0.672573 
 S25-7/Ef1α 1.929397 1.643282 2.145428 1.153399 1.648044 2.081022 1.900588 
         
Set 3 INVX 10737345 10797999 11582737 8702796 5839413 7718583 10758916 
 S25-7 11070283 10865791 11698725 9537938 6781220 7661509 8779635 
 Ef1α 9209861 10529102 11234584 13396560 8857660 8899872 7363618 
 INVX/Ef1α 1.165853 1.025538 1.030989 0.649629 0.65925 0.867269 1.461091 
 S25-7/Ef1α 1.202003 1.031977 1.041314 0.711969 0.765577 0.860856 1.192299 
         
 Avg INVX/Ef1 α 1.282662 1.014784 0.887081 0.521396 0.614797 0.842982 1.038346 
 St Dev 0.107492 0.162366 0.249627 0.135566 0.240423 0.223417 0.397334 
         
 Avg S25-7/Ef1 α 1.457 1.378 1.552 0.987 1.249 1.572 1.435 




Table B.20:  Densitometry analysis for Western blot analysis of INVX protein level in PMA 
stimulated RTS11.  Western blot analysis was performed on three sets of RTS11.  The INVX protein 
migrates as a doublet in western blot analysis, the INVX_1 and INVX_2 represent the corrected 
intensity for the upper and lower bands of the doublet.  The corrected intensity of the 50kDa band in 
the ponceau stain is also shown and a ratio of the sum of the INVX bands to the 50kDa band is shown 
(Ratio B:P).  Finally, the average INVX/50kDa for each time point, along with the standard deviation 
for each, is shown at the bottom of the table. 
 
  Control 8h 24h 48h 96h 120h 168h 
Set 1 INVX_1 2379098 2572181 2040546 1871130 1250120 1706647 2064766 
 INVX_2 546077 484072.5 291863.7 72261.5 113586.2 195750.7 290506.7 
 Sum 2.93E+06 3.06E+06 2.33E+06 1.94E+06 1.36E+06 1.90E+06 2.36E+06 
 Ponceau 926967.4 786292.4 815338.2 1130766 1350114 1756150 2520134 
 Ratio B:P 3.16 3.89 2.86 1.72 1.01 1.08 0.93 
         
Set 2 INVX_1 825548.1 1503690 714245.1 633566.2 488568.6 316896 678139.9 
 INVX_2 4033154 4277444 3090600 2789332 2483171 1353963 2169293 
 Sum 4.86E+06 5.78E+06 3.80E+06 3.42E+06 2.97E+06 1.67E+06 2.85E+06 
 Ponceau 1017589 963264.5 920492.5 792174 684125.8 245834.2 1013756 
 Ratio B:P 4.77 6.00 4.13 4.32 4.34 6.80 2.81 
         
Set 3 INVX_1 575826.3 901168.7 639342.5 921060.3 761760 846205.7 1279946 
 INVX_2 1861621 1491867 998765.5 2529228 3373179 4497368 5008831 
 Sum 2.44E+06 2.39E+06 1.64E+06 3.45E+06 4.13E+06 5.34E+06 6.29E+06 
 Ponceau 1164852 1758672 1246990 1784311 1139539 1005240 1617337 
 Ratio B:P 2.09 1.36 1.31 1.93 3.63 5.32 3.89 
         
 Avg B:P 3.34 3.75 2.77 2.66 2.99 4.40 2.54 
 St Dev 1.35068 2.323489 1.412139 1.444338 1.755108 2.965073 1.494595 
 
 153 
Table B.21:  Densitometry analysis for Western blot analysis of S25-7 protein level in PMA 
stimulated RTS11.  Western blot analysis was performed on two sets of RTS11.  The S25-7 protein 
migrates as a doublet in western blot analysis, the S25-7_1 and S25-7_2 represent the corrected 
intensity for the upper and lower bands of the doublet.  The corrected intensity of the 50kDa band in 
the ponceau stain is also shown and a ratio of the sum of the INVX bands to the 50kDa band is shown 
(Ratio B:P).  Finally, the average S25-7/50kDa for each time point, along with the standard deviation 
for each, is shown at the bottom of the table. 
 
  Control 8h 24h 48h 96h 120h 168h 
Set 2  S25-7_1 14941285 9537447 12904742 10768662 11147291 9286578 5654822 
 S25-7_2 15020643 8335006 9794905 5658449 7282035 4618839 6685085 
 Sum 3.00E+07 1.79E+07 2.27E+07 1.64E+07 1.84E+07 1.39E+07 1.23E+07 
 Ponceau 865618.3 643905 1171181 911384.7 826288.7 818345.9 992787.9 
 Ratio B:P 34.61 27.76 19.38 18.02 22.30 16.99 12.43 
         
Set 3 S25-7_1 9399268 9878345 5401350 3649803 4523715 1640100 2776325 
 S25-7_2 9843977 7840849 5043136 1415580 1524985 2366564 3967253 
 Sum 1.92E+07 1.77E+07 1.04E+07 5.07E+06 6.05E+06 4.01E+06 6.74E+06 
 Ponceau 882759.9 699817.8 1076706 1572068 828083.6 1287304 680817.8 
 Ratio B:P 21.80 25.32 9.70 3.22 7.30 3.11 9.91 
         
 Avg B:P 28.21 26.54 14.54 10.62 14.80 10.05 11.17 
 St Dev 9.06 1.72 6.85 10.47 10.61 9.81 1.79 
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